Document:

exv4w3

 

Exhibit 4.3

Execution Copy

REGISTRATION RIGHTS AGREEMENT

Dated as of December 20, 2006

by and among

UCI Holdco, Inc.

as the Company

and

Lehman Brothers Inc.

and

Goldman, Sachs & Co.

as the Initial Purchasers

 

 

          This Registration Rights Agreement (this “Agreement”) is dated as of December 20, 2006, by and
between UCI Holdco, Inc., a Delaware corporation (the “Company”) and Lehman Brothers Inc. and
Goldman, Sachs & Co. (each an “Initial Purchaser” and, collectively, the “Initial Purchasers”),
each of whom has agreed to purchase the Company’s Floating Rate Senior PIK Notes due 2013 (the
“Notes”) pursuant to the Purchase Agreement (as defined below).

          This Agreement is made pursuant to the Purchase Agreement, dated December 15, 2006 (the
“Purchase Agreement”), by and between the Company and the Initial Purchasers. In order to induce
the Initial Purchasers to purchase the Notes, the Company has agreed to provide the registration
rights set forth in this Agreement. The execution and delivery of this Agreement is a condition to
the obligations of the Initial Purchasers set forth in Section 7 of the Purchase Agreement.
Capitalized terms used herein and not otherwise defined shall have the meanings assigned to them in
the Indenture, dated the date hereof (the “Indenture”), between the Company and Wells Fargo Bank,
National Association, as trustee (the “Trustee”), relating to the Notes and the Exchange Notes (as
defined below).

          The parties hereby agree as follows:

SECTION 1. DEFINITIONS

          As used in this Agreement, the following capitalized terms shall have the following meanings:

          Act: The U.S. Securities Act of 1933, as amended.

          Additional Interest: As defined in Section 5 hereof.

          Affiliate: As defined in Rule 144 of the Act.

          Broker-Dealer: Any broker or dealer registered under the Exchange Act.

          Business Day: Any day other than a Saturday, a Sunday or a day on which banking institutions
in the City of New York are authorized or obligated by law, regulation or executive order to remain
closed. If the time to perform any action hereunder falls on a day that is not a Business Day,
such time will be extended to the next Business Day and no Additional Interest shall accrue on such
payment for the intervening period.

          Certificated Securities: Definitive Notes, as defined in the Indenture.

          Closing Date: The date of this Agreement.

          Commission: The U.S. Securities and Exchange Commission.

          Consummate: An Exchange Offer shall be deemed “Consummated” for purposes of this Agreement
upon the occurrence of (a) the filing and effectiveness under the Act of the Exchange Offer
Registration Statement relating to the Exchange Notes to be issued in the Exchange Offer, (b) the
maintenance of such Exchange Offer Registration Statement

 

2

continuously effective and the keeping of the Exchange Offer open for a period not less than
the period required pursuant to Section 3(b) hereof and (c) the delivery by the Company to the
Registrar under the Indenture of Exchange Notes in the same aggregate principal amount as the
aggregate principal amount of Notes tendered by Holders thereof pursuant to the Exchange Offer.

          Consummation Deadline: As defined in Section 3(a) hereof.

          Exchange Act: The U.S. Securities Exchange Act of 1934.

          Exchange Notes: The Company’s Floating Rate Senior PIK Notes due 2013, registered under the
Act, to be issued pursuant to the Indenture (a) in the Exchange Offer or (b) as contemplated by
Section 4 hereof.

          Exchange Offer: The exchange and issuance by the Company of a principal amount of Exchange
Notes (which shall be registered pursuant to the Exchange Offer Registration Statement) equal to
the outstanding principal amount of Notes that are tendered by such Holders in connection with such
exchange and issuance.

          Exchange Offer Registration Statement: The Registration Statement relating to the Exchange
Offer, including the related Prospectus.

          Exempt Resales: The transactions in which the Initial Purchasers propose to sell the Notes to
certain “qualified institutional buyers,” as such term is defined in Rule 144A under the Act, and
certain persons who are not U.S. Persons (as defined in Regulation S) in offshore transactions
pursuant to Regulation S under the Act.

          Free Writing Prospectus: Each free writing prospectus (as defined in Rule 405 under the
Securities Act) prepared by or on behalf of the Company or used or referred to by the Company in
connection with the sale of the Notes or the Exchange Notes.

          Holders: As defined in Section 2 hereof.

          Interest Payment Date: As defined in the Notes and the Exchange Notes.

          Person: As defined in the Indenture.

          Prospectus: The prospectus included in a Registration Statement at the time such Registration
Statement is declared effective, as amended or supplemented by any prospectus supplement and by all
other amendments thereto, including post-effective amendments, and all material incorporated by
reference into such Prospectus.

          Recommencement Date: As defined in Section 6(e) hereof.

          Registration Default: As defined in Section 5 hereof.

          Registration Period: As defined in Section 3(c) hereof.

 

3

          Registration Statement: Any registration statement of the Company relating to (a) an offering
of Exchange Notes and any related Subsidiary Guarantees pursuant to an Exchange Offer or (b) the
registration for resale of Transfer Restricted Securities pursuant to the Shelf Registration
Statement, in each case (i) that is filed pursuant to the provisions of this Agreement and (ii)
including the Prospectus included therein, all amendments and supplements thereto (including
post-effective amendments) and all exhibits and material incorporated by reference therein.

          Regulation S: Regulation S promulgated under the Act.

          Rule 144: Rule 144 promulgated under the Act.

          Shelf Effectiveness Deadline: As defined in Section 4(a) hereof.

          Shelf Registration Statement: As defined in Section 4(a) hereof.

          Shelf Period: As defined in Section 4(a) hereof.

          Subsidiary Guarantees: Guarantees of the Notes and Exchange Notes by Guarantors under the
Indenture, as amended from time to time.

          Suspension Notice: As defined in Section 6(e) hereof.

          TIA: The U.S. Trust Indenture Act of 1939 (15 U.S.C. Section 77aaa-77bbbb) as amended, or
any successor statute and the rules and regulations promulgated thereunder.

          Transfer Restricted Securities: (a) Each Note (including additional PIK Notes) and any
related Subsidiary Guarantees, until the earliest to occur of (i) the date on which such Note has
been exchanged by a Person other than a Broker-Dealer for an Exchange Note in the Exchange Offer
and entitled to be resold to the public by such Person without complying with the prospectus
delivery requirements of the Act, (ii) the date on which such Note has been effectively registered
under the Act and disposed of in accordance with the Shelf Registration Statement, or (iii) the
date on which such Note is eligible to be distributed to the public pursuant to Rule 144(k) under
the Act, and (b) each Exchange Note and any related Subsidiary Guarantees acquired by a
Broker-Dealer in the Exchange Offer of a Note for such Exchange Note, until the date on which such
Exchange Note is sold to a purchaser who receives from such Broker-Dealer on or prior to the date
of such sale a copy of the Prospectus contained in the Exchange Offer Registration Statement.

SECTION 2. HOLDERS

          A Person is deemed to be a holder of Transfer Restricted Securities (each, a “Holder”)
whenever such Person owns Transfer Restricted Securities.

SECTION 3. REGISTERED EXCHANGE OFFER

          (a) Unless the Exchange Offer shall not be permitted by applicable federal law or Commission
policy (after the procedures set forth in Section 6(a)(i) below have been

 

4

complied with), the Company shall (i) cause the Exchange Offer Registration Statement to be
filed with the Commission, (ii) use its reasonable best efforts to cause such Exchange Offer
Registration Statement to become effective, (iii) in connection with the foregoing, (A) file all
pre-effective amendments to such Exchange Offer Registration Statement as may be necessary in order
to cause it to become effective, (B) file, if applicable, a post-effective amendment to such
Exchange Offer Registration Statement pursuant to Rule 430A under the Act and (C) cause all
necessary filings, if any, in connection with the registration and qualification of the Exchange
Notes to be made under the Blue Sky laws of such jurisdictions as are necessary to permit
Consummation of the Exchange Offer and (iv) commence and use its reasonable best efforts to
Consummate the Exchange Offer on or prior to the date that is 420 days after the Closing Date (the
“Consummation Deadline”). The Exchange Offer shall be on the appropriate form permitting (I)
registration of the Exchange Notes to be offered in exchange for the Transfer Restricted Securities
and (II) resales of Exchange Notes by Broker-Dealers that tendered into the Exchange Offer Notes
that such Broker-Dealers acquired for their own account as a result of market-making activities or
other trading activities (other than Notes acquired directly from the Company or any its
Affiliates) as contemplated by Section 3(c) below.

          (b) The Company shall use its reasonable best efforts to cause the Exchange Offer Registration
Statement to be effective continuously, and shall keep the Exchange Offer open for a period of not
less than the minimum period required under applicable federal and state securities laws to
Consummate the Exchange Offer; provided, however, that in no event shall such period be less than
20 Business Days. The Company shall cause the Exchange Offer to comply with all applicable federal
and state securities laws. No securities other than the Exchange Notes shall be included in the
Exchange Offer Registration Statement.

          (c) The Company shall include a “Plan of Distribution” section in the Prospectus contained in
the Exchange Offer Registration Statement and indicate therein that any Broker-Dealer who holds
Transfer Restricted Securities that were acquired for the account of such Broker-Dealer as a result
of market-making activities or other trading activities (other than Notes acquired directly from
the Company or any Affiliate of the Company), may exchange such Transfer Restricted Securities
pursuant to the Exchange Offer. Such “Plan of Distribution” section shall also contain all other
information with respect to such sales by such Broker-Dealers that the Commission may require in
order to permit such sales pursuant thereto, but such “Plan of Distribution” shall not name any
such Broker-Dealer or disclose the amount of Transfer Restricted Securities held by any such
Broker-Dealer, except to the extent required by the Commission as a result of a change in policy,
rules or regulations after the date of this Agreement. See the Shearman & Sterling
no-action letter dated July 2, 1993.

          Because such Broker-Dealer may be deemed to be an “underwriter” within the meaning of the Act
and must, therefore, deliver a prospectus meeting the requirements of the Act in connection with
its initial sale of any Exchange Notes received by such Broker-Dealer in the Exchange Offer, the
Company shall permit the use of the Prospectus contained in the Exchange Offer Registration
Statement by such Broker-Dealer to satisfy such prospectus delivery requirement. To the extent
necessary to ensure that the Prospectus contained in the Exchange Offer Registration Statement is
available for sales of Exchange Notes by Broker-Dealers, the Company agrees to use its reasonable
best efforts to keep the Exchange Offer Registration Statement continuously effective,
supplemented, amended and current as required by and subject

 

5

to the provisions of Sections 6(a) and 6(c) hereof and in conformity with the requirements of
this Agreement, the Act and the policies, rules and regulations of the Commission as announced from
time to time, for a period of one year from the date on which the Exchange Offer Registration
Statement is declared effective or such shorter period as will terminate when all Transfer
Restricted Securities covered by such Registration Statement have been sold pursuant thereto (the
“Registration Period”). The Company shall provide sufficient copies of the latest version of such
Prospectus to such Broker-Dealers, promptly upon request at any time during such one-year period in
order to facilitate resales.

SECTION 4. SHELF REGISTRATION

          (a) Shelf Registration. If (i) the Exchange Offer is not permitted by applicable law
or Commission policy (after the Company has complied with the procedures set forth in Section
6(a)(i) hereof) or (ii) if any Holder of Transfer Restricted Securities shall notify the Company
prior to the 20th Business Day following the Consummation of the Exchange Offer that (A) such
Holder was prohibited by applicable law or Commission policy from participating in the Exchange
Offer or (B) such Holder may not resell the Exchange Notes acquired by it in the Exchange Offer to
the public without delivering a prospectus and the Prospectus contained in the Exchange Offer
Registration Statement is not appropriate or available for such resales by such Holder or (C) such
Holder is a Broker-Dealer and holds Notes acquired directly from the Company or any of its
Affiliates, then the Company shall use its reasonable best efforts to:

          (I) cause to be filed a shelf registration statement pursuant to Rule 415 under the Act (which
may be an amendment to the Exchange Offer Registration Statement (the “Shelf Registration
Statement”)), relating to all Transfer Restricted Securities; and

          (II) cause such Shelf Registration Statement to become effective at the earliest possible
time, but in no event later than on or prior to the date that is 420 days after the Closing Date
(such later date, the “Shelf Effectiveness Deadline”).

          If, after the Company has filed an Exchange Offer Registration Statement that satisfies the
requirements of Section 3(a) above, the Company is required to file and make effective a Shelf
Registration Statement solely because the Exchange Offer is not permitted under applicable federal
law or Commission policy (i.e., clause (a)(i) of this Section), then the filing of the Exchange
Offer Registration Statement shall be deemed to satisfy the requirements of clause (I) above;
provided that, in such event, the Company shall remain obligated to meet the Shelf Effectiveness
Deadline set forth in clause (II) above.

          To the extent necessary to ensure that the Shelf Registration Statement is available for sales
of Transfer Restricted Securities by the Holders thereof entitled to the benefit of this Section
4(a) and the other securities required to be registered therein pursuant to Section 6(b)(ii)
hereof, the Company shall use its reasonable best efforts to keep any Shelf Registration Statement
required by this Section 4(a) continuously effective, supplemented, amended and current as required
by and subject to the provisions of Sections 6(b) hereof and 6(c) hereof and in conformity with the
requirements of this Agreement, the Act and the policies, rules and regulations of the Commission
as announced from time to time, for a period of at least two years (as extended pursuant to Section
6(c)(i)hereof) following the Closing Date, or such shorter

 

6

period as will terminate when all Transfer Restricted Securities covered by such Shelf
Registration Statement have been sold pursuant thereto (the “Shelf Period”).

          (b) Provision by Holders of Certain Information in Connection with the Shelf Registration
Statement. No Holder of Transfer Restricted Securities may include any of its Transfer
Restricted Securities in any Shelf Registration Statement pursuant to this Agreement unless and
until such Holder furnishes to the Company in writing, within 20 days after receipt of a request
therefor, such information as the Company may reasonably request in connection with any Shelf
Registration Statement or Prospectus or preliminary Prospectus included therein, including, but not
limited to, the information specified in Item 507 or 508 of Regulation S-K, as applicable, of the
Act for use in connection with any Shelf Registration Statement or Prospectus or preliminary
Prospectus included therein. No Holder of Transfer Restricted Securities shall be entitled to
Additional Interest pursuant to Section 5 hereof unless and until such Holder shall have provided
all such information. By its acceptance of Transfer Restricted Securities, each Holder agrees to
promptly furnish additional information required to be disclosed in order to make the information
previously furnished to the Company by such Holder not materially misleading.

SECTION 5. ADDITIONAL INTEREST

          If (a) the Exchange Offer has not been Consummated on or prior to the Consummation Deadline,
(b) the Shelf Registration Statement has not been declared effective by the Commission on or prior
to the Shelf Effectiveness Deadline or (c) any Registration Statement required by this Agreement is
filed and declared effective but shall thereafter cease to be effective or fail to be usable for
its intended purpose, during the Registration Period or Shelf Period, as applicable, without being
succeeded within two Business Days by a post-effective amendment to such Registration Statement
that cures such failure and that is itself declared effective within five Business Days of filing
such post-effective amendment to such Registration Statement (each such event referred to in
clauses (a) through (d), a “Registration Default”; except as permitted in paragraph (b), such
period of time during which any such Registration Statement is not effective or any such
Registration Statement or the related Prospectus is not usable being referred to as a “Blackout
Period”), then the Company hereby agrees to pay to each Holder of Transfer Restricted Securities
affected thereby Additional Interest in an amount equal to $.05 per week per $1,000 in principal
amount of Transfer Restricted Securities held by such Holder for the first 90-day period
immediately following the occurrence of such Registration Default. The amount of the Additional
Interest shall increase by an additional $.05 per week per $1,000 in principal amount of Transfer
Restricted Securities with respect to each subsequent 90-day period until all Registration Defaults
have been cured, up to a maximum amount of Additional Interest of $.50 per week per $1,000 in
principal amount of Transfer Restricted Securities; provided that the Company shall in no event be
required to pay Additional Interest for more than one Registration Default at any given time.
Notwithstanding anything to the contrary set forth herein, (i) upon filing of the Exchange Offer
Registration Statement (and/or, if applicable, the Shelf Registration Statement), in the case of
clause (a) above, (ii) upon the effectiveness of the Exchange Offer Registration Statement (and/or,
if applicable, the Shelf Registration Statement), in the case of clause (b) above, (iii) upon
Consummation of the Exchange Offer, in the case of clause (c) above, or (iv) upon the filing of a
post-effective amendment to the Registration Statement or an additional Registration Statement that
causes the

 

7

Exchange Offer Registration Statement (and/or, if applicable, the Shelf Registration
Statement) to again be declared effective or made usable, in the case of clause (d) above, the
Additional Interest payable with respect to the Transfer Restricted Securities as a result of such
clause (a), (b), (c) or (d), as applicable, shall cease on the date of such cure and the interest
rate on such Transfer Restricted Securities will revert to the interest rate on such Transfer
Restricted Securities prior to the applicable Registration Default.

          A Registration Default referred to in clause (d) above shall be deemed not to have occurred
and be continuing in respect of a Registration Statement or the related Prospectus if (A) the
Blackout Period has occurred solely as a result of (x) the filing of a post-effective amendment to
such Registration Statement to incorporate annual audited financial information with respect to the
Company where such post-effective amendment is not yet effective and needs to be declared effective
to permit Holders to use the related Prospectus or (y) the occurrence of other material events with
respect to the Company that would need to be described in such Registration Statement or the
related Prospectus and (B) in the case of clause (y), the Company is proceeding promptly and in
good faith to amend or supplement (including by way of filing documents under the Exchange Act
which are incorporated by reference into the Registration Statement) such Registration Statement
and the related Prospectus to describe such events; provided, however, that in the event a Blackout
Period occurs for a continuous period in excess of 30 days, a Registration Default shall be deemed
to have occurred on the 31st day of such Blackout Period and Additional Interest shall be payable
in accordance with the above paragraph from the day such Registration Default occurs until such
Registration Default is cured or until the Company is no longer required pursuant to this Agreement
to keep such Registration Statement effective or such Registration Statement or the related
Prospectus usable; provided, further, that in no event shall the total of all Blackout Periods
exceed 45 days in the aggregate for any 12-month period.

          All accrued Additional Interest shall be paid to the Holders entitled thereto, in the manner
provided for the payment of interest in the Indenture, on each Interest Payment Date, as more fully
set forth in the Indenture and the Notes and the Exchange Notes. Notwithstanding the fact that any
securities for which Additional Interest are due cease to be Transfer Restricted Securities, all
obligations of the Company to pay Additional Interest with respect to securities shall survive
until such time as such obligations with respect to such securities shall have been satisfied in
full.

          A Holder of Notes or Exchange Notes who is not entitled to the benefits of a Shelf
Registration Statement shall not be entitled to Additional Interest with respect to a Registration
Default that pertains to such Shelf Registration Statement.

SECTION 6. REGISTRATION PROCEDURES

          (a) Exchange Offer Registration Statement. In connection with the Exchange Offer, the
Company shall (i) comply with all applicable provisions of Section 6(c) below, (ii) use its
reasonable best efforts to effect such exchange and to permit the resale of Exchange Notes by any
Broker-Dealer that tendered Notes in the Exchange Offer that such Broker-Dealer acquired for its
own account as a result of its market making activities or other trading activities (other than
Notes acquired directly from the Company or any of its Affiliates) being sold in accordance

 

8

with the intended method or methods of distribution thereof, and (iii) comply with all of the
following provisions:

      (A) If, following the date hereof there has been announced a change in Commission
policy with respect to exchange offers such as the Exchange Offer, that in the reasonable
opinion of counsel to the Company raises a question as to whether the Exchange Offer is
permitted by applicable federal law, the Company hereby agrees to seek a no-action letter or
other favorable decision from the Commission allowing the Company to Consummate an Exchange
Offer for such Transfer Restricted Securities. the Company hereby agrees to pursue the
issuance of such a decision to the Commission staff level, but shall not be required to take
commercially unreasonable action to effect a change of Commission policy. Notwithstanding
the foregoing, the Company hereby agrees to take all such other actions as may be requested
by the Commission or otherwise required in connection with the issuance of such decision,
including without limitation (I) participating in telephonic conferences with the Commission
staff, (II) delivering to the Commission staff an analysis prepared by counsel to the
Company setting forth the legal bases, if any, upon which such counsel has concluded that
such an Exchange Offer should be permitted and (III) diligently pursuing a resolution (which
need not be favorable) by the Commission staff.

      (B) As a condition to its participation in the Exchange Offer, each Holder of Transfer
Restricted Securities (including, without limitation, any Holder who is a Broker-Dealer)
shall furnish, upon the request of the Company, prior to the Consummation of the Exchange
Offer, a written representation to the Company (which may be contained in the letter of
transmittal contemplated by the Exchange Offer Registration Statement) to the effect that
(I) it is not an Affiliate of the Company, (II) it is not engaged in, and does not intend to
engage in, and has no arrangement or understanding with any Person to participate in, a
distribution of the Exchange Notes to be issued in the Exchange Offer, (III) it is acquiring
the Exchange Notes in its ordinary course of business and (IV) if such Holder is a
Broker-Dealer, that it will receive Exchange Notes for its own account in exchange for Notes
that were acquired as a result of market-making activities or other trading activities and
that it will deliver a Prospectus in connection with any resale of such Exchange Notes. As
a condition to its participation in the Exchange offer, each Holder shall be required to
make such other representations as may be reasonably necessary under applicable Commission
rules, regulations or interpretations to render the use of Form S-4 or another appropriate
form under the Act available and will be required to agree to comply with their agreements
and covenants set forth in this Agreement. Each Holder using the Exchange Offer to
participate in a distribution of the Exchange Notes will be required to acknowledge and
agree that, if the resales are of Exchange Notes obtained by such Holder in exchange for
Notes acquired directly from the Company or an Affiliate thereof, it (1) could not, under
Commission policy as in effect on the date of this Agreement, rely on the position of the
Commission enunciated in Morgan Stanley and Co., Inc. (available June 5, 1991) and
Exxon Capital Holdings Corporation (available May 13, 1988), as interpreted in the
Commission’s letter to Shearman & Sterling dated July 2, 1993, and similar no-action
letters (including, if applicable, any no-action letter obtained pursuant to clause (A)
above), and (2) must comply with the registration and prospectus delivery requirements of
the Act in

 

9

connection with a secondary resale transaction and that such a secondary resale
transaction must be covered by an effective Registration Statement containing the selling
security holder information required by Item 507 or 508, as applicable, of Regulation S-K

      (C) Prior to effectiveness of the Exchange Offer Registration Statement, the Company
shall provide a supplemental letter to the Commission (I) stating that the Company is
registering the Exchange Offer in reliance on the position of the Commission enunciated in
Exxon Capital Holdings Corporation (available May 13, 1988), Morgan Stanley and
Co., Inc. (available June 5, 1991) as interpreted in the Commission’s letter to
Shearman & Sterling dated July 2, 1993, and, if applicable, any no-action letter
obtained pursuant to clause (A) above, (II) including a representation that the Company has
not entered into any arrangement or understanding with any Person to distribute the Exchange
Notes to be received in the Exchange Offer and that, to the best of the Company’s
information and belief, each Holder participating in the Exchange Offer is acquiring the
Exchange Notes in its ordinary course of business and has no arrangement or understanding
with any Person to participate in the distribution of the Exchange Notes received in the
Exchange Offer and (III) any other undertaking or representation required by the Commission
as set forth in any no-action letter obtained pursuant to clause (A) above, if applicable.

          (b) Shelf Registration Statement. In connection with the Shelf Registration
Statement, the Company shall:

               (i) comply with all the provisions of Sections 6(c) and 6(d) below and use its reasonable best
efforts to effect such registration to permit the sale of the Transfer Restricted Securities being
sold in accordance with the intended method or methods of distribution thereof (as indicated in the
information furnished to the Company pursuant to Section 4(b) hereof), and pursuant thereto the
Company will prepare and file with the Commission a Registration Statement relating to the
registration on any appropriate form under the Act, which form shall be available for the sale of
the Transfer Restricted Securities in accordance with the intended method or methods of
distribution thereof within the time periods and otherwise in accordance with the provisions
hereof; and

               (ii) issue, upon the request of any Holder or purchaser of Notes covered by any Shelf
Registration Statement contemplated by this Agreement, Exchange Notes having an aggregate principal
amount equal to the aggregate principal amount of Notes sold pursuant to the Shelf Registration
Statement and surrendered to the Company for cancellation; provided that such Holder provides all
documentation reasonably requested by the Company in connection with such issuance; the Company
shall register Exchange Notes and any related Subsidiary Guarantees on the Shelf Registration
Statement for this purpose and issue the Exchange Notes to the purchaser(s) of securities subject
to the Shelf Registration Statement in the names as such purchaser(s) shall designate.

          (c) General Provisions. In connection with any Registration Statement and any related
Prospectus required by this Agreement, the Company shall:

 

10

               (i) use its reasonable best efforts to keep such Registration Statement continuously effective
and provide all requisite financial statements for the period specified in Section 3 or 4 hereof,
as applicable. Upon the occurrence of any event that would cause (A) any such Registration
Statement to contain an untrue statement of material fact or omit to state any material fact
necessary to make the statements therein not misleading or the Prospectus contained in such
Registration Statement to contain an untrue statement of a material fact or omit to state any
material fact necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading or (B) such Registration Statement or Prospectus contained
therein not to be effective and usable for resale of Transfer Restricted Securities during the
period required by this Agreement, the Company shall file promptly an appropriate amendment to such
Registration Statement curing such defect, and, if Commission review is required, use its
reasonable best efforts to cause such amendment to be declared effective as soon as practicable.
If at any time the Commission shall issue any stop order suspending the effectiveness of any
Registration Statement, or any state securities commission or other regulatory authority shall
issue an order suspending the qualification or exemption from qualification of the Transfer
Restricted Securities under state securities or Blue Sky laws, the Company shall use its reasonable
best efforts to obtain the withdrawal or lifting of such order at the earliest possible time;

               (ii) use its reasonable best efforts to prepare and file with the Commission such amendments
and post-effective amendments to the applicable Registration Statement as may be necessary to keep
such Registration Statement effective for the applicable period set forth in Section 3 or 4 hereof,
as the case may be; cause the Prospectus to be supplemented by any required Prospectus supplement,
and as so supplemented to be filed pursuant to Rule 424 under the Act, and to comply fully with
Rules 424, 430A and 462, as applicable, under the Act in a timely manner; and comply with the
provisions of the Act with respect to the disposition of all securities covered by such
Registration Statement during the applicable period in accordance with the intended method or
methods of distribution by the sellers thereof set forth in such Registration Statement or
supplement to the Prospectus;

               (iii) in connection with any sale of Transfer Restricted Securities that will result in such
securities no longer being Transfer Restricted Securities, cooperate with the Holders to facilitate
the timely preparation and delivery of certificates representing Transfer Restricted Securities to
be sold and not bearing any restrictive legends; and enable such Transfer Restricted Securities to
be registered in such denominations and such names as the selling Holders may request at least two
Business Days prior to such sale of Transfer Restricted Securities;

               (iv) use its reasonable best efforts to cause the disposition of the Transfer Restricted
Securities covered by the Registration Statement to be registered with or approved by such other
governmental agencies or authorities as may be necessary to enable the seller or sellers thereof to
consummate the disposition of such Transfer Restricted Securities; provided, however, that the
Company shall not be required to register or qualify as a foreign corporation where it is not now
so qualified or to take any action that would subject it to the service of process in suits or to
taxation, other than as to matters and transactions relating to the Registration Statement, in any
jurisdiction where it is not now so subject;

 

11

               (v) provide a CUSIP number for all Transfer Restricted Securities not later than the effective
date of a Registration Statement covering such Transfer Restricted Securities and provide the
Trustee under the Indenture with certificates for the Transfer Restricted Securities which are in a
form eligible for deposit with The Depository Trust Company;

               (vi) otherwise use its reasonable best efforts to comply with all applicable rules and
regulations of the Commission, and make generally available to its security holders with regard to
any applicable Registration Statement, as soon as practicable, a consolidated earnings statement
meeting the requirements of Rule 158 (which need not be audited) covering a twelve-month period
beginning with the first month of the Compay’s first fiscal quarter commencing after the effective
date of the Registration Statement (as such term is defined in paragraph (c) of Rule 158 under the
Act); and

               (vii) use its reasonable best efforts to cause the Indenture to be qualified under the TIA not
later than the effective date of the first Registration Statement required by this Agreement and,
in connection therewith, cooperate with the Trustee and the Holders to effect such changes to the
Indenture as may be required for such Indenture to be so qualified in accordance with the terms of
the TIA; and execute and use its reasonable best efforts to cause the Trustee to execute, all
documents that may be required to effect such changes and all other forms and documents required to
be filed with the Commission to enable such Indenture to be so qualified in a timely manner.

          (d) Additional Provisions Applicable to Shelf Registration Statements and Certain Exchange
Offer Prospectuses. In connection with each Shelf Registration Statement, and each Exchange
Offer Registration Statement if and to the extent that an Initial Purchaser has notified the
Company that it is a holder of Exchange Notes that are Transfer Restricted Securities (for so long
as such Exchange Notes are Transfer Restricted Securities or for the period provided in Section 3
hereof, whichever is shorter), the Company shall:

               (i) advise each Holder promptly and, if requested by such Holder, confirm such advice in
writing, (A) when the Prospectus or any Prospectus supplement or post-effective amendment has been
filed, and, with respect to any applicable Registration Statement or any post-effective amendment
thereto, when the same has become effective, (B) of any request by the Commission for amendments to
the Registration Statement or amendments or supplements to the Prospectus or for additional
information relating thereto, (C) of the issuance by the Commission of any stop order suspending
the effectiveness of the Registration Statement under the Act or of the suspension by any state
securities commission of the qualification of the Transfer Restricted Securities for offering or
sale in any jurisdiction, or the initiation of any proceeding for any of the preceding purposes,
(D) of the existence of any fact or the happening of any event that makes any statement of a
material fact made in the Registration Statement, the Prospectus, any amendment or supplement
thereto or any document incorporated by reference therein untrue, or that requires the making of
any additions to or changes in the Registration Statement in order to make the statements therein
not misleading, or that requires the making of any additions to or changes in the Prospectus in
order to make the statements therein, in the light of the circumstances under which they were made,
not misleading;

 

12

               (ii) subject to Section 6(c)(i) hereof, if any fact or event contemplated by Section
6(d)(i)(D) above shall exist or have occurred, use its reasonable best efforts to prepare a
supplement or post-effective amendment to the Registration Statement or related Prospectus or any
document incorporated therein by reference or file any other required document so that, as
thereafter delivered to the purchasers of Transfer Restricted Securities, the Prospectus will not
contain an untrue statement of a material fact or omit to state any material fact necessary to make
the statements therein, in the light of the circumstances under which they were made, not
misleading;

               (iii) furnish to each Holder in connection with such exchange or sale, if any, before filing
with the Commission, copies of any Registration Statement or any Prospectus included therein
(except the Prospectus included in the Exchange Offer Registration Statement at the time it was
declared effective) or any amendments or supplements to any such Registration Statement or
Prospectus (but excluding any documents incorporated by reference as a result of the Company’s
periodic reporting requirements under the Exchange Act), which documents will be subject to the
review and comment of such Holders in connection with such sale, if any, for a period of at least
four Business Days, and the Company will not file any such Registration Statement or Prospectus or
any amendment or supplement to any such Registration Statement or Prospectus (excluding all such
documents incorporated by reference as a result of the Company’s periodic reporting requirements
under the Exchange Act) to which such Holders shall reasonably object within five Business Days
after the receipt thereof. A Holder shall be deemed to have reasonably objected to such filing if
such Registration Statement, amendment, Prospectus or supplement, as applicable, as proposed to be
filed, contains an untrue statement of a material fact or omits to state any material fact
necessary to make the statements therein not misleading or fails to comply with the applicable
requirements of the Act;

               (iv) prior to the filing of any document that is to be incorporated by reference into a
Registration Statement or Prospectus, provide copies of such document to each Holder in connection
with such exchange or sale, if any, make the Company’s representatives available for discussion of
such document and other customary due diligence matters, and include such information in such
document prior to the filing thereof as such Holders may reasonably request;

               (v) make available, at reasonable times, for inspection by each Holder and any attorney or
accountant retained by such Holders, all relevant financial and other records, pertinent corporate
documents of the Company and cause the Company’s officers, directors and employees to supply all
information reasonably requested by any such Holder, attorney or accountant in connection with such
Registration Statement or any post-effective amendment thereto subsequent to the filing thereof and
prior to its effectiveness; provided, however, that the foregoing inspection and information
gathering (A) shall be coordinated on behalf of the selling Holders, underwriters or any
representative thereof by one counsel, who shall be Latham & Watkins LLP or such other counsel as
may be chosen by the Holders of a majority in principal amount of Transfer Restricted Securities,
and (B) shall not be available or any such Holder who does not agree to hold such information in
confidence.

               (vi) if requested by any Holders in connection with such exchange or sale, use its reasonable
best efforts to include promptly in any Registration Statement or

 

13

Prospectus, pursuant to a supplement or post-effective amendment if necessary, such
information as such Holders may reasonably request to have included therein, including, without
limitation, information relating to the “Plan of Distribution” of the Transfer Restricted
Securities; and make all required filings of such Prospectus supplement or post-effective amendment
as soon as practicable after the Company is notified of the matters to be included in such
Prospectus supplement or post-effective amendment;

               (vii) furnish to each Holder in connection with such exchange or sale without charge, at least
one copy of the Registration Statement, as first filed with the Commission, and of each amendment
thereto, and upon request all documents incorporated by reference therein and all exhibits
(including exhibits incorporated therein by reference);

               (viii) deliver to each Holder without charge, as many copies of the Prospectus (including each
preliminary prospectus) and any amendment or supplement thereto as such Holder reasonably may
request; the Company hereby consents to the use (in accordance with law) of the Prospectus and any
amendment or supplement thereto by each selling Holder in connection with the offering and the sale
of the Transfer Restricted Securities covered by the Prospectus or any amendment or supplement
thereto; provided that such use of the Prospectus and any amendment or supplement thereto and such
offering and sale conforms to the Plan of Distribution set forth in the Prospectus and complies
with the terms of this Agreement and all applicable laws and regulations thereunder;

               (ix) upon the request of any Holder, enter into such customary agreements (including an
underwriting agreement) and make such customary representations and warranties and take all such
other customary actions in connection therewith in order to expedite or facilitate the disposition
of the Transfer Restricted Securities pursuant to any applicable Registration Statement
contemplated by this Agreement as may be reasonably requested by any Holder in connection with any
sale or resale pursuant to any applicable Registration Statement. In such connection, the Company
shall have no obligation to enter into an underwriting agreement or permit an underwritten offering
unless a request therefore shall have been received from Holders of not less than 33% of the
aggregate principal amount of Transfer Restricted Securities then outstanding; and whether or not
an underwriting agreement is entered into and whether or not the registration is an underwritten
registration, the Company shall:

     (A) upon request of any Holder, furnish (or in the case of paragraphs (2) and (3), use
its reasonable best efforts to cause to be furnished) to each Holder, upon Consummation of
the Exchange Offer or upon the effectiveness of the Shelf Registration Statement, as the
case may be:

     (1) a certificate, dated such date, signed on behalf of the Company by (x) two senior
officers and (y) a principal financial or accounting officer of the Company, confirming, as
of the date thereof, the matters set forth in Sections 7(f) and (g) of the Purchase
Agreement and such other similar matters as such Holders may reasonably request;

     (2) an opinion, dated the date of Consummation of the Exchange Offer or the date of
effectiveness of the Shelf Registration Statement, as the case may be, of counsel

 

14

for the Company covering the matters set forth in Section 7 (a) of the Purchase
Agreement and such other matters as such Holder may reasonably request, and in any event
including a representation to the effect that such counsel has participated in conferences
with officers and other representatives of the Company, representatives of the independent
public accountants for the Company and has considered the matters required to be stated
therein and the statements contained therein, although such counsel has not independently
verified the accuracy, completeness or fairness of such statements; and that such counsel
advises that, on the basis of the foregoing, no facts came to such counsel’s attention that
caused such counsel to believe that the applicable Registration Statement, at the time such
Registration Statement or any post-effective amendment thereto became effective and, in the
case of the Exchange Offer Registration Statement, as of the date of Consummation of the
Exchange Offer, contained an untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary to make the statements therein not
misleading, or that the Prospectus contained in such Registration Statement as of its date
and, in the case of the opinion dated the date of Consummation of the Exchange Offer, as of
the date of Consummation, contained an untrue statement of a material fact or omitted to
state a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading. Without limiting the foregoing,
such counsel may state further that such counsel assumes no responsibility for, and has not
independently verified, the accuracy, completeness or fairness of the financial statements,
notes and schedules and other financial data included in any Registration Statement
contemplated by this Agreement or the related Prospectus; and

     (3) a customary comfort letter, dated the date of Consummation of the Exchange Offer,
or as of the date of effectiveness of the Shelf Registration Statement, as the case may be,
from the Company’s independent accountants, in the customary form and covering matters of
the type customarily covered in comfort letters to underwriters in connection with
underwritten offerings, and affirming the matters set forth in the comfort letters delivered
pursuant to Section 7(c) of the Purchase Agreement; and

     (B) deliver such other documents and certificates as may be reasonably requested by the
selling Holders to evidence compliance with the matters covered in clause (A) above and with
any customary conditions contained in any agreement entered into by the Company pursuant to
this clause (ix);

               (x) prior to any public offering of Transfer Restricted Securities, cooperate with the selling
Holders and their counsel in connection with the registration and qualification of the Transfer
Restricted Securities under the securities or Blue Sky laws of such jurisdictions as the selling
Holders may request and do any and all other acts or things reasonably necessary or advisable to
enable the disposition in such jurisdictions of the Transfer Restricted Securities covered by the
applicable Registration Statement; provided, however, that the Company shall not be required to
register or qualify as a foreign corporation where it is not now so qualified or to take any action
that would subject it to the service of process in suits or to taxation, other than as to matters
and transactions relating to the Registration Statement, in any jurisdiction where it is not now so
subject; and

 

15

               (xi) provide promptly to each Holder, upon written request, each document filed with the
Commission pursuant to the requirements of Section 13 or Section 15(d) of the Exchange Act.

          (e) Restrictions on Holders. Each Holder’s acquisition of a Transfer Restricted
Security constitutes such Holder’s agreement that, upon receipt of the notice referred to in
Section 6(d)(i)(C) or any notice from the Company of the existence of any fact of the kind
described in Section 6(d)(i)(D) hereof (in each case, a “Suspension Notice”), such Holder will
forthwith discontinue disposition of Transfer Restricted Securities pursuant to the applicable
Registration Statement until (i) such Holder has received copies of the supplemented or amended
Prospectus contemplated by Section 6(d)(ii) hereof, or (ii) such Holder is advised in writing by
the Company that the use of the Prospectus may be resumed, and has received copies of any
additional or supplemental filings that are incorporated by reference in the Prospectus (in each
case, the “Recommencement Date”). Each Holder receiving a Suspension Notice shall be required to
either (I) destroy any Prospectuses, other than permanent file copies, then in such Holder’s
possession that have been replaced by the Company with a more recently dated Prospectus or (II)
deliver to the Company (at the Company’s expense) all copies, other than permanent file copies,
then in such Holder’s possession of the Prospectuses covering such Transfer Restricted Securities
that was current at the time of receipt of the Suspension Notice. The time period regarding the
effectiveness of such Registration Statement set forth in Section 3 or 4 hereof, as applicable,
shall be extended by a number of days equal to the number of days in the period from and including
the date of delivery of the Suspension Notice to the date of delivery of the Recommencement Date.

SECTION 7. REGISTRATION EXPENSES

          (a) All expenses incident to the Company’s performance of or compliance with this Agreement
will be borne by the Company, regardless of whether a Registration Statement becomes effective,
including without limitation: (i) all registration and filing fees and expenses; (ii) all fees and
expenses of compliance with federal securities and state Blue Sky or securities laws; (iii) all
expenses of printing (including certificates for the Exchange Notes to be issued in the Exchange
Offer and printing of Prospectuses), messenger and delivery services and telephone; (iv) all fees
and disbursements of counsel for the Company and one counsel for the Holders of Transfer Restricted
Securities (which shall be Simpson Thacher & Bartlett or such other counsel as may be selected by a
majority of such Holders); (v) all application and filing fees in connection with listing the
Exchange Notes on a national securities exchange or automated quotation system pursuant to the
requirements hereof; and (vi) all fees and disbursements of independent certified public
accountants of the Company (including the expenses of any special audit and comfort letters
required by or incident to such performance).

          The Company will, in any event, bear its internal expenses (including, without limitation, all
salaries and expenses of its officers and employees performing legal or accounting duties), the
expenses of any annual audit and the fees and expenses of any Person, including special experts,
retained by the Company.

          (b) In connection with any Registration Statement required by this Agreement (including,
without limitation, the Exchange Offer Registration Statement and the Shelf

 

16

Registration Statement), the Company will reimburse the Initial Purchasers and the Holders of
Transfer Restricted Securities who are tendering Notes in the Exchange Offer and/or selling or
reselling Notes or Exchange Notes pursuant to the “Plan of Distribution” contained in the Exchange
Offer Registration Statement or the Shelf Registration Statement, as applicable, for the reasonable
fees and disbursements of not more than one counsel (who shall be Simpson Thacher & Bartlett LLP
unless another firm shall be chosen by the Holders of a majority in principal amount of the
Transfer Restricted Securities for whose benefit such Registration Statement is being prepared).

SECTION 8. INDEMNIFICATION

          (a) The Company agrees to indemnify and hold harmless each Holder, its directors, officers and
each Person, if any, who controls such Holder (within the meaning of Section 15 of the Act or
Section 20 of the Exchange Act), to the fullest extent lawful from and against any and all losses,
claims, damages, liabilities or judgments (including without limitation, any reasonable legal or
other expenses incurred in connection with investigating or defending any matter, including any
action that could give rise to any such losses, claims, damages, liabilities or judgments) to which
they or any of them may become subject under the Act, the Exchange Act or otherwise, insofar as
such losses, claims, damages, liabilities, judgments and expenses are caused by any untrue
statement or alleged untrue statement of a material fact contained in any Registration Statement,
preliminary prospectus, Prospectus, Free Writing Prospectus or any “issuer information” (as defined
in Rule 433 of the Securities Act) filed or required to be filed pursuant to Rule 433(d) under the
Securities Act (or any amendment or supplement thereto) provided by the Company to any Holder or
any prospective purchaser of Exchange Notes or registered Notes, or caused by any omission alleged
omission to state therein a material fact required to be stated therein or necessary to make the
statements therein not misleading, except insofar as such losses, claims, damages, liabilities or
judgments are caused by an untrue statement or omission or alleged untrue statement or omission
that is based upon information relating to any of the Holders furnished in writing to the Company
by any of the Holders.

          (b) By its acquisition of Transfer Restricted Securities, each Holder of Transfer Restricted
Securities agrees, severally and not jointly, to indemnify and hold harmless the Company, and its
respective directors and officers, and each person, if any, who controls (within the meaning of
Section 15 of the Act or Section 20 of the Exchange Act) the Company to the same extent as the
foregoing indemnity from the Company set forth in Section 8(a) hereof, but only with reference to
information relating to such Holder furnished in writing to the Company by such Holder expressly
for use in any Registration Statement or in any amendment or supplement thereto. In no event shall
any Holder, its directors, officers or any Person who controls such Holder be liable or responsible
for any amount in excess of the amount by which the total amount received by such Holder with
respect to its sale of Transfer Restricted Securities pursuant to a Registration Statement exceeds
(i) the amount paid by such Holder for such Transfer Restricted Securities and (ii) the amount of
any damages that such Holder, its directors, officers or any Person who controls such Holder has
otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or
alleged omission.

 

17

          (c) In case any action shall be commenced involving any Person in respect of which indemnity
may be sought pursuant to Section 8(a) or (b) hereof (the “indemnified party”), the indemnified
party shall promptly notify the Person against whom such indemnity may be sought (the “indemnifying
person”) in writing and the indemnifying party shall assume the defense of such action, including
the employment of counsel reasonably satisfactory to the indemnified party and the payment of all
fees and expenses of such counsel, as incurred (except that in the case of any action in respect of
which indemnity may be sought pursuant to both Sections 8(a) and (b) hereof, a Holder shall not be
required to assume the defense of such action pursuant to this Section 8(c), but may employ
separate counsel and participate in the defense thereof, but the fees and expenses of such counsel,
except as provided below, shall be at the expense of the Holder). Any indemnified party shall have
the right to employ separate counsel in any such action and participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of the indemnified party unless (i)
the employment of such counsel shall have been specifically authorized in writing by the
indemnifying party, (ii) the indemnifying party shall have failed to assume the defense of such
action or employ counsel reasonably satisfactory to the indemnified party or (iii) the named
parties to any such action (including any impleaded parties) include both the indemnified party and
the indemnifying party, and the indemnified party shall have been advised by such counsel that
there may be one or more legal defenses available to it which are different from or additional to
those available to the indemnifying party (in which case the indemnifying party shall not have the
right to assume the defense of such action on behalf of the indemnified party). In any such case,
the indemnifying party shall not, in connection with any one action or separate but substantially
similar or related actions in the same jurisdiction arising out of the same general allegations or
circumstances, be liable for the fees and expenses of more than one separate firm of attorneys (in
addition to any local counsel) for all indemnified parties and all such fees and expenses shall be
reimbursed as they are incurred. Such firm shall be designated in writing by a majority of the
Holders, in the case of the parties indemnified, pursuant to Section 8(a) hereof, and by the
Company, in the case of parties indemnified, pursuant to Section 8(b) hereof. The indemnifying
party shall indemnify and hold harmless the indemnified party from and against any and all losses,
claims, damages, liabilities and judgments by reason of any settlement of any action (A) effected
with its written consent or (B) effected without its written consent if the settlement is entered
into more than 20 Business Days after the indemnifying party shall have received a request from the
indemnified party for reimbursement for the fees and expenses of counsel (in any case where such
fees and expenses are at the expense of the indemnifying party) and, prior to the date of such
settlement, the indemnifying party shall have failed to comply with such reimbursement request. No
indemnifying party shall, without the prior written consent of the indemnified party, effect any
settlement or compromise of, or consent to the entry of judgment with respect to, any pending or
threatened action in respect of which the indemnified party is or could have been a party and
indemnity or contribution may be or could have been sought hereunder by the indemnified party,
unless such settlement, compromise or judgment (I) includes an unconditional release of the
indemnified party from all liability on claims that are or could have been the subject matter of
such action and (II) does not include a statement as to or an admission of fault, culpability or a
failure to act, by or on behalf of the indemnified party.

          (d) To the extent that the indemnification provided for in this Section 8 is unavailable to an
indemnified party in respect of any losses, claims, damages, liabilities or judgments referred to
therein, then each indemnifying party, in lieu of indemnifying such

 

18

indemnified party shall contribute to the amount paid or payable by such indemnified party as
a result of such losses, claims, damages, liabilities or judgments (i) in such proportion as is
appropriate to reflect the relative benefits received by the Company on the one hand, and the
Holders, on the other hand, from their initial sale of Transfer Restricted Securities (or in the
case of Exchange Notes that are Transfer Restricted Securities, the sale of the Notes for which
such Exchange Notes were exchanged) or (ii) if the allocation provided by clause 8(d)(i) above is
not permitted by applicable law, in such proportion as is appropriate to reflect not only the
relative benefits referred to in such clause 8(d)(i) but also the relative fault of the Company, on
the one hand, and of the Holder, on the other hand, in connection with the statements or omissions
which resulted in such losses, claims, damages, liabilities or judgments, as well as any other
relevant equitable considerations. The relative fault of the Company, on the one hand, and of the
Holder, on the other hand, shall be determined by reference to, among other things, whether the
untrue or alleged untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company, on the one hand, or by the Holder,
on the other hand, and the parties’ relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission. The amount paid or payable by a
party as a result of the losses, claims, damages, liabilities and judgments referred to above shall
be deemed to include, subject to the limitations set forth in Section 8(c) hereof, any legal or
other fees or expenses reasonably incurred by such party in connection with investigating or
defending any action or claim.

          The Company and, by its acquisition of Transfer Restricted Securities, each Holder agree that
it would not be just and equitable if contribution pursuant to this Section 8(d) were determined by
pro rata allocation (even if the Holders were treated as one entity for such purpose) or by any
other method of allocation which does not take account of the equitable considerations referred to
in the immediately preceding paragraph. The amount paid or payable by an indemnified party as a
result of the losses, claims, damages, liabilities or judgments referred to in the immediately
preceding paragraph shall be deemed to include, subject to the limitations set forth above, any
legal or other expenses reasonably incurred by such indemnified party in connection with
investigating or defending any matter, including any action that could have given rise to such
losses, claims, damages, liabilities or judgments. Notwithstanding the provisions of this Section
8, no Holder, its directors, its officers or any Person, if any, who controls such Holder shall be
required to contribute, in the aggregate, any amount in excess of the amount by which the total
received by such Holder with respect to the sale of Transfer Restricted Securities pursuant to a
Registration Statement exceeds (i) the amount paid by such Holder for such Transfer Restricted
Securities and (ii) the amount of any damages which such Holder has otherwise been required to pay
by reason of such untrue or alleged untrue statement or omission or alleged omission. No Person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be
entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.
The Holders’ obligations to contribute pursuant to this Section 8(d) are several in proportion to
the respective principal amount of Transfer Restricted Securities held by each Holder hereunder and
not joint.

SECTION 9. RULE 144A AND RULE 144

          The Company agrees with each Holder, for so long as any Transfer Restricted Securities remain
outstanding and during any period in which the Company (a) is not subject to

 

19

Section 13 or 15(d) of the Exchange Act, to make available, upon request of any Holder or
beneficial owner of Transfer Restricted Securities in connection with any sale thereof and any
prospective purchaser of such Transfer Restricted Securities designated by such Holder or
beneficial owner, the information required by Rule 144A(d)(4) under the Act in order to permit
resales of such Transfer Restricted Securities pursuant to Rule 144A, and (b) is subject to Section
13 or 15(d) of the Exchange Act, to use its reasonable best efforts to make all filings required
thereby in a timely manner in order to permit resales of such Transfer Restricted Securities
pursuant to Rule 144.

SECTION 10. FUTURE SUBSIDIARY GUARANTEES

          If, prior to the Consummation of the Exchange Offer or prior to the effectiveness of the Shelf
Registration Statement, as the case may be, any subsidiary of the Company executes a Subsidiary
Guarantee in accordance with the terms and provisions of the Indenture, the Company shall cause
such subsidiary to execute and deliver to the parties hereto a counterpart signature page to this
Agreement and such subsidiary shall be bound by all the provisions of this Agreement as a guarantor
of the Company’s obligations and act as a registrant on any Registration Statement.

SECTION 11. MISCELLANEOUS

          (a) Remedies. The Company acknowledges and agrees that monetary damages (including
the Additional Interest contemplated by Section 5 hereof) would not be adequate compensation for
any loss incurred by reason of a breach by the Company of the provisions of this Agreement and the
Company hereby agrees to waive the defense in any action for specific performance that a remedy at
law would be adequate; provided that the Additional Interest contemplated by Section 5 hereof shall
be the exclusive remedy for any such breach of Section 3 or 4 of this Agreement.

          (b) No Free Writing Prospectus. The Company represents, warrants and covenants that
it (including its agents and representatives) will not prepare, make, use, authorize, approve or
refer to any “written communication” (as defined in Rule 405 under the Securities Act), including
any Free Writing Prospectus, in connection with the issuance and sale of the Notes and the Exchange
Notes, other than any communication pursuant to Rule 134, Rule 135 or Rule 135c under the
Securities Act, any document constituting an offer to sell or solicitation of an offer to buy the
Notes or the Exchange Notes that falls within the exception from the definition of prospectus in
Section 2(a)(10)(a) of the Securities Act or a prospectus satisfying the requirements of Section
10(a) of the Securities Act or of Rule 430, Rule 430A, Rule 430B, Rule 430C or Rule 431 under the
Securities Act.

          (c) No Inconsistent Agreements. The Company will not, on or after the date of this
Agreement, enter into any agreement with respect to its securities that is inconsistent with the
rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof.
The Company has not previously entered into any agreement granting any registration rights with
respect to its securities to any Person that would require such securities to be included in any
Registration Statement filed hereunder. The rights granted to the Holders hereunder do

 

20

not in any way conflict with and are not inconsistent with the rights granted to the holders
of the Company’s securities under any agreement in effect on the date hereof.

          (d) Amendments and Waivers. The provisions of this Agreement may not be amended,
modified or supplemented, and waivers or consents to or departures from the provisions hereof may
not be given unless (i) in the case of Section 5 hereof and this Section 11(c)(i), the Company has
obtained the written consent of Holders of all outstanding Transfer Restricted Securities and (ii)
in the case of all other provisions hereof, the Company has obtained the written consent of Holders
of a majority of the outstanding principal amount of Transfer Restricted Securities (excluding
Transfer Restricted Securities held by the Company or its Affiliates). Notwithstanding the
foregoing, a waiver of or consent to departure from the provisions hereof that relates exclusively
to the rights of Holders whose Transfer Restricted Securities are being tendered pursuant to the
Exchange Offer, and that does not affect directly or indirectly the rights of other Holders whose
Transfer Restricted Securities are not being tendered pursuant to such Exchange Offer, may be given
by the Holders of a majority of the outstanding principal amount of Transfer Restricted Securities
subject to such Exchange Offer.

          (e) Third Party Beneficiary. The Holders shall be third party beneficiaries to the
agreements made hereunder between the Company, on the one hand, and the Initial Purchasers, on the
other hand, and shall have the right to enforce such agreements directly to the extent they may
deem such enforcement necessary or advisable to protect their rights hereunder.

          By acquiring the Transfer Restricted Securities, a Holder will be deemed to have agreed to
indemnify and hold harmless the Company and its respective directors and officers, and each person,
if any, who controls (within the meaning of Section 15 of the Act or Section 20 of the Exchange Act
to the same extent as the indemnity from the Company set forth in Section 8(a) hereof, but only
with reference to information relating to such Holder and provided in writing by such Holder for
inclusion in the Shelf Registration Statement.

          (f) Notices. All notices and other communications provided for or permitted hereunder
shall be made in writing by hand-delivery, first-class mail (registered or certified, return
receipt requested), telecopier, or air courier guaranteeing overnight delivery:

               (i) if to a Holder, at the address set forth on the records of the Registrar under the
Indenture, with a copy to the Registrar under the Indenture; and

               (ii) if to the Company:

UCI Holdco, Inc.

14601 Highway 41 North

Evansville, Indiana 47725

Attention: Bruce M. Zorich

Facsimile: (618) 456-2260

          All such notices and communications shall be deemed to have been duly given at the time
delivered by hand; when receipt is acknowledged, if telecopied; and on the next Business Day, if
timely delivered to an air courier guaranteeing overnight delivery.

 

21

          Copies of all such notices, demands or other communications shall be concurrently delivered by
the Person giving the same to the Trustee at the address specified in the Indenture.

          (g) Successors and Assigns. This Agreement shall inure to the benefit of and be
binding upon the successors and assigns of each of the parties, including without limitation and
without the need for an express assignment, subsequent Holders; provided that nothing herein shall
be deemed to permit any assignment, transfer or other disposition of Transfer Restricted Securities
in violation of the terms hereof or of the Purchase Agreement or the Indenture. If any transferee
of any Holder shall acquire Transfer Restricted Securities in any manner, whether by operation of
law or otherwise, such Transfer Restricted Securities shall be held subject to all of the terms of
this Agreement, and by taking and holding such Transfer Restricted Securities such Person shall be
conclusively deemed to have agreed to be bound by and to perform all of the terms and provisions of
this Agreement, including the restrictions on resale set forth in this Agreement and, if
applicable, the Purchase Agreement, and such Person shall be entitled to receive the benefits
hereof.

          (h) Counterparts. This Agreement may be executed in any number of counterparts and by
the parties hereto in separate counterparts, each of which when so executed shall be deemed to be
an original and all of which taken together shall constitute one and the same agreement.

          (i) Headings. The headings in this Agreement are for convenience of reference only
and shall not limit or otherwise affect the meaning hereof.

          (i) Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE
WITH, THE LAWS OF THE STATE OF NEW YORK.

          (j) Severability. In the event that any one or more of the provisions contained
herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable,
the validity, legality and enforceability of any such provision in every other respect and of the
remaining provisions contained herein shall not be affected or impaired thereby.

          (k) Entire Agreement. This Agreement is intended by the parties as a final expression
of their agreement and intended to be a complete and exclusive statement of the agreement and
understanding of the parties hereto in respect of the subject matter contained herein. There are
no restrictions, promises, warranties or undertakings, other than those set forth or referred to
herein with respect to the registration rights granted with respect to the Transfer Restricted
Securities. This Agreement supersedes all prior agreements and understandings between the parties
with respect to such subject matter.

 

 

          IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above.

	 	 	 	 	 	 	 
	 	 	UCI Holdco, Inc.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	   /s/   Charles T. Dickson
 

Name: Charles T. Dickson
	 	 
	 

	 	 	 	Title: Chief Financial Officer	 	 

	 	 	 	 	 
	Accepted:	 	 
	 
	 	 	 	 
	Lehman Brothers Inc.

Goldman, Sachs & Co.	 	 
	 
	 	 	 	 
	By Lehman Brothers Inc.	 	 
	 
	 	 	 	 
	By:

	 	   /s/   Timothy N. Hartzell
 

Name: Timothy N. Hartzell
	 	 
	 

	 	Title: Managing Director	 	 
	 
	 	 	 	 
	By Goldman, Sachs & Co.	 	 
	 
	 	 	 	 
	By:

	 	   /s/   Goldman, Sachs & Co.
 

(Goldman, Sachs & Co.)exv10w13

 

Exhibit 10.13

EXECUTION VERSION

STOCK PURCHASE AGREEMENT

BY AND AMONG

UNITED COMPONENTS, INC.,

ACAS ACQUISITIONS (ASC), INC.

AND

THE SELLERS

NAMED HEREIN

 

Dated as of March 8, 2006

 

 

TABLE OF CONTENTS

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Page
	ARTICLE I DEFINITIONS	 	 	2	 
	 	1.1	 	 	Certain Definitions
	 	 	2	 
	 	1.2	 	 	Terms Defined Elsewhere in this Agreement
	 	 	13	 
	 	1.3	 	 	Other Definitional and Interpretive Matters
	 	 	16	 
	ARTICLE II SALE AND PURCHASE OF SECURITIES	 	 	18	 
	 	2.1	 	 	Purchase and Sale of Shares
	 	 	18	 
	 	2.2	 	 	Exchange of Rollover Shares for Parent Common Stock
	 	 	18	 
	 	2.3	 	 	Cancellation of Options
	 	 	18	 
	 	2.4	 	 	Cancellation of Warrants
	 	 	19	 
	 	2.5	 	 	Redemption of the Preferred Stock
	 	 	19	 
	 	2.6	 	 	Earn-Out Agreement
	 	 	19	 
	ARTICLE III PURCHASE PRICE	 	 	20	 
	 	3.1	 	 	Payment of Initial Cash Purchase Price and Other Amounts
	 	 	20	 
	 	3.2	 	 	Purchase Price Adjustment
	 	 	21	 
	ARTICLE IV CLOSING AND TERMINATION	 	 	24	 
	 	4.1	 	 	Closing Date
	 	 	24	 
	 	4.2	 	 	Termination of Agreement
	 	 	25	 
	 	4.3	 	 	Procedure Upon Termination
	 	 	26	 
	 	4.4	 	 	Effect of Termination
	 	 	26	 
	ARTICLE V REPRESENTATIONS AND WARRANTIES OF THE COMPANY	 	 	26	 
	 	5.1	 	 	Organization and Good Standing
	 	 	26	 
	 	5.2	 	 	Authorization of Agreement
	 	 	26	 
	 	5.3	 	 	Conflicts; Consents of Third Parties
	 	 	27	 
	 	5.4	 	 	Capitalization
	 	 	27	 
	 	5.5	 	 	Subsidiaries
	 	 	28	 
	 	5.6	 	 	Financial Statements
	 	 	29	 
	 	5.7	 	 	No Undisclosed Liabilities
	 	 	29	 
	 	5.8	 	 	Absence of Certain Developments
	 	 	30	 
	 	5.9	 	 	Taxes
	 	 	32	 

i

 

TABLE
OF CONTENTS
(continued)

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Page
	 	5.10	 	 	Real Property
	 	 	35	 
	 	5.11	 	 	Tangible Personal Property
	 	 	36	 
	 	5.12	 	 	Intellectual Property
	 	 	37	 
	 	5.13	 	 	Material Contracts
	 	 	38	 
	 	5.14	 	 	Employee Benefits Plans
	 	 	40	 
	 	5.15	 	 	Labor
	 	 	42	 
	 	5.16	 	 	Litigation
	 	 	43	 
	 	5.17	 	 	Compliance with Laws; Permits
	 	 	43	 
	 	5.18	 	 	Environmental Matters
	 	 	44	 
	 	5.19	 	 	Product Liability, Warranty and Product Recalls
	 	 	45	 
	 	5.20	 	 	Insurance
	 	 	45	 
	 	5.21	 	 	Customers and Suppliers
	 	 	46	 
	 	5.22	 	 	Affiliate Transactions
	 	 	46	 
	 	5.23	 	 	Financial Advisors
	 	 	47	 
	 	5.24	 	 	No Other Representations or Warranties; Schedules
	 	 	47	 
	ARTICLE VI REPRESENTATIONS AND WARRANTIES OF THE SELLERS	 	 	47	 
	 	6.1	 	 	Organization and Good Standing
	 	 	47	 
	 	6.2	 	 	Authorization of Agreement
	 	 	47	 
	 	6.3	 	 	Conflicts; Consents of Third Parties
	 	 	48	 
	 	6.4	 	 	Ownership and Transfer of Securities
	 	 	48	 
	 	6.5	 	 	Litigation
	 	 	48	 
	 	6.6	 	 	Financial Advisors
	 	 	49	 
	ARTICLE VII REPRESENTATIONS AND WARRANTIES OF PURCHASER	 	 	49	 
	 	7.1	 	 	Organization and Good Standing
	 	 	49	 
	 	7.2	 	 	Authorization of Agreement
	 	 	49	 
	 	7.3	 	 	Conflicts; Consents of Third Parties
	 	 	49	 
	 	7.4	 	 	Litigation
	 	 	50	 
	 	7.5	 	 	Investment Intention
	 	 	50	 
	 	7.6	 	 	Financial Advisors
	 	 	50	 

ii

 

TABLE
OF CONTENTS
(continued)

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Page
	 	7.7	 	 	Financing
	 	 	50	 
	 	7.8	 	 	Condition of the Business
	 	 	50	 
	ARTICLE VIII COVENANTS	 	 	51	 
	 	8.1	 	 	Access to Information
	 	 	51	 
	 	8.2	 	 	Conduct of the Business Pending the Closing
	 	 	51	 
	 	8.3	 	 	Consents
	 	 	54	 
	 	8.4	 	 	Regulatory Approvals
	 	 	54	 
	 	8.5	 	 	Further Assurances
	 	 	55	 
	 	8.6	 	 	Confidentiality
	 	 	56	 
	 	8.7	 	 	Indemnification, Exculpation and Insurance
	 	 	57	 
	 	8.8	 	 	Preservation of Records
	 	 	59	 
	 	8.9	 	 	Publicity
	 	 	59	 
	 	8.10	 	 	Financing
	 	 	60	 
	 	8.11	 	 	Update of Schedules
	 	 	60	 
	 	8.12	 	 	Exclusivity
	 	 	62	 
	 	8.13	 	 	Affiliate Transactions
	 	 	62	 
	 	8.14	 	 	Joint Venture Supply Agreement
	 	 	62	 
	 	8.15	 	 	Amendment to Company’s Certificate of Incorporation
	 	 	62	 
	 	8.16	 	 	[Intentionally Omitted]
	 	 	62	 
	 	8.17	 	 	Termination of Tax Sharing Agreements
	 	 	62	 
	 	8.18	 	 	Section 280G
	 	 	63	 
	 	8.19	 	 	Environmental Matters
	 	 	63	 
	ARTICLE IX CONDITIONS TO CLOSING	 	 	64	 
	 	9.1	 	 	Conditions Precedent to Obligations of Purchaser
	 	 	64	 
	 	9.2	 	 	Conditions Precedent to Obligations of the Sellers
	 	 	66	 
	ARTICLE X INDEMNIFICATION	 	 	68	 
	 	10.1	 	 	Survival of Representations and Warranties
	 	 	68	 
	 	10.2	 	 	Indemnification by Primary Indemnitors
	 	 	69	 
	 	10.3	 	 	Indemnification by Purchaser
	 	 	70	 

iii

 

TABLE
OF CONTENTS
(continued)

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Page
	 	10.4	 	 	Indemnification Procedures
	 	 	70	 
	 	10.5	 	 	Certain Limitations on Indemnification
	 	 	72	 
	 	10.6	 	 	Indemnity Escrow
	 	 	73	 
	 	10.7	 	 	Calculation of Losses
	 	 	74	 
	 	10.8	 	 	Tax Treatment of Indemnity Payments
	 	 	75	 
	 	10.9	 	 	Exclusive Remedy
	 	 	75	 
	ARTICLE XI TAX MATTERS	 	 	76	 
	 	11.1	 	 	Indemnification for Tax Obligations
	 	 	76	 
	 	11.2	 	 	Allocation of Taxes
	 	 	77	 
	 	11.3	 	 	Indemnity Payments
	 	 	77	 
	 	11.4	 	 	Tax Benefits
	 	 	77	 
	 	11.5	 	 	Tax Contests
	 	 	79	 
	 	11.6	 	 	Preparation of Tax Returns
	 	 	79	 
	 	11.7	 	 	Cooperation
	 	 	81	 
	 	11.8	 	 	Conflict
	 	 	81	 
	 	11.9	 	 	Survival
	 	 	81	 
	 	11.10	 	 	Successors
	 	 	81	 
	ARTICLE XII MISCELLANEOUS	 	 	81	 
	 	12.1	 	 	Payment of Sales, Use or Similar Taxes
	 	 	81	 
	 	12.2	 	 	Expenses
	 	 	81	 
	 	12.3	 	 	Seller Representative and Equity Sellers Representative
	 	 	82	 
	 	12.4	 	 	Submission to Jurisdiction; Consent to Service of Process
	 	 	84	 
	 	12.5	 	 	Entire Agreement; Amendments and Waivers
	 	 	84	 
	 	12.6	 	 	Governing Law
	 	 	85	 
	 	12.7	 	 	Notices
	 	 	85	 
	 	12.8	 	 	Severability
	 	 	86	 
	 	12.9	 	 	No Conflict
	 	 	86	 
	 	12.10	 	 	Binding Effect; Assignment
	 	 	87	 
	 	12.11	 	 	Counterparts
	 	 	87	 

iv

 

TABLE
OF CONTENTS
(continued)

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Page
	 	12.12	 	 	Termination of Agreements
	 	 	87	 
	 	12.13	 	 	Specific Performance
	 	 	88	 

v

 

Schedules

	 	 	 
	Schedule 1.1(a)

	 	CapEx Budget
	Schedule 3.2

	 	Agreed Principles
	 
	Schedule 5.3(a)

	 	No Conflicts
	Schedule 5.3(b)

	 	Consents
	Schedule 5.4(a)

	 	Reservation of Equity Securities
	Schedule 5.4(b)

	 	Capitalization
	Schedule 5.5

	 	Subsidiaries
	Section 5.7

	 	Liabilities
	Schedule 5.8

	 	Absence of Certain Developments
	Schedule 5.9

	 	Taxes
	Schedule 5.10(a)

	 	Real Property
	Schedule 5.11(a)

	 	Tangible Personal Property
	Schedule 5.11(b)

	 	Exceptions to Title of Machinery and Equipment
	Schedule 5.12(a)

	 	Intellectual Property
	Schedule 5.12(b)

	 	Licenses
	Schedule 5.12(c)

	 	Protection of Proprietary Rights
	Schedule 5.13(d)

	 	Intellectual Property Infringement
	 
	 	 
	Schedule 5.13(a)

	 	Material Contracts
	Schedule 5.13(b)

	 	Breaches of Material Contracts
	Schedule 5.14(a)

	 	Employee Benefit Plans
	Schedule 5.14(b)

	 	Post-Termination Benefits
	 
	 	 
	Schedule 5.14(e)

	 	Foreign Benefits Plans
	 
	 	 
	Schedule 5.15(a)

	 	Severance Arrangements
	Schedule 5.15(c)

	 	Compliance with Employment Laws
	Schedule 5.16

	 	Litigation
	Schedule 5.17

	 	Compliance with Laws
	Schedule 5.18

	 	Environmental Matters
	Schedule 5.19

	 	Product Liability, Warranty and Product Recalls
	Schedule 5.20

	 	Insurance
	Schedule 5.21(a)

	 	Customers
	Schedule 5.21(b)

	 	Suppliers
	Schedule 5.22

	 	Affiliate Transactions
	Schedule 5.23

	 	Financial Advisors (Company)
	Schedule 6.6

	 	Financial Advisors (Sellers)
	 
	 	 
	Schedule 8.13

	 	Affiliate Transactions

vi

 

Exhibits

Exhibit A – Seller Information and Indemnification Percentage

Exhibit B – Form of Legal Opinion

Exhibit C – Debt Commitment Letter

Exhibit D – Form of Contribution and Subscription Agreement

Exhibit E – Form of Letter Agreement regarding North Canton, OH Facility Sublease

Exhibit F – Form of Swaldo Employment Agreement

Exhibit G – Form of Blackerby Employment Agreement

Exhibit H – Form of Parent Stockholders Agreement

Exhibit I – Form of Investor Rights Agreement

Exhibit J — Form of Option Cancellation Agreement

Exhibit K – Form of Earn-Out Agreement

Exhibit L – Form of Pledge Agreement

vii

 

STOCK PURCHASE AGREEMENT

          This STOCK PURCHASE AGREEMENT, (the “Agreement”), dated as of March 8, 2006, by and
among UNITED COMPONENTS, INC., a Delaware corporation (“Purchaser”), ACAS ACQUISITIONS
(ASC), INC., a Delaware corporation (the “Company”), and the securityholders of the Company
listed on the signature pages hereof (collectively, the “Sellers”).

W I T N E S S E T H:

          WHEREAS, certain of the Sellers are the record and beneficial owners of an aggregate of
150,000 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share
(“Common Stock”), which constitute all of the issued and outstanding shares of Common Stock
of the Company;

          WHEREAS, certain of the Sellers are the record and beneficial owners of warrants
(“Warrants”) to purchase an aggregate of 74,888 shares of Common Stock, which constitute
all of the issued and outstanding Warrants of the Company;

          WHEREAS, certain of the Sellers are the record and beneficial owners of options
(“Options,” together with the Shares and the Warrants, referred to collectively as the
“Securities”) to purchase an aggregate of 11,267 shares of Common Stock, which constitute
all of the issued and outstanding Options of the Company;

          WHEREAS, the Securities and the Preferred Stock (as defined below) represent one hundred
percent (100%) of the issued and outstanding Equity Securities of the Company;

          WHEREAS, Purchaser desires to purchase all of the Common Stock other than the Rollover Shares
(as defined below) from the Sellers and the Sellers desire to sell all of such Common Stock to
Purchaser;

          WHEREAS, concurrently with the execution and delivery of this Agreement and as a condition to
the willingness of Purchaser to enter into this Agreement, certain of the Sellers are entering into
an agreement (the “Contribution and Subscription Agreement”) with UCI Acquisition Holdings,
Inc., a Delaware corporation and the record owner of 100% of the issued and outstanding Equity
Securities of Purchaser (“UCI”), Carlyle Partners III, L.P., a Delaware limited partnership
(“CPIII”) and UCI Holdco, Inc., a Delaware corporation (“Parent”) pursuant to
which, among other things, such Sellers will contribute their Rollover Shares to Parent and CPIII
will contribute to Parent 100% of the shares of UCI held by it and will cause each other
shareholder of UCI to contribute to Parent 100% of the shares of UCI held by such other
shareholder, in each case concurrently with the Closing in exchange for shares of Parent Common
Stock (as defined below);

          WHEREAS, Purchaser and each Option Holder desires that such Option Holders receive payment
from the Company for their Options in consideration of their cancellation; and

 

 

          WHEREAS, Purchaser and each holder of Warrants desires that such holders of Warrants receive
payment from the Company for their Warrants in consideration of their cancellation.

          NOW, THEREFORE, in consideration of the premises and the mutual covenants and agreements
hereinafter contained, the parties hereby agree as follows:

ARTICLE I

DEFINITIONS

     1.1 Certain Definitions.

          (a) For purposes of this Agreement, the following terms shall have the meanings specified in
this Section 1.1:

          “ACAS” means American Capital Strategies, Ltd., a Delaware corporation.

          “ACAS Contribution Agreement” means the Contribution Agreement, dated the date hereof,
among ACAS, Theodore V. Swaldo and William T. Blackerby, Jr.

          “ACAS Management Agreement” means that certain Investment Banking Services Agreement,
dated as of October 29, 2002, between the Company and American Capital Financial Services, Inc.

          “ACAS Warrant Amount” means $26,000,000.

          “Advance Auto Factored Receivables” means the aggregate invoiced amount of all
accounts receivable due from Advance Stores Company Incorporated to the Company or its Subsidiaries
that have been purchased by SunTrust, for which the Company has received cash as of the Closing,
and for which the “Due Date,” as set forth on the SunTrust Draft (as defined in the SunTrust
(Advance Auto) Factoring Agreement) received from SunTrust in accordance with the SunTrust (Advance
Auto) Factoring Agreement, has not occurred as of the Closing Date.

          “Affiliate” means, with respect to any Person, any other Person that, directly or
indirectly through one or more intermediaries, controls, or is controlled by, or is under common
control with, such Person, and the term “control” (including the terms “controlled by” and “under
common control with”) means the possession, directly or indirectly, of the power to direct or cause
the direction of the management and policies of such Person, whether through ownership of voting
securities, by contract or otherwise.

          “Aggregate Equity Value” means an amount equal to (i) the Enterprise Value,
minus (ii) the Closing Date Indebtedness Amount, minus (iii) Transaction Expenses,
minus (iv) the Preferred Stock Redemption Amount, minus (v) Factored
Receivables, minus (vi) POS Payables, minus (vii) the ACAS Warrant Amount
plus (viii) the aggregate amount of the exercise price for all issued and outstanding
Options

2

 

immediately prior to Closing, plus (ix) Cash, plus or minus (as the
case may be) (x) the CapEx Adjustment Amount, plus or minus (as the case may be)
(xi) the Estimated Working Capital Adjustment in accordance with Section 3.2(a).

          “Agreed Principles” means the accounting principles set forth on Schedule 3.2
or, to the extent not included thereon, the accounting principles, practices and procedures used by
the Company in the preparation of the Unaudited Financial Statements.

          “Assets” means all properties, assets and rights of any kind, whether tangible or
intangible, real or personal, owned, leased or licensed by the Company or any of its Subsidiaries.

          “Autozone Factored Receivables” means the aggregate invoiced amount of all accounts
receivable due from Autozone, Inc. to the Company or its Subsidiaries that have been purchased by
SunTrust, for which the Company has received cash as of the Closing, and for which the “Maturity
Date,” as set forth on the Confirmation (as defined in the SunTrust (Autozone) Factoring Agreement)
received from SunTrust in accordance with the SunTrust (Autozone) Factoring Agreement, has not
occurred as of the Closing Date.

          “BB&T Factoring Agreement” means that certain Supplier Agreement BB&T Factors Draft
Program, effective November 1, 2004, by and between ASC Industries, Inc. and BB&T Factors
Corporation.

          “Books and Records” means all books of account, ledgers, general, financial, legal,
regulatory, Tax, accounting, personnel and employment records, files, customers’ and suppliers’
lists, sales and promotional literature, correspondence, manuals, data, papers and other
information, whether in hard copy or computer or other format, pertaining to the Company and its
Subsidiaries.

          “Business Day” means any day of the year on which national banking institutions in New
York are open to the public for conducting business and are not required or authorized to close.

          “CapEx Budget” means the Company’s monthly capital expenditures budget for 2006
attached as Schedule 1.1(a) hereto.

          “CapEx Adjustment Amount” means (x) the lesser of (i) $965,000 and (ii) one-half of
the amount by which the aggregate amount of capital expenditures related to future sales by the
Company and its Subsidiaries to NAPA Autoparts that are included in the CapEx Budget under the row
labeled “NAPA Project Total” that are made by the Company or its Subsidiaries prior to the Closing
exceeds $2,450,000, minus (y) the amount by which the aggregate amount budgeted for capital
expenditures by the Company and its Subsidiaries as set forth on the CapEx Budget (including, for
the avoidance of doubt amounts described in clause (x)) for the period from and after March
1, 2006 to the Closing exceeds the actual amount of capital expenditures by the Company and
its Subsidiaries for such period (provided, however for the purposes of calculating

3

 

the CapEx
Adjustment Amount, in no event shall clause (y) be less than zero). In calculating the CapEx
Adjustment Amount, in the event that the Closing occurs on a date that is prior to the last
Business Day of any calendar month, the budgeted capital expenditures for such month shall be pro
rated based on the total number of Business Days in such month that have elapsed.

          “CarQuest/GPI Factored Receivables” means the aggregate invoiced amount of all
accounts receivable due from General Parts, Inc. to the Company or its Subsidiaries that have been
purchased by BB&T Factors Corporation, for which the Company has received cash as of the Closing,
and for which the “Due Date,” as set forth on the BBTF Draft (as defined in the BB&T Factoring
Agreement) received from BB&T Factors Corporation in accordance with the BB&T Factoring Agreement,
has not occurred as of the Closing Date.

          “Cash” means consolidated cash and cash equivalents (other than cash that is posted as
a security deposits or cash collateral securing Indebtedness or other obligations of the Company or
its Subsidiaries) of the Company and its consolidated Subsidiaries immediately prior to the Closing
as determined in accordance with GAAP as consistently applied using the principles, practices and
procedures used by the Company and its Subsidiaries in the preparation of the Balance Sheet (to the
extent consistent with GAAP) and the Agreed Principles.

          “Closing Date Indebtedness Amount” means the sum (without duplication) of: (i) the
aggregate amount of consolidated Indebtedness of the Company and its consolidated Subsidiaries
immediately prior to the Closing as determined in accordance with GAAP as consistently applied
using the principles, practices and procedures used by the Company and its Subsidiaries in the
preparation of the Balance Sheet (to the extent consistent with GAAP) and the Agreed Principles
plus (ii)(A) all “breakage costs” or other similar expenses in connection with the
termination of any interest rate swap of other hedging arrangement on the Closing Date, (B) all
other fees, expenses or other amounts payable to the lenders of any Indebtedness in accordance with
the terms thereof, and (C) all amounts owed to ACAS or its Affiliates pursuant to the ACAS
Management Agreement in connection with any unpaid management fees or otherwise (which, for
purposes of clarification, shall not include any amounts paid to ACAS hereunder in respect of the
Preferred Stock and Warrants), in each case to the extent not included in the amount in clause (i)
above and whether or not all or any portion of such amount would be included on a balance sheet
prepared in accordance with GAAP or the Agreed Principles.

          “Code” means the Internal Revenue Code of 1986, as amended.

          “Common Stock Sellers” means the “Common Stock Sellers” listed on Exhibit A.

          “Contract” means any written contract, agreement, indenture, note, bond, mortgage,
loan, instrument, lease, or license.

4

 

          “Current Assets” means an amount equal to the consolidated current assets of the
Company and its consolidated Subsidiaries immediately prior to the Closing including trade accounts
receivable, non-trade accounts receivable, VAT receivable inventory (including POS Inventory),
prepaid expenses, other current assets of the Company and its consolidated Subsidiaries (but
excluding Cash, all tax assets, including any refundable income taxes, the tax-effected amount of
the Closing Deductions and any deferred tax assets), in each case as determined in accordance with
GAAP as consistently applied using the principles, practices and procedures used by the Company and
its Subsidiaries in the preparation of the Balance Sheet (to the extent consistent with GAAP) and
the Agreed Principles.

          “Current Liabilities” means the consolidated current liabilities of the Company and
its consolidated Subsidiaries immediately prior to the Closing including accounts payable
(excluding POS Payables) and other current liabilities of the Company and its consolidated
Subsidiaries (excluding POS Payables, deferred tax liabilities and any amounts included within
Closing Date Indebtedness) and without reduction for the tax-effected amount of the Closing
Deductions, in each case as determined in accordance with GAAP as consistently applied using the
principles, practices and procedures used by the Company and its Subsidiaries in the preparation of
the Balance Sheet (to the extent consistent with GAAP) and the Agreed Principles.

          “Enterprise Value” means $154,700,000.

          “Environment” means any surface water, groundwater, land surface, subsurface strata,
river sediment, plant or animal life, natural resources, air (including indoor air and ambient air)
and soil.

          “Environmental Claim” shall mean any claim, action, cause of action, investigation,
demand, order, directive or written notice by, or on behalf of, any Governmental Body or Person
alleging potential liability (including potential liability for investigatory costs, cleanup costs,
personal injuries, or penalties) arising out of, based on or resulting from: (i) the Handling of
Substances as of or prior to the Closing Date; (ii) the presence, Release or threatened Release of
any Substance at a Company Property as of or prior to the Closing Date; (iii) exposure to any
Substance as of or prior to the Closing Date; or (iii) requirements or violation of any
Environmental Law or Permit as of or prior to the Closing Date.

          “Environmental Condition” shall mean any Environmental Claim and Existing
Contamination.

          “Environmental Law” means any Law in effect as of the Closing Date concerning: (a) the
Environment, including related to pollution, contamination, cleanup, preservation, protection, and
reclamation of the Environment; (b) health or safety, including occupational safety and the
exposure of employees and other persons to any
Substances; (c) any Release or threatened Release of any Substance, including investigation,
monitoring, clean up, removal, treatment, or any other action to address such Release or threatened
Release; and (d) the Handling of Substances.

5

 

          “Environmental Response Action” shall mean any action of any kind to address, correct
or respond to any Environmental Condition, or to comply with Environmental Laws with respect to
matters first arising as of or prior to the Closing Date, including the following activities: (i)
monitoring, investigation, assessment, treatment, cleanup, containment, removal, mitigation,
response or restoration work; (ii) responding to any notice, claim, cause of action, order, action,
or investigation by any Person alleging potential liability for property damage (including claims
for interference with use and diminution in value) or death or injury to Persons; (iii) negotiation
with or obtaining any permits, consents, approvals or authorizations from any Governmental Body
necessary to address, correct or respond to an Environmental Condition or to comply with
Environmental Laws; (iv) preparing and implementing any plans or studies for any such activity; (v)
actions necessary to obtain a written notice from a Governmental Body with jurisdiction over any
Company Property that no material additional work is required by such Governmental Body; (vi) the
use, implementation, application, installation, operation or maintenance on any Company Property of
remedial technologies applied to the surface or subsurface soils, excavation and treatment or
disposal of soils at such Company Property, systems for long-term treatment or surface water or
groundwater, engineering controls or institutional controls; (vii) the design, acquisition and
installation of pollution control equipment required under Environmental Laws; and (viii) any other
activities reasonably determined to be necessary or required under Environmental Laws to address or
respond to an Environmental Condition.

          “Equity Securities” of any Person means (i) shares of capital stock, limited liability
company interests, partnership interests or other equity securities of such Person, including, with
respect to the Company, the Company Common Stock, (ii) subscriptions, calls, warrants, options or
commitments of any kind or character relating to, or entitling any Person to purchase or otherwise
acquire, any capital stock, limited liability company interests, partnership interests or other
equity securities of such Person, (iii) securities convertible into or exercisable or exchangeable
for shares of capital stock, limited liability company interests, partnership interests or other
equity securities of such Person, and (iv) share of registered capital, equity equivalents,
interests in the ownership or earnings of, or equity appreciation, phantom stock or other similar
rights of, or with respect to, such Person.

          “Equity Sellers” means the Common Stock Sellers and the Option Holders.

          “ERISA Affiliate” means any Person that is (or at any relevant time was) a member of a
“controlled group of corporations” with, under “common control” with, or a member of an “affiliated
service group” with, or otherwise required to be aggregated with, the Company or any of its
Subsidiaries as set forth in Section 414(b), (c), (m) or (o) of the Code.

          “Existing Contamination” shall mean (i) any Release of a Substance or (ii) any soil or
groundwater contamination by Substances, in each case, present as of the Closing Date, on or from
any of the Company Property.

6

 

          “Factored Receivables” means an amount equal to the sum of: Autozone Factored
Receivables plus Advance Auto Factored Receivables plus CarQuest/GPI Factored
Receivables plus the aggregate invoiced amount of all other accounts receivable due to the
Company or its Subsidiaries that have been purchased for cash as part of a similar factoring
arrangement and that were invoiced by the Company or its Subsidiaries and purchased by the bank or
other Person providing such financing prior to the Closing Date, for which the Company has received
cash as of the Closing, and for which the bank has not received cash from the applicable third
party in accordance with the terms of the applicable factoring arrangement as of the Closing Date.

          “GAAP” means generally accepted accounting principles in the United States as of the
date hereof.

          “Governmental Body” means any government or governmental or regulatory body thereof,
or political subdivision thereof, whether federal, state, local, foreign or multinational, or any
agency, instrumentality or authority thereof, or any court or arbitrator (public or private).

          “Handling of Substances” means the production, use, generation, Release, storage,
treatment, formulation, processing, labeling, distribution, introduction into commerce,
registration, transportation, reclamation, recycling or other handling or disposition of
Substances.

          “HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended
and the rules and regulations promulgated thereunder.

          “Improvements” means any buildings, facilities, other structures and improvements,
building systems and fixtures located on or under any Company Properties.

          “Indebtedness” of the Company means, without duplication, (i) the principal of and,
accreted value and/or accrued and unpaid interest in respect of (A) indebtedness of the Company and
its consolidated Subsidiaries for money borrowed and (B) indebtedness evidenced by notes,
debentures, bonds, letters of credit or other similar instruments for the payment of which any of
them is responsible or liable; (ii) all obligations of the Company and its consolidated
Subsidiaries issued or assumed as the deferred purchase price of property, all conditional sale
obligations of any of them and all obligations of any of them under any title retention agreement
(but excluding trade accounts payable and other current liabilities to the extent included in the
calculation of Closing Working Capital); (iii) all obligations of the Company and its consolidated
Subsidiaries in respect of leases required to be capitalized in accordance with GAAP; (iv) all
obligations of the Company and its consolidated Subsidiaries in respect of interest rate and
currency obligation swaps, hedges or similar arrangements (other than interest rate
caps, the cost of which have been paid in full prior to the date hereof); (v) all obligations
of the type referred to in clauses (i) through (iv) of any Persons the payment of which the Company
or any of its consolidated Subsidiaries is responsible or liable, directly or indirectly, as
obligor, guarantor, surety or otherwise; and (vi) all obligations of the type

7

 

referred to in
clauses (i) through (v) of the Company and its consolidated Subsidiaries secured by any Lien on any
of their Assets (whether or not such obligation is assumed by any of them).

          “Indemnification Percentage” means with respect to Linda Swaldo and William T.
Blackerby, Jr. collectively, 66.70% and, with respect to ACAS 33.30%.

          “Initial Cash Purchase Price” means an amount in cash equal to the Aggregate Equity
Value minus $8,300,000 (which represents the sum of all Rollover Sellers’ Rollover
Amounts).

          “Intellectual Property” means all intellectual property rights used by the Company and
the Subsidiaries arising from or in respect of the following: (i) all patents, utility models and
other rights in and to inventions and industrial designs and applications therefor, including
continuations, divisionals, continuations-in-part, or reissues of patent applications and patents
issuing thereon (collectively, “Patents”), (ii) all trademarks, service marks, trade names,
service names, brand names, trade dress rights, logos, Internet domain names and corporate names,
together with the goodwill associated with any of the foregoing, and all applications,
registrations and renewals thereof, (collectively, “Marks”), (iii) copyrights and
registrations, works of authorship and mask work rights, and all applications, registrations and
renewals thereof, (collectively, “Copyrights”), (iv) all Software and Technology of the
Company and the Subsidiaries, (v) trade secrets and other confidential and proprietary business
information, including but not limited to all designs, plans, drawings, flow charts, state
diagrams, specifications, technology, know-how, methods, designs, concepts and other proprietary
rights, whether or not registered, and (vi) rights under any licenses to use any of the
intellectual property described in clauses (i) to (v) above.

          “IRS” means the United States Internal Revenue Service and, to the extent relevant,
the United States Department of Treasury.

          “Joint Venture” means Shandong Yanzhou ASC Liancheng Industries Co., Ltd. a company
established in accordance with the laws of the PRC.

          “Knowledge” or “Known” means (i) with respect to the Sellers or the Company,
those facts or circumstances actually known by any of Theodore V. Swaldo, William T. Blackerby,
Jr., Lloyd Shi, Tao Qin or Geoff Doke, or any facts which would be known by a reasonable prudent
Person holding a comparable office or job or with comparable experience or responsibilities, and
(ii) with respect to the Purchaser, those facts or circumstances actually known by any of the
directors, officers and management-level employees of the Purchaser, or any facts or circumstances
which would be known after due inquiry by a person holding a comparable office or job or with
comparable experience or responsibilities.

          “Law” means any law (including common law), statute, code, ordinance, rule, regulation
or other similar pronouncement binding on the Company or any of its

8

 

Subsidiaries in each case,
issued by any Governmental Body (including the PRC) and in effect on the date hereof or the Closing
Date.

          “Legal Proceeding” means any judicial, administrative or arbitral actions, suits or
proceedings (public or private) by or before a Governmental Body.

          “Letter Agreement” means that certain letter agreement between the Company and ACAS
dated October 29, 2002 with respect to corporate opportunities.

          “Liability” means any debt, liability or obligation (whether direct or indirect,
absolute or contingent, accrued or unaccrued, liquidated or unliquidated, known or unknown, or due
or to become due) and including all costs and expenses relating thereto.

          “Lien” means any lien, encumbrance, pledge, mortgage, deed of trust, security
interest, claim, lease, charge, option, right of first refusal, easement, servitude or transfer
restriction.

          “Material Adverse Effect” means a material adverse change in or effect on (i) the
business, Assets, results of operations or financial condition of the Company and the Subsidiaries
(taken as a whole) or (ii) the ability of the Company to consummate the transactions contemplated
by this Agreement, other than, when the term “Material Adverse Effect” is used in Section
5.8 as it relates to the condition in Section 9.1(a) and in Section 9.1(f), an
event, occurrence or change resulting from an Excluded Matter. “Excluded Matter” means any
one or more of the following: (i) the effect of any change in the United States or foreign
economies or securities or financial markets in general (but solely to the extent that any such
change does not have a disproportionate effect on the Company or its Subsidiaries); (ii) the effect
of any change that generally affects any industry in which the Company or any of the Subsidiaries
operates (but solely to the extent that any such change does not have a disproportionate effect on
the Company or its Subsidiaries); (iii) the effect of any action taken by Purchaser or its
Affiliates with respect to the transactions contemplated hereby; (iv) the effect of any changes in
applicable Laws or accounting rules (but solely to the extent that any such change does not have a
disproportionate effect on the Company or its Subsidiaries) or (v) any effect resulting from the
public announcement of this Agreement, compliance with terms of this Agreement or the consummation
of the transactions contemplated by this Agreement.

          “Net Working Capital” means an amount equal to (i) Current Assets minus (ii)
Current Liabilities plus (iii) the aggregate amount of Factored Receivables.

          “Option Cancellation Agreements” means the agreement between the Company and each
Option Holder in the form attached as Exhibit J hereto, whereby such Option Holder agrees
to cancellation of his Options in consideration of receipt of payment pursuant to Section
2.3, as adjusted pursuant to Section 3.2.

          “Option Cancellation Amount” means the aggregate amount payable in respect of Options
pursuant to Section 2.3, as adjusted pursuant to Section 3.2 and the Option
Cancellation Agreements.

9

 

          “Option Holders” means each of Ying Hua Li, Tao Qin, Jeff Sandt, Scott Swaldo, Geoff
Doke, Dave Tate, Chris Johnson, Song De Shi, William Thomas and Al Barry.

          “Order” means any order, injunction, judgment, decree, ruling, writ, assessment or
arbitration award of a Governmental Body.

          “Ordinary Course of Business” means the ordinary and usual course of normal day-to-day
operations of the Company and the Subsidiaries as conducted during the twelve (12) months prior to
the date hereof.

          “Parent Common Stock” means the common stock, par value $0.01 per share, of Parent.

          “Per Share Equity Value” means an amount equal to the quotient of (a) the
Aggregate Equity Value, divided by (b) the sum of (i) the aggregate number of shares of
Common Stock issued and outstanding immediately prior to the Closing plus (ii) the aggregate number
of shares of Common Stock issuable upon exercise of all Options issued and outstanding immediately
prior to the Closing (and for the avoidance of doubt excluding any shares of Common Stock issuable
upon exercise of Warrants issued and outstanding immediately prior to the Closing).

          “Permits” means all of the approvals, authorizations, consents, licenses, permits or
certificates required by a Governmental Body for the ownership, leasing or operation of the Assets
or business of the Company or any of its Subsidiaries as conducted as of the date of this Agreement
or as of the Closing Date.

          “Permitted Exceptions” means (i) all defects, exceptions, restrictions, easements,
rights of way and encumbrances disclosed in policies of title insurance ,made available to
Purchaser prior to the date hereof; (ii) liens for Taxes, assessments or other governmental charges
or claims that are not yet due and payable or being contested in good faith by appropriate
proceedings, if a reserve or other appropriate provision, if any as required by GAAP shall have
been made therefor; (iii) mechanics’, carriers’, workers’, repairers’ and other Liens imposed by
law incurred in the Ordinary Course of Business for sums that are not yet due and payable or being
contested in good faith, if a reserve or other appropriate provision, if any, as required by GAAP
shall have been made therefor; (iv) zoning, entitlement and other land use and environmental
regulations by any Governmental Body; (v) title of a lessor under a capital or operating lease;
(vi) Liens securing Indebtedness of the Company and (vii) such other imperfections in title,
charges, easements, restrictions and encumbrances which do not materially impair the use or any
material Asset of the Company or its Subsidiaries in the Ordinary Course of Business or are not
otherwise material to the business of the Company and its Subsidiaries (taken as a whole).

          “Person” means any individual, corporation, partnership, limited liability company,
firm, joint venture, association, joint-stock company, trust, unincorporated organization,
Governmental Body or other entity.

10

 

          “Personnel” means all employees, officers, directors and independent contractors of,
employed by or contracting with the Company or any of its Subsidiaries.

          “POS Inventory” means (i) all inventory sold by the Company or its Subsidiaries to
Autozone Parts, Inc. and repurchased by POS Sales Corp. No. 7, Inc. in August 2004, April 2005, and
August 2005, minus (ii) all inventory of the Company or any of its Subsidiaries
subsequently resold to Autozone Parts, Inc. plus (iii) all inventory purchased by POS Sales
Corp. No. 7, Inc.

          “POS Payables” means all accounts payable by the Company or any of its Subsidiaries
(including POS Sales Corp. #7, Inc.) related to any repurchases by the Company or its Subsidiaries
of products previously sold to any of their respective customers prior to the Closing (including,
but not limited to, the three purchases from Autozone Parts, Inc. in August 2004, April 2005, and
August 2005 of POS Inventory).

          “PRC” means the People’s Republic of China.

          “Pre-Closing Tax Period” means the taxable periods ending on or before the Closing
Date.

          “Preferred Stock” means the Series A PIK Redeemable Preferred Stock of the Company,
par value $.001 per share.

          “Preferred Stock Redemption Amount” means the amount necessary to fully repay the
liquidation value and all accrued dividends on the Preferred Stock. Not more than three (3)
Business Days prior to the Closing, the Company shall deliver to Purchaser a letter confirmed in
writing by ACAS setting forth such amount and per diem interest on such amount.

          “Primary Indemnitors” means Linda Swaldo, William T. Blackerby, Jr. and ACAS.

          “Pro Rata Share” means the percentage of each Seller under the heading “Pro Rata
Share” on Exhibit A.

          “Purchase Price” means the Initial Cash Purchase Price, as adjusted pursuant to
Section 3.2(f).

          “Release” means any release, spill, emission, leaking, pumping, injection, deposit,
disposal, discharge, dispersal, leaching, or migration at, into or onto the Environment, including
movement or migration through or in the Environment, whether sudden or non-sudden and whether
accidental or non-accidental, or any release, emission or discharge as those terms are defined in
any applicable Environmental Law.

          “Rollover Amount” means, with respect to any Rollover Seller, the amount set forth in
the column headed “Rollover Amount” next to such Rollover Seller’s name on Exhibit A
hereto.

11

 

          “Rollover Sellers” shall mean each of Linda Swaldo and William T. Blackerby, Jr.

          “Seller Stockholders Agreement” means that certain Stockholders Agreement dated as of
October 29, 2002, by and among the Company, ACAS, Theodore V. Swaldo, Linda Swaldo, William T.
Blackerby, Jr., Christina Blackerby and each other person who executed such agreement as a
stockholder in the Company.

          “Software” means any and all (i) computer programs, applications and other computer
software, including, with respect to each, any and all processes, scripts and routines used to
process data, software implementations of algorithms, models and methodologies, whether in source
code or object code and documentation for any of the foregoing, and (ii) databases, compilations
and web sites, including any and all data and collections of data, whether machine readable or
otherwise.

          “Straddle Period” means any taxable period that begins before and ends after the
Closing Date.

          “Subsidiary” means any Person of which a majority of the outstanding share capital,
voting securities or other Equity Securities are owned, directly or indirectly, by the Company
and/or one or more other Subsidiaries of the Company.

          “Substances” means any wastes, substances, products, pollutants or materials, whether
solid, liquid or gaseous, that (i) is or contains asbestos, polychlorinated biphenyls, radioactive
materials, oil, petroleum or any fraction thereof, (ii) requires removal, remediation or reporting
under any Environmental Law, or is defined, listed or identified as a “contaminant”, “pollutant”,
“toxic substance”, “toxic material”, “hazardous waste” or “hazardous substance” or words of similar
meaning and regulatory effect thereunder, or (iii) is toxic, explosive, corrosive, flammable,
infectious, radioactive, carcinogenic, mutagenic or otherwise hazardous and is regulated as such by
any Governmental Authority under any Environmental Law.

          “SunTrust” means SunTrust Bank, a Georgia banking corporation.

          “SunTrust (Advance Auto) Factoring Agreement” means that certain Letter of
Understanding and Agreement, dated February 9, 2004, by and between ASC Industries, Inc. and
SunTrust.

          “SunTrust (Autozone) Factoring Agreement” means that certain Supplier Agreement, dated
as of November 30, 2004, by and between ASC Industries, Inc. and SunTrust.

          “Swaldo and Blackerby” means each of Linda Swaldo and William T. Blackerby, Jr.

          “Target Net Working Capital” means an amount equal to $52,640,000.

12

 

          “Tax” or “Taxes” means (i) any and all federal, state, local or foreign taxes,
charges, fees, imposts, levies or other assessments, including all net income, gross receipts,
capital, sales, use, ad valorem, value added, transfer, franchise, profits, inventory, capital
stock, license, withholding, payroll, employment, social security, unemployment, excise, severance,
stamp, occupation, property and estimated taxes, customs duties, fees, assessments and charges of
any kind whatsoever, and (ii) all interest, penalties, fines, additions to tax or additional
amounts imposed by any Taxing Authority.

          “Tax Return” means any return, report or statement required to be filed to a Taxing
Authority with respect to any Tax (including any schedule or attachments thereto, and any amendment
thereof), including any election, disclosure, information return, claim for refund, amended return
or declaration of estimated Tax, and including, where permitted or required, combined, consolidated
or unitary returns for any group of entities that includes Seller, any of the Subsidiaries, or any
of their Affiliates.

          “Taxing Authority” means the IRS and any other Governmental Body responsible for the
administration of any Tax.

          “Technology” means, collectively, all designs, formulae, algorithms, procedures,
methods, techniques, ideas, know-how, research and development, technical data, programs,
subroutines, tools, materials, specifications, processes, inventions (whether patentable or
unpatentable and whether or not reduced to practice), apparatus, creations, improvements, works of
authorship and other similar materials, and all recordings, graphs, drawings, reports, analyses,
and other writings, and other tangible embodiments of the foregoing, in any form whether or not
specifically listed herein, and all related technology, that are used in, incorporated in, embodied
in, displayed by or relate to, or are used by the Company or any Subsidiary.

          “Transaction Expenses” means obligations of the Company, the Subsidiaries and the
Sellers for all legal and other expenses incurred in connection with the transactions contemplated
herein (including any fees and expenses of (i) Weil, Gotshal & Manges LLP, (ii) Calfee, Halter &
Griswold LLP, (iii) Arnold & Porter LLP and (iv) any other advisers to ACAS or the Company
including Edgeview Partners); provided that Purchaser shall pay for all filing fees payable
to any Governmental Body in connection with the filing of notification under the HSR Act.

          “WARN” means the Worker Adjustment and Retraining Notification Act of 1988, as
amended, and the rules and regulations promulgated thereunder.

     1.2 Terms Defined Elsewhere in this Agreement. For purposes of this Agreement, the
following terms have meanings set forth in the sections indicated:

	 	 	 
	Term	 	Section
	280G Approval
	 	  8.18
	ACAS Cap
	 	10.5(c)
	ACAS Cap Exceptions
	 	10.5(c)

13

 

	 	 	 
	Term	 	Section
	Adjusted Tax Reserve
	 	11.1
	Adjustment Escrow Account
	 	  3.1(a)(ii)
	Adjustment Escrow Agreement
	 	  3.1(a)(ii)
	Agreement
	 	Recitals
	Antitrust Laws
	 	  8.4(a)
	Audited Financial Statements
	 	  5.6(a)
	Balance Sheet
	 	  5.6(a)
	Balance Sheet Date
	 	  5.6(a)
	Basket
	 	10.5(a)
	Buying Group
	 	11.4(b)(iii)
	Cancelled Options
	 	  2.3
	Cap
	 	10.5(a)
	Cap Exceptions
	 	10.5(a)
	Carlyle
	 	  8.9(c)
	CERCLA
	 	  5.18(c)
	CHG
	 	12.9
	Claim
	 	  8.7(c)
	Closing
	 	  4.1
	Closing Date
	 	  4.1
	Closing Deduction Refund or
Credit
	 	11.4(b)(i)
	Closing Deductions
	 	11.4(a)
	Closing Statement
	 	  3.2(b)
	Closing Working Capital
	 	  3.2(b)
	Collateral Source
	 	10.7(a)
	Common Stock
	 	Recitals
	Company
	 	Recitals
	Company Benefit Plan
	 	  5.14(a)
	Company Confidentiality
Agreement
	 	  8.6(a)
	Company Documents
	 	  5.2
	Company Pension Plan
	 	  5.14(c)
	Company Property
	 	  5.10(a)
	Company Properties
	 	  5.10(a)
	Contribution and
Subscription Agreement
	 	Recitals
	Copyrights
	 	  1.1 (in Intellectual Property definition)
	CPIII
	 	Recitals
	Debt Commitment Letter
	 	  7.7
	Employee
	 	  5.14(a)
	Employment Laws
	 	  5.15(c)
	Environmental Permits
	 	  5.18(a)
	Equity Sellers Representative
	 	12.3(b)
	ERISA
	 	  5.14(a)
	Estimated CapEx Adjustment
Amount
	 	  3.2(a)

14

 

	 	 	 
	Term	 	Section
	Estimated Cash
	 	  3.2(a)
	Estimated Closing Statement
	 	  3.2(a)
	Estimated Debt Amount
	 	  3.2(a)
	Estimated Net Working Capital
	 	  3.2(a)
	Estimated Working Capital
Adjustment
	 	  3.2(a)
	Excluded Matter
	 	  1.1 (in definition of Material Adverse Effect)
	Facility Sublease Amendment
	 	  8.13
	Final CapEx Adjustment Amount
	 	  3.2(f)(v)
	Final Cash
	 	  3.2(f)(v)
	Final Closing Date
Indebtedness Amount
	 	  3.2(f)(v)
	Final Working Capital
	 	  3.2(f)(v)
	Financial Statements
	 	  5.6(a)
	Financing Fees Deduction
	 	11.4(a)
	Foreign Benefit Plan
	 	  5.14(e)
	Group
	 	  5.9(n)
	Indemnification Claim
	 	10.4(b)
	Indemnitees
	 	  8.7(a)
	Indemnity Escrow Account
	 	10.6(a)
	Indemnity Escrow Agreement
	 	  3.1(a)(i)
	Indemnity Escrow Amount
	 	10.6(a)
	Independent Accountant
	 	  3.2(d)
	Loss
	 	10.2(a)
	Losses
	 	10.2(a)
	Machinery and Equipment
	 	  5.11(b)
	Marks
	 	  1.1 (in Intellectual Property definition)
	Material Contracts
	 	5.13(a)
	Maximum Amount
	 	  8.7(f)
	Net Debt Adjustment Amount
	 	  3.2(f)(iv)
	Options
	 	Recitals
	Option Deduction
	 	11.4(a)
	Ordering Rule
	 	11.4(b)(iii)
	Owned Property
	 	  5.10(a)
	Owned Properties
	 	  5.10(a)
	Parent
	 	Recitals
	Patents
	 	  1.1 (in Intellectual Property definition)
	Personal Property Leases
	 	  5.11(a)
	Post-Closing Tax Period
	 	  5.9(p)
	Pre-Closing Tax Returns
	 	11.6(b)
	Prior Return(s)
	 	11.4(b)(i)
	Purchaser
	 	Recitals
	Purchaser Confidentiality
Agreement
	 	  8.6(b)

15

 

	 	 	 
	Term	 	Section
	Purchaser Documents
	 	  7.2
	Purchaser Indemnified Parties
	 	10.2(a)
	Real Property Lease
	 	  5.10(a)
	Real Property Leases
	 	  5.10(a)
	Related Party Transaction
	 	  5.22
	Related Persons
	 	10.9
	Releasee/Releasees
	 	10.9
	Rollover Shares
	 	  2.2
	Securities
	 	Recitals
	Securities Act
	 	  7.5
	Sellers
	 	Recitals
	Seller Documents
	 	6.2
	Seller Indemnified Parties
	 	10.3(a)
	Seller Representative
	 	12.3(a)
	Sellers’ Tax Contest Claim
	 	11.5
	Shares
	 	Recitals
	Short Period
	 	11.6(a)
	Step-Down Date
	 	10.6(b)(i)
	Straddle Period Return(s)
	 	11.6(c)
	Stub Period Return(s)
	 	11.6(b)
	Sub-Basket
	 	10.5(a)
	Subsidiary Equity Securities
	 	  5.5(a)
	Survival Period
	 	10.1
	Taxpayer
	 	  5.9(a)
	Tax Benefit Amount
	 	11.1(b)
	Tax Claim Notice
	 	11.5
	Tax Contest Claim
	 	11.5
	Termination Date
	 	  4.2
	Transaction Fees Deduction
	 	11.4(a)
	UCI
	 	Recitals
	Unaudited Financial
Statements
	 	  5.6(a)
	Unresolved Claims
	 	10.6(b)(i)
	Updated Schedules
	 	  8.11(a)
	Utilized Tax Attributes
	 	11.4(b)(iii)
	Warrants
	 	Recitals
	WGM
	 	12.9

     1.3 Other Definitional and Interpretive Matters.

          (a) Unless otherwise expressly provided, for purposes of this Agreement, the following rules
of interpretation shall apply:

          Calculation of Time Period. When calculating the period of time before which, within
which or following which any act is to be done or step taken pursuant to

16

 

this Agreement, the date
that is the reference date in calculating such period shall be excluded. If the last day of such
period is a non-Business Day, the period in question shall end on the next succeeding Business Day.

          Dollars. Any reference in this Agreement to $ shall mean U.S. dollars.

          Exhibits/Schedules. All Exhibits and Schedules annexed hereto or referred to herein
are hereby incorporated in and made a part of this Agreement as if set forth in full herein. Any
matter or item disclosed on one Schedule shall be deemed to have been disclosed on each other
Schedule to the extent the applicability of such disclosure to the matters required to be disclosed
on such other Schedule are reasonably apparent based solely upon the face of such disclosure.
Disclosure of any item on any Schedule shall not constitute an admission or indication that such
item or matter is material or would have a Material Adverse Effect. No disclosure on a Schedule
relating to a possible breach or violation of any Contract, Law or Order shall be construed as an
admission or indication that breach or violation exists or has actually occurred. Any capitalized
terms used in any Schedule or Exhibit but not otherwise defined therein shall be defined as set
forth in this Agreement.

          Gender and Number. Any reference in this Agreement to gender shall include all
genders, and words imparting the singular number only shall include the plural and vice versa.

          Headings. The provision of a Table of Contents, the division of this Agreement into
Articles, Sections and other subdivisions and the insertion of headings are for convenience of
reference only and shall not affect or be utilized in construing or interpreting this Agreement.
All references in this Agreement to any “Section” are to the corresponding Section of this
Agreement unless otherwise specified.

          Herein. The words such as “herein,” “hereinafter,” “hereof,”
and “hereunder” refer to this Agreement as a whole and not merely to a subdivision in which
such words appear unless the context otherwise requires.

          Including. The word “including” or any variation thereof means (unless the
context of its usage otherwise requires) “including, without limitation” and shall not be
construed to limit any general statement that it follows to the specific or similar items or
matters immediately following it.

          (b) The parties hereto have participated jointly in the negotiation and drafting of this
Agreement and, in the event an ambiguity or question of intent or interpretation arises, this
Agreement shall be construed as jointly drafted by the parties hereto and no presumption or burden
of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision
of this Agreement.

17

 

ARTICLE II

SALE AND PURCHASE OF SECURITIES

     2.1 Purchase and Sale of Shares. At the Closing, each Common Stock Seller shall sell
to Purchaser, and Purchaser shall purchase from each such Common Stock Seller, that number of
Shares set forth opposite each Common Stock Seller’s name under the heading “Total Shares” on
Exhibit A attached hereto, less the aggregate number of Rollover Shares
transferred to Parent by such Common Stock Seller as provided in Section 2.2, free and
clear of all Liens. In consideration of the sale of such Shares, at the Closing and upon delivery
of one or more certificates representing such Shares together with stock powers with respect to
such Shares duly endorsed in blank, Purchaser agrees to pay to each such Common Stock Seller an
aggregate amount of cash (subject to adjustment in accordance with Section 3.2(f)) equal to (x) the
number of Shares of Common Stock sold by such Common Stock Seller as determined in accordance with
the preceding sentence multiplied by (y) the Per Share Equity Value. Notwithstanding the
foregoing, (1) a portion of the consideration otherwise payable pursuant to the preceding sentence
(i) to Linda Swaldo equal to $6,650,000 and (ii) to William T. Blackerby, Jr. equal to $350,000,
shall be deposited with the Escrow Agent as the Indemnity Escrow Amount in accordance with
Section 3.1(a)(i) and (2) a portion of the consideration otherwise payable pursuant to the
preceding sentence to the Equity Sellers equal to $2,000,000 (pro rata in accordance with the
amount of such consideration otherwise payable to each of them) shall be deposited with the Escrow
Agent as the Adjustment Escrow Amount in accordance with Section 3.1(a)(ii).

     2.2 Exchange of Rollover Shares for Parent Common Stock. At the Closing, the Rollover
Sellers shall contribute, convey, grant, transfer and deliver to Parent free and clear of all
Liens, and Parent shall accept and take delivery from each Rollover Seller, a number of shares of
Common Stock (the “Rollover Shares”) equal to such Rollover Seller’s Rollover Amount
divided by the Per Share Equity Value (prior to adjustment pursuant to Section 3.2(f))
pursuant to a Contribution and Subscription Agreement in the form attached hereto as Exhibit
D. In consideration of (x) the transfer by Linda Swaldo to Parent of such number of Rollover
Shares as is required to be contributed by her pursuant to this Section 2.2 and upon
delivery of an executed Contribution and Subscription Agreement and one or more certificates
representing such Rollover Shares together with stock powers with respect to such Rollover Shares
duly endorsed in blank, Parent agrees to issue to Linda Swaldo 80,000 shares of Parent Common Stock
and (y) the transfer by William T. Blackerby, Jr. to Parent of such number of Rollover Shares as is
required to be contributed by him pursuant to this Section 2.2 and upon delivery of an
executed Contribution and Subscription Agreement and one or more certificates representing such
Rollover Shares together with stock powers with respect to such Rollover Shares duly endorsed in
blank, Parent agrees to issue to William T. Blackerby, Jr. 3,000 shares of Parent Common Stock.
Parent and the Rollover Sellers hereby acknowledge and agree that the
conveyance of the Rollover Shares for Parent Common Stock, by reason of being part of an
overall integrated transaction, is intended to qualify as an exchange under Section 351 of the
Code, and the parties hereto shall file all Tax Returns or other reports, as required, consistent
with such position, and shall take no contrary position, unless required to do so by applicable
Law.

     2.3 Cancellation of Options. Prior to the Closing, the Company shall take all actions
to provide for the cancellation, effective at the Closing, subject to the payment as

18

 

provided for
herein, of all Options set forth under the heading “Cancelled Options” opposite each Option
Holder’s name on Exhibit A attached hereto (the “Cancelled Options”). Immediately
prior to the Closing, each Cancelled Option (as set forth on Exhibit A), shall no longer be
exercisable for the purchase of shares of Common Stock but shall entitle each holder thereof, in
cancellation and settlement therefor, to a payment by the Company in cash, at the Closing, equal to
(i) the product of (x) the total number of shares of Common Stock that would have otherwise been
issuable upon the exercise of such Cancelled Option, and (y) the Per Share Equity Value,
minus (ii) the aggregate exercise price payable upon exercise in full of such Cancelled
Option. It shall be a condition precedent to the right of any Cancelled Option Holder to receive
the consideration contemplated by the preceding sentence in respect of such Cancelled Option
Holder’s Cancelled Options, that such Cancelled Option Holder execute an Option Cancellation
Agreement with respect thereto, and the Company shall take all actions reasonably requested by
Purchaser to provide for the execution of all Option Cancellation Agreements prior to Closing. Any
payments made to the Option Holders under this Agreement, the Earn-Out Agreement and the Option
Cancellation Agreements (including any amounts to be distributed from the Adjustment Escrow Account
to such Option Holders) shall be subject to reduction as required by applicable federal and state
withholding Laws, and all such withheld amounts shall be paid to the Company and thereafter
remitted by the Company to the applicable Taxing Authorities promptly following the date of
payment. The vesting schedule of all Cancelled Options shall be accelerated so that 100% of the
Cancelled Options shall be vested on the Closing Date.

     2.4 Cancellation of Warrants. Prior to the Closing, the Company and ACAS shall take
all actions reasonably requested by Purchaser to cancel, effective at the Closing and subject to
the payment of the ACAS Warrant Amount, all Warrants.

     2.5 Redemption of the Preferred Stock. Prior to the Closing, the Company and ACAS
shall take all actions reasonably requested by Purchaser to cause the Company to redeem, effective
at the Closing and subject to the payment of the Preferred Stock Redemption Amount, all shares of
Preferred Stock outstanding as of the Closing. In consideration therefor, at the Closing,
Purchaser shall cause the Company to pay to ACAS the Preferred Stock Redemption Amount against
delivery of the certificates representing the shares of
Preferred Stock being redeemed together with stock powers with respect to such Shares duly
endorsed in blank.

     2.6 Earn-Out Agreement. At the Closing, Purchaser and Sellers shall execute and
deliver to each other an Earn-Out Agreement, substantially in the form of Exhibit K hereof
(the “Earn-Out Agreement”) pursuant to which each of the Equity Sellers each of the Equity Sellers
shall receive up to an amount equal to $4,000,000 to the extent the conditions for payment thereof
in the Earn-Out Agreement have been satisfied multiplied by such Equity Seller’s Pro Rata
Share as additional consideration for the sale of Shares and/or cancellation of Options held by
them prior to the Closing. Such additional payment, if any, shall be treated as additional
purchase price payable to such Equity Sellers for all purposes hereunder.

19

 

ARTICLE III

PURCHASE PRICE

     3.1 Payment of Initial Cash Purchase Price and Other Amounts.

          (a) At the Closing, Purchaser shall pay the Initial Cash Purchase Price, which shall be paid
by wire transfer of immediately available funds as follows:

     (i) $7,000,000 shall be paid to the Escrow Agent to be deposited in the Indemnity
Escrow Account and held and disbursed in accordance with a joint instruction escrow
agreement, the form of which shall mutually acceptable to Purchaser, the Equity Sellers
Representative and the Escrow Agent (the “Indemnity Escrow Agreement”) and this
Agreement;

     (ii) $2,000,000 shall be paid to the Escrow Agent to be deposited in an account (the
“Adjustment Escrow Account”) and held and disbursed in accordance with the a joint
instruction escrow agreement, the form of which shall be mutually acceptable to Purchaser,
Theodore W. Swaldo (on behalf of Linda Swaldo) and the Escrow Agent (the “Adjustment
Escrow Agreement”) and this Agreement;

     (iii) to each Common Stock Seller, an amount equal to the amount specified in
Section 2.1 (less, with respect to payments made to Linda Swaldo and
William T. Blackerby, Jr., the Indemnity Escrow Amount and their Pro Rata Share of the
Adjustment Escrow Amount); and

     (iv) to the Company on behalf of and for payment to the Option Holders, the Option
Cancellation Amount (less the Option Holder’s Pro Rata Share of the Adjusted Escrow
Amount).

          (b) At the Closing, Purchaser shall or shall provide the Company with sufficient funds and
cause the Company to, by wire transfer of immediately available funds, pay the Closing Date
Indebtedness to the lenders of the Company and the Subsidiaries (other than any Indebtedness of the
Company pursuant to capital leases to which the Company or its Subsidiaries is a Party) to such
account or accounts as such lenders shall direct in their respective debt payoff letters.

          (c) At the Closing, Purchaser shall or shall provide the Company with sufficient funds and
cause the Company to, by wire transfer of immediately available funds, pay the Transaction Expenses
due at Closing, as the Seller Representative shall direct.

          (d) At the Closing, Purchaser shall or shall provide the Company with sufficient funds and
cause the Company to, by wire transfer of immediately available funds, pay the Preferred Stock
Redemption Amount to ACAS in redemption of the Preferred Stock.

20

 

          (e) At the Closing, Purchaser shall or shall provide the Company with sufficient funds and
cause the Company to, by wire transfer of immediately available funds, pay the ACAS Warrant Amount
to ACAS as consideration for the cancellation of the Warrants.

     3.2 Purchase Price Adjustment.

          (a) Not less than three (3) Business Days prior to the Closing Date, the Equity Sellers
Representative shall cause the Company to deliver to Purchaser a statement (the “Estimated
Closing Statement”) certified by the Company’s chief financial officer setting forth in
reasonable detail (i) the Company’s estimated Net Working Capital as of the time of the Closing
(“Estimated Net Working Capital”) and the calculation thereof, (ii) the Company’s estimated
Cash as of the Closing (“Estimated Cash”) and the calculation thereof, (iii) the Company’s
estimated Closing Date Indebtedness Amount (“Estimated Debt Amount”) and the calculation
thereof and (iv) the Company’s estimate of the CapEx Adjustment Amount (the “Estimated CapEx
Adjustment Amount”) and a reasonably detailed calculation thereof. If Target Net Working
Capital exceeds Estimated Net Working Capital by more than $1,500,000, then the amount of such
excess above $1,500,000 shall be deducted from clause (a) in the definition of “Aggregate Equity
Value” as provided therein. If Estimated Net Working Capital exceeds Target Net Working Capital by
more than $1,500,000, then the amount of such excess above $1,500,000 shall be added to clause (a)
in the definition of “Aggregate Equity Value” as provided therein. Such deduction or addition is
sometimes referred to herein as the “Estimated Working Capital Adjustment.” The Estimated
Cash, Estimated Debt Amount and Estimated CapEx Adjustment Amount will be used for the purposes of
calculating the “Aggregate Equity Value” at Closing and in the event that actual Cash, Closing Date
Indebtedness Amount or actual CapEx Adjustment Amount is greater than or less than the Estimated
Cash, the Estimated Debt Amount, or the
Estimated CapEx Amount respectively, the Aggregate Equity Value will be subject to adjustment
in accordance with Section 3.2(f) below.

          (b) As promptly as practicable, but no later than ninety (90) days after the Closing Date,
Purchaser shall cause to be prepared and delivered to the Equity Sellers Representative a closing
statement (the “Closing Statement”) and a certificate based on such Closing Statement
setting forth in reasonable detail the Purchaser’s calculation of (i) Net Working Capital
(“Closing Working Capital”), (ii) Cash, (iii) Closing Date Indebtedness Amount and (iv) the
CapEx Adjustment Amount, in each case, as of immediately prior to the time of the Closing. The
preparation of the Closing Statement shall be for the sole purpose of determining differences in
Closing Working Capital from Estimated Net Working Capital, and for determining Cash, Closing Date
Indebtedness Amount and the CapEx Adjustment Amount as of the Closing.

          (c) If the Equity Sellers Representative disagrees with Purchaser’s calculation of Closing
Working Capital, Cash, Closing Date Indebtedness Amount and/or CapEx Adjustment Amount delivered
pursuant to Section 3.2(b), the Equity Sellers Representative may, within fifteen (15) days
after delivery of the Closing Statement, deliver a notice to Purchaser stating that the Equity
Sellers Representative disagrees with

21

 

such calculation and specifying in reasonable detail those
items or amounts as to which the Equity Sellers Representative disagrees and the basis therefor.

          (d) If a notice of disagreement shall be duly delivered pursuant to Section 3.2(c),
the Equity Sellers Representative and Purchaser shall, during the fifteen (15) days following such
delivery, use their commercially reasonable efforts to reach agreement on the disputed items or
amounts in order to determine, as may be required, the amount of Closing Working Capital, Cash,
Closing Date Indebtedness Amount and CapEx Adjustment Amount. If during such period, the Equity
Sellers Representative and Purchaser are unable to reach such agreement, they shall promptly
thereafter cause Deloitte & Touche LLP or such other mutually agreeable independent accounting
firm, as the case may be (the “Independent Accountant”), to review this Agreement and the
disputed items or amounts for the purpose of calculating Closing Working Capital, Cash, Closing
Date Indebtedness Amount and CapEx Adjustment Amount (it being understood that in making such
calculation, the Independent Accountant shall be functioning as an expert and not as an
arbitrator). Purchaser and the Equity Sellers Representative shall cooperate with the Independent
Accountant and promptly provide all documents and information requested by the Independent
Accountant. In making such calculation, the Independent Accountant shall consider only those items
or amounts in the Closing Statement and Purchaser’s calculation of Closing Working Capital, Cash,
Closing Date Indebtedness Amount and CapEx Adjustment Amount as to which the Equity Sellers
Representative has disagreed in its notice of disagreement duly delivered pursuant to Section
3.2(c) and may not assign a value greater then the greatest positive or negative adjustment
requested by a party and in no event shall Final Working Capital be less than the Purchaser’s
calculation of Closing Working Capital delivered pursuant to Section 3.2(b) or more than
Equity Sellers Representative’s calculation of Closing Working Capital delivered pursuant to
Section 3.2(c). The Independent Accountant shall deliver to the Equity Sellers
Representative and Purchaser, as promptly as practicable (but in any
case no later than thirty (30) days from the date of engagement of the Independent
Accountant), a report setting forth such calculation. Such report shall be final and binding upon
the Equity Sellers and Purchaser, shall be deemed a final arbitration award that is binding on
Purchaser and the Equity Sellers, and neither Purchaser nor the Equity Sellers shall seek further
recourse to courts or other tribunals, other than to enforce such report. Judgment may be entered
to enforce such report in any court of competent jurisdiction. The Independent Accountant will
determine the allocation of the cost of its review and report based on the inverse of the
percentage its determination (before such allocation) bears to the total amount of the total items
in dispute as originally submitted to the Independent Accountant. For example, should the items in
dispute total in amount to $1,000 and the Independent Accountant awards $600 in favor of the Equity
Sellers’ position, 60% of the costs of its review would be borne by Purchaser and 40% of the costs
would be borne by the Equity Sellers.

          (e) The Equity Sellers, Purchaser and the Company shall, and shall cause their respective
representatives to, cooperate and assist in the preparation of the Closing Statement and the
calculation of Closing Working Capital, Cash, Closing Date Indebtedness Amount and CapEx Adjustment
Amount and in the conduct of the review

22

 

referred to in this Section 3.2, including the
making available to the extent necessary of books, records, work papers and personnel.

          (f) Payments of Adjustment Amounts.

     (i) If Final Working Capital exceeds the Target Net Working Capital by more than
$1,500,000, Purchaser shall pay to the Equity Sellers, in the manner and with interest as
provided in Section 3.2(g), the amount of such excess above $1,500,000, net of the
Estimated Working Capital Adjustment, if any, added to or subtracted from Aggregate Equity
Value (with an additive Estimated Working Capital Adjustment to be subtracted from the
amount payable by Purchaser hereunder and a subtracting Estimated Working Capital
Adjustment to be added to the amount payable by Purchaser hereunder). If, upon netting
such excess against the Estimated Working Capital Adjustment, the result is a negative
number, the absolute value of the amount thereof shall be paid by the Equity Sellers to the
Purchaser.

     (ii) If the Target Net Working Capital exceeds Final Working Capital by more than
$1,500,000, the Equity Sellers shall pay to Purchaser, in the manner and with interest as
provided in Section 3.2(g), the amount of such excess above $1,500,000, net of the
Estimated Working Capital Adjustment, if any, added to or subtracted from Aggregate Equity
Value (with a subtracting Estimated Working Capital Adjustment to be subtracted from the
amount payable by Equity Sellers hereunder and an additive Estimated Working Capital
Adjustment to be added to the amount payable by Equity Sellers). If, upon netting such
excess against the Estimated Working Capital Adjustment, the result is a negative number,
the absolute value of the amount thereof shall be paid by the Purchaser to the Equity
Sellers.

     (iii) In the event that the difference between Final Working Capital and Target
Working Capital is less than $1,500,000, the amount of Estimated Working Capital
Adjustment, if any, shall be paid by Equity Sellers to Purchaser (if the Estimated Working
Capital Adjustment was added to Aggregate Equity Value paid on the Closing Date) or by
Purchaser to Equity Sellers (if the Estimated Working Capital Adjustment was subtracted
from Aggregate Equity Value paid on the Closing Date).

     (iv) In the event that the Net Debt Adjustment Amount is greater than zero the Equity
Sellers shall pay to the Purchaser such amount, in the manner and with interest as provided
in Section 3.2(g). In the event that the Net Debt Adjustment Amount is less than
zero, the Purchaser shall pay to the Equity Sellers the absolute value of such amount, in
the manner and with interest as provided in Section 3.2(g). As used herein the
“Net Debt Adjustment Amount” shall mean an amount equal to (u) the Final CapEx Adjustment
Amount minus (v) the Estimated CapEx Adjustment Amount plus (w) the Final
Closing Date Indebtedness Amount minus (x) the Estimated Closing Date Indebtedness
Amount minus (y) the Estimated Cash plus (z) Final Cash.

23

 

     (v) “Final Working Capital,” “Final Cash,” “Final Closing Date
Indebtedness Amount” and “Final CapEx Adjustment Amount” mean respectively,
Closing Working Capital, Cash, Closing Date Indebtedness Amount and CapEx Adjustment Amount
(i) as shown in Purchaser’s calculation delivered pursuant to Section 3.2(b) if no
notice of disagreement with respect thereto is duly delivered pursuant to Section
3.2(c); or (ii) if such a notice of disagreement is delivered, (A) as agreed by the
Equity Sellers Representative and Purchaser pursuant to Section 3.2(d) or (B) in
the absence of such agreement, as shown in the Independent Accountant’s calculation
delivered pursuant to Section 3.2(d).

          (g) Any payment pursuant to Section 3.2(f) shall be made within five (5) Business Days
after all of Final Working Capital, Final Cash, Final Closing Date Indebtedness Amount and Final
CapEx Adjustment Amount have been determined by wire transfer of immediately available funds. Any
payment by Purchaser to the Equity Sellers shall be made to the Equity Sellers Representative, on
behalf of the Equity Sellers, and shall thereafter be distributed by the Equity Sellers
Representative to the Equity Sellers in accordance with their respective Pro Rata Shares. Any
payment required to be made by the Equity Sellers to Purchaser pursuant to Section 3.2(f)
shall be funded first from the Adjustment Escrow Amount. In the event that the amount of such
payment exceeds the Adjustment Escrow Amount plus any interest earned thereon, the Equity Sellers
Representative shall pay such excess amount to Purchaser on behalf of the Equity Sellers. Each
Equity Seller shall be obligated to reimburse the Equity Sellers Representative for its Pro Rata
Share of such payment. The amount of any payment to be made pursuant to Section 3.2(f)
shall bear interest from and including the date due pursuant to this Section 3.2(g) to, but
excluding, the date of payment at a rate per annum equal to eight percent (8%). Such interest
shall be payable at the same time as the payment to which it relates and shall be calculated daily
on the basis of a year of three hundred sixty five (365) days and the actual number of days
elapsed. Upon final
determination of the Final Working Capital, Final Cash, Final Closing Date Indebtedness Amount
and Final CapEx Adjustment Amount, any cash remaining in the Adjustment Escrow Account following
any disbursement required to be made to Purchaser shall be paid to the Equity Sellers
Representative for distribution to the Equity Sellers pro rata in accordance with their respective
Pro Rata Shares. The Equity Sellers Representative and Purchaser shall each execute joint
instructions to the Escrow Agent to disburse the Adjustment Escrow Amount in accordance with this
Section 3.2.

ARTICLE IV

CLOSING AND TERMINATION

     4.1 Closing Date. The closing of the sale and purchase of the Shares provided for in
Article II hereof (the “Closing”) shall take place at the offices of Weil, Gotshal
& Manges LLP located at 767 Fifth Avenue, New York, New York 10153 at 10:00 a.m. (New York City
time) on a date to be specified by the parties (the “Closing Date”), which date shall be no
later than the third Business Day after the satisfaction or waiver of the conditions set forth in
Article IX (other than conditions that by their nature are to be

24

 

satisfied at the Closing,
but subject to the satisfaction or waiver of those conditions at such time), unless another time,
date or place is agreed to in writing by the parties hereto.

     4.2 Termination of Agreement. This Agreement may be terminated on any date (the
“Termination Date”) prior to the Closing as follows:

          (a) by Seller Representative and the Equity Sellers Representative, acting together, or by
Purchaser on or after October 31, 2006, if the Closing shall not have occurred by the close of
business on such date, provided that the terminating party is not in breach in any material respect
of any of its obligations hereunder;

          (b) by mutual written consent of the Seller Representative, Equity Sellers Representative and
Purchaser;

          (c) by the Seller Representative and the Equity Sellers Representative, acting together or
Purchaser if there shall be in effect a final nonappealable Order of a Governmental Body of
competent jurisdiction restraining, enjoining or otherwise prohibiting the consummation of the
transactions contemplated hereby; it being agreed that, subject to the last sentence of Section
8.4(b) hereof, the parties hereto shall promptly appeal any adverse determination which is
not nonappealable (and pursue such appeal with reasonable diligence); provided,
however, that the right to terminate this Agreement under this Section 4.2(c) shall
not be available to a party if such Order was primarily due to the failure of such party to perform
any of its obligations under this Agreement;

          (d) at any time before the Closing, by notice given by Seller Representative and the Equity
Sellers Representative, acting together, to Purchaser (i) in
the event of a material breach of this Agreement by Purchaser if Purchaser fails to cure such
breach within thirty (30) days following notification thereof by the Seller Representative and the
Equity Sellers Representative or (ii) upon the satisfaction of any condition to the Sellers’
obligations under this Agreement becoming impossible or impracticable with the use of commercially
reasonable efforts, if the failure of such condition to be satisfied is not caused by a breach of
this Agreement by any Seller or the Company;

          (e) at any time before the Closing, by notice given by Purchaser to Seller Representative and
Equity Sellers Representative (i) in the event of a material breach of this Agreement by any Seller
or the Company if such breaching party fails to cure such breach within thirty (30) days following
notification thereof by Purchaser or (ii) upon the satisfaction of any condition to the Purchaser’s
obligations under this Agreement becoming impossible or impracticable with the use of commercially
reasonable efforts, if the failure of such condition to be satisfied is not caused by a breach of
this Agreement by Purchaser; or

          (f) after delivery by the Company (if it so elects) of the Updated Schedules, by notice given
by Purchaser to the Seller Representative in accordance with and subject to, Section
8.11(a) hereof.

25

 

     4.3 Procedure Upon Termination. In the event of termination and abandonment by
Purchaser or Seller Representative and the Equity Sellers Representative (Seller Representative and
Equity Sellers Representative being considered one party), pursuant to Section 4.2 hereof,
written notice thereof shall forthwith be given to the other party or parties, and this Agreement
shall terminate, and the purchase of the Shares hereunder shall be abandoned, without further
action by Purchaser or the Sellers.

     4.4 Effect of Termination. In the event that this Agreement is validly terminated in
accordance with Section 4.2 and 4.3, then each of the parties shall be relieved of
their duties and obligations arising under this Agreement after the date of such termination and
such termination shall be without liability to Purchaser, the Company or any Seller other than
liability for any willful breach of this Agreement prior to the date of termination and,
provided, that the obligations of the parties set forth in the Confidentiality Agreement
and Article XII hereof shall survive any such termination and shall be enforceable
thereunder and hereunder.

ARTICLE V

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

          The Company hereby represents and warrants to Purchaser that:

     5.1 Organization and Good Standing. The Company is a corporation duly organized, validly existing and in good standing under
the laws of the State of Delaware and has all requisite corporate power and authority to own, lease
and operate its properties and to carry on its business as now conducted. The Company is duly
qualified or authorized to do business as a foreign corporation and is in good standing under the
laws of each jurisdiction in which it owns or leases real property and each other jurisdiction in
which the conduct of its business or the ownership of its properties requires such qualification or
authorization, except where the failure to be so qualified, authorized or in good standing,
individually and in the aggregate, has not had and would not reasonably be expected to have a
Material Adverse Effect.

     5.2 Authorization of Agreement. The Company has all requisite corporate power and
authority to execute and deliver this Agreement and each other agreement, document, or instrument
or certificate contemplated by this Agreement or to be executed by the Company in connection with
the consummation of the transactions contemplated by this Agreement (the “Company
Documents”), and to consummate the transactions contemplated hereby and thereby. The execution
and delivery of this Agreement and the Company Documents and the consummation of the transactions
contemplated hereby and thereby have been duly authorized by all requisite corporate action on the
part of the Company. This Agreement has been, and each of the Company Documents will be at or
prior to the Closing, duly and validly executed and delivered by the Company and (assuming the due
authorization, execution and delivery by the other parties hereto and thereto) this Agreement
constitutes, and each of the Company Documents will, when so executed and delivered, constitute,
the legal, valid and binding obligations of the Company, enforceable against it in accordance with
its terms, subject to applicable

26

 

bankruptcy, insolvency, reorganization, moratorium and similar
laws affecting creditors’ rights and remedies generally, and subject, as to enforceability, to
general principles of equity, including principles of commercial reasonableness, good faith and
fair dealing (regardless of whether enforcement is sought in a proceeding at law or in equity).

     5.3 Conflicts; Consents of Third Parties.

          (a) Except as set forth on Schedule 5.3(a), none of the execution and delivery by the
Company of this Agreement or any of the Company Documents, the consummation of the transactions
contemplated hereby or thereby, or compliance by the Company with any of the provisions hereof or
thereof will conflict with, or result in any violation of or default (with or without notice or
lapse of time, or both) under, or give rise to a right of termination or cancellation under, any
provision of, or result in the creation of any Encumbrance on any of the Assets of the Company or
its Subsidiaries pursuant to (i) the certificate of incorporation and by-laws or comparable
organizational documents of the Company or any Subsidiary; (ii) any Contract or Permit to which the
Company or any Subsidiary is a party or by which any of the Assets of the Company or any Subsidiary
are bound; (iii) any Order of any Governmental Body applicable to the
Company or any Subsidiary or by which any of the Assets of the Company or any Subsidiary are
bound; or (iv) any applicable Law, other than, in the case of clauses (ii), (iii) and (iv), such
conflicts, violations, defaults, terminations or cancellations that would not, individually or in
the aggregate, result in or reasonably be expected to result in a Material Adverse Effect.

          (b) Except as set forth on Schedule 5.3(b), no consent, waiver, approval, Order,
Permit or authorization of, or declaration or filing with, novation by, or notification to, any
Person or Governmental Body is required on the part of the Company or any Subsidiary in connection
with the execution and delivery of this Agreement or the Company Documents or the compliance by the
Company with any of the provisions hereof or thereof, or the consummation of the transactions
contemplated hereby or thereby, except for (i) compliance with the applicable requirements of the
HSR Act and (ii) such other consents, waivers, approvals, Orders, Permits or authorizations the
failure of which to obtain would not, individually or in the aggregate, result in or reasonably be
expected to result in a Material Adverse Effect.

     5.4 Capitalization.

          (a) The authorized capital stock of the Company consists solely of (i) 300,000 shares of
Common Stock, of which 150,000 shares are issued and outstanding and (ii) 200,000 shares of
Preferred Stock, of which 72,000 shares are issued and outstanding. All of the issued and
outstanding shares of Common Stock and Preferred Stock were duly authorized for issuance and are
validly issued, fully paid and non-assessable, are not subject to any preemptive rights and were
not issued in violation of the Securities Act or any other applicable Laws (including state “Blue
Sky” laws). Except as set forth on Schedule 5.4(a), no shares of Common Stock, Preferred
Stock or any other class of Equity Securities are reserved for issuance.

27

 

          (b) Except as set forth on Schedule 5.4(b), (i) there is no existing option, warrant,
call, right, or Contract of any character to which the Company is a party requiring, and there are
no securities of the Company outstanding that are convertible into or exchangeable or exercisable
for shares of Common Stock, Preferred Stock or any other Equity Securities of the Company, (ii)
there are no commitments or obligations of any kind or character providing for the issuance of
additional shares of Common Stock, Preferred Stock or any other Equity Securities of the Company,
the sale of treasury shares, or the repurchase, redemption or other acquisition of shares of Common
Stock, Preferred Stock or any other Equity Securities of the Company, or any obligations arising
from canceled stock, (iii) there are no agreements or circumstances of any kind which may obligate
the Company to issue, purchase, register for sale, redeem or otherwise acquire any of its Common
Stock, Preferred Stock or any other Equity Securities of the Company and (iv) there are no voting
trusts, shareholder agreements, proxies or other agreements in effect to which the Company is a
party or by which it may be bound with respect to the voting or transfer of the shares of Common
Stock or Preferred Stock.

     5.5 Subsidiaries.

          (a) Schedule 5.5 sets forth the name of each Subsidiary, and, with respect to each
Subsidiary, the jurisdiction in which it is incorporated or organized, the jurisdictions, if any,
in which it is qualified to do business, the number and type of its authorized Equity Securities,
the number of each class of Equity Securities duly issued and outstanding or the registered capital
of such Subsidiary (collectively, the “Subsidiary Equity Securities”), the current record
and beneficial ownership or the amount of the registered capital contributed by the Company and its
Subsidiaries of such Subsidiary Equity Securities and the identity of any other record and, to the
Knowledge of the Company, beneficial holder or contributor of registered capital of Subsidiary
Equity Securities. The Subsidiary Equity Securities described in Schedule 5.5 constitute
all the issued and outstanding Equity Securities of the respective Subsidiaries. Each Subsidiary
is a duly organized and validly existing corporation or other entity in good standing under the
laws of the jurisdiction of its incorporation or organization and is duly qualified or authorized
to do business as a foreign corporation or entity and is in good standing under the laws of each
jurisdiction in which the conduct of its business or the ownership of its properties requires such
qualification or authorization, except where the failure to be so qualified, authorized or in good
standing, individually and in the aggregate, has not had and would not reasonably be expected to
have a Material Adverse Effect. Each Subsidiary has all requisite corporate or entity power and
authority to own, lease and operate its properties and carry on its business as now conducted.

          (b) The Subsidiary Equity Securities are duly authorized and validly issued, fully paid and
non-assessable, are not subject to any pre-emptive rights and were not issued in violation of the
Securities Act or any other applicable Laws (including state “Blue Sky” laws), and all such shares
or other equity interests represented as being owned by Company or a Subsidiary are owned by it
free and clear of any and all Liens except as set forth on Schedule 5.5. There is no
existing option, warrant, call, right or Contract to which the Company or any Subsidiary is a party
requiring, and there are no convertible securities of any Subsidiary outstanding which upon
conversion would

28

 

require, the issuance of any shares of Subsidiary Equity Securities, the sale of
treasury shares, or the repurchase, redemption or other acquisition of any Subsidiary Equity
Securities, or any obligations arising from cancelled stock. Except as set forth in Schedule
5.5, there are no voting trusts, shareholder agreements, proxies or other agreements in effect
with respect to the voting or transfer of the Subsidiary Equity Securities held by the Company or
any of its Subsidiaries or to the Knowledge of the Company, the Subsidiary Equity Securities held
by any other Person. Except for the Subsidiary Equity Securities described in Schedule
5.5, neither the Company nor any of its Subsidiaries owns of record or beneficially any Equity
Securities of any Person or any right (contingent or otherwise) to acquire the same.

     5.6 Financial Statements.

          (a) The Company has made available to Purchaser true, correct and complete copies of (i) the
audited consolidated balance sheets of the Company and the Subsidiaries as at December 31, 2002,
2003 and 2004 and the related audited consolidated statements of income and of cash flows of the
Company and the Subsidiaries for the years then ended (the “Audited Financial Statements”)
and (ii) the unaudited consolidated balance sheet of the Company and the Subsidiaries as at
September 30, 2005 and the related consolidated statements of income and cash flows of the Company
and the Subsidiaries for the nine-month period then ended (the “Unaudited Financial
Statements” and together with the Audited Financial Statements, including the related notes
and schedules thereto, the “Financial Statements”). Except as set forth in the notes
thereto, each of the Financial Statements has been prepared in accordance with GAAP consistently
applied using the Agreed Principles (other than (i) the absence of footnotes and other presentation
items in the case of the Unaudited Financial Statements and (ii) normal year-end adjustments none
of which are material individually or in the aggregate) and presents fairly in all material
respects the consolidated financial position, results of operations and cash flows of the Company
and the Subsidiaries as at the dates and for the periods indicated therein.

     For the purposes hereof, the unaudited consolidated balance sheet of the Company and the
Subsidiaries as at September 30, 2005 is referred to as the “Balance Sheet” and September
30, 2005 is referred to as the “Balance Sheet Date.”

     5.7 No Undisclosed Liabilities. Neither the Company nor any Subsidiary has any
Liabilities of any kind that would have been required to be accrued, reflected in, reserved against
or otherwise described on a balance sheet or in the notes thereto prepared in accordance with GAAP
applied on a basis consistent with the Balance Sheet and were not so accrued, reflected, reserved
against or described, other than (a) Liabilities incurred in the Ordinary Course of Business after
the Balance Sheet Date, (b) Liabilities incurred in connection with the transactions contemplated
hereby, (c) Liabilities reflected and reserved against on the Balance Sheet or disclosed on
Schedule 5.7 and (d) Liabilities that individually or in the aggregate have not had, or
would not reasonably be expected to have, a Material Adverse Effect.

29

 

     5.8 Absence of Certain Developments. Except as expressly contemplated by this
Agreement or set forth on Schedule 5.8, since the Balance Sheet Date (a) the Company and
the Subsidiaries have conducted their respective businesses only in the Ordinary Course of Business
and have used their respective commercially reasonable efforts to preserve the business intact and
(b) there has not been any event, change, occurrence or circumstance that, individually or in the
aggregate, has had or would reasonably be expected to have a Material Adverse Effect. Without
limiting the generality of the foregoing, since the Balance Sheet Date:

     (i) there has not been any damage, destruction or loss, whether or not covered by
insurance, with respect to the Assets of the Company or any
Subsidiary having a replacement cost of more than $50,000 for any single loss or
$250,000 for all such losses;

     (ii) except in the Ordinary Course of Business pursuant to the terms of existing
Company Benefit Plans described on Schedule 5.14(a) or as required by Law, neither
the Company nor any Subsidiary has (1) awarded, paid, made, accrued, contingently or
otherwise, or granted, any bonus, incentive compensation, service award or other similar
benefit to Personnel, (2) entered into any employment, deferred compensation, severance or
similar agreement or agreed to increase the compensation payable or to become payable by it
to any of the Company’s or any Subsidiary’s current or former directors, officers or
employees, or (3) agreed to increase the coverage or benefits available under any severance
pay, termination pay, vacation pay, salary continuation for disability, sick leave,
deferred compensation, bonus or other incentive compensation, insurance, pension or other
employee benefit plan made to, for or with such directors, officers or employees;

     (iii) except in the ordinary course of business, neither the Company nor any
Subsidiary has made or rescinded any election relating to Taxes, or settled or compromised
any claim, action, suit, litigation, proceeding, arbitration, investigation, audit or
controversy relating to Taxes, or except as required by applicable law, made any change to
any of its methods of accounting or methods of reporting income or deductions for Tax or
accounting practice or policy, or filed any amended Tax Returns or consented to any
extension or waiver of the limitation period applicable to any claim or assessment relating
to Taxes;

     (iv) neither the Company nor any Subsidiary has acquired any Assets or sold, assigned,
transferred, conveyed, leased or otherwise disposed of any Assets of the Company or any
Subsidiary, except, for Assets acquired, sold, assigned, transferred, conveyed, leased or
otherwise disposed of in the Ordinary Course of Business;

     (v) neither the Company nor any Subsidiary has discharged or satisfied any Lien, or
paid any Liability, except in the Ordinary Course of Business;

30

 

     (vi) neither the Company nor any Subsidiary has canceled or compromised any debt or
claim or amended, canceled, terminated, relinquished, waived or released any Contract or
right except in the Ordinary Course of Business and which, in the aggregate, would not be
material to the Company and the Subsidiaries taken as a whole;

     (vii) neither the Company nor any Subsidiary has made or committed to make any capital
expenditures or capital additions or betterments in excess of $100,000 individually or
$250,000 in the aggregate;

     (viii) neither Company nor any Subsidiary has issued, created, incurred, assumed,
guaranteed, endorsed or otherwise become liable or responsible with respect to (whether
directly, contingently, or otherwise) any Indebtedness (other than the advancement of
expenses to Personnel of the Company or any of its Subsidiaries in the Ordinary Course of
Business);

     (ix) the Company has not granted any license or sublicense of any rights under or with
respect to any Intellectual Property except in the Ordinary Course of Business;

     (x) neither the Company nor any Subsidiary has amended or modified the Company Benefit
Plans, other than (i) amendments or modifications to such plans made in the Ordinary Course
of Business pursuant to the terms of such plans or as required by Law or (ii) the extension
of coverage to Personnel of the Company or any of its Subsidiaries who became eligible
after the Balance Sheet Date;

     (xi) neither the Company nor any Subsidiary has revalued any of their respective
Assets, including writing off notes or accounts receivable or revaluing inventory;

     (xii) neither the Company nor any Subsidiary has declared, set aside for payment or
paid any dividends or distributions (other than cash) in respect of any Equity Securities
of the Company or any of its Subsidiaries, or redeemed, purchased or otherwise acquired any
of the Company’s or any of the Subsidiary Equity Securities;

     (xiii) neither the Company nor any Subsidiary has issued or reserved for issuance, or
committed (including any stock option or other stock incentive award) to issue or reserve
for issuance, any Equity Securities of the Company or any of its Subsidiaries;

     (xiv) neither the Company nor any Subsidiary has materially and adversely modified or
terminated any material policy of insurance, any Material Contract or any Contract that
would be a Material Contract if in existence on the date hereof;

31

 

     (xv) neither the Company nor any Subsidiary has created, incurred or otherwise
suffered any Lien on any Asset of the Company or any of its Subsidiaries, other than
Permitted Exceptions;

     (xvi) neither the Company nor any Subsidiary has instituted or settled any Legal
Proceeding involving a claim or claims in excess of $50,000 in the aggregate; and

     (xvii) none of the Sellers or the Company has agreed, committed, arranged or entered
into any understanding to do anything set forth in this Section 5.8.

     5.9 Taxes. Except as set forth on Schedule 5.9:

          (a) Each of the Company and the Subsidiaries (each a “Taxpayer,” together the
“Taxpayers”) has timely filed with the appropriate Taxing Authority (or there has been
filed on its behalf) all income, franchise and other material federal, state and foreign Tax
Returns and reports required to be filed by it with the appropriate Taxing Authority and all such
Tax Returns are true, correct and complete in all material respects.

          (b) The unpaid Taxes of the Taxpayers attributable to the Pre-Closing Tax Period will not, as
of the Closing Date, exceed the reserve for Tax liability (other than a reserve for deferred Taxes
established to reflect timing differences between book and Tax income) set forth on the face of the
Closing Statement and taken into account in determining Closing Working Capital.

          (c) Each Taxpayer has in all material respects (i) withheld from any employee, customer,
independent contractor, creditor, shareholder and any other applicable payee the required amounts
for all taxable periods in compliance with all Tax withholding provisions of applicable federal,
state, local, or foreign laws; (ii) has remitted or will remit on a timely basis, such amounts to
the appropriate Taxing Authority; and (iii) has furnished properly completed sales and use tax
exemption certificates for all exempt transactions.

          (d) None of the Taxpayers has waived any statute of limitations for the assessment of any Tax
or agreed to a Tax assessment or deficiency for any taxable period that (after giving effect to
such extension or waiver) has not expired, nor is any request to so waive or extend outstanding.

          (e) None of the Taxpayers is a party to any Tax sharing, Tax indemnity or Tax allocation
agreement or other similar arrangement pursuant to which it will have any obligation to make
payments after the Closing Date.

          (f) No federal, state, local or foreign audits or other administrative or judicial Tax
proceedings by the IRS or by any state or foreign Taxing Authority are pending with respect to
Taxes or Tax Returns of any of the Taxpayers and, to the knowledge of the Taxpayers, no such audits
are threatened. There are no matters under discussion with any Taxing Authority or any matters
known to the Taxpayers with

32

 

respect to Taxes that would reasonably be expected to result in any
additional liability with respect to any Taxpayer.

          (g) There are no Liens for Taxes upon any property or Assets of any of the Taxpayers, except
for Liens for Taxes in the definition of Permitted Exceptions.

          (h) None of the Taxpayers has constituted either a “distributing corporation” or a “controlled
corporation” (within the meaning of Section 355(a)(1)(A) of the Code) in a distribution of stock
qualifying for tax-free treatment under Section 355 of the Code (A) in the two years prior to the
date of this Agreement or (B) in a distribution
which could otherwise constitute part of a “plan” or “series of related transactions” (within
the meaning of Section 355(e) of the Code) in conjunction with the transactions contemplated by
this Agreement.

          (i) No power of attorney has been granted that is currently in force by or with respect to any
Taxpayer with respect to any matter relating to Taxes.

          (j) No claim has been made in the last 5 years by any Taxing authority in a jurisdiction where
any of the Taxpayers do not file Tax Returns that any Taxpayer is subject to taxation in that
jurisdiction.

          (k) No Taxpayer (i) has consented at any time under former Section 341(f)(1) of the Code to
have the provisions of former Section 341(f)(2) of the Code apply to any disposition of any assets;
(ii) made an election, or is required to treat any asset as owned by another person pursuant to the
provisions of former Section 168(f) of the Code or as a tax-exempt bond financed property or
tax-exempt use property within the meaning of Section 168 of the Code; and (iii) has acquired or
owns any assets that directly or indirectly secure any debt the interest of which is tax exempt
under Section 103(a) of the Code.

          (l) None of the Taxpayers has participated in or cooperated with an international boycott.

          (m) No payment or other benefit that has been or may be made to any current or former employee
or independent contractor of any Taxpayer under any Company Benefit Plan may be characterized as an
“excess parachute payment” or, individually or collectively, would give rise to the payment of any
amount that would not be deductible pursuant to the terms of Section 280G of the Code. No Company
Benefit Plan provides to any “service provider” (within the meaning of Section 409A of the Code)
any compensation or benefits which could subject such service provider to gross income inclusion or
tax pursuant to Section 409A(a)(1) of the Code.

          (n) None of the Taxpayers has been a member of any “affiliated group” of corporations within
the meaning of Section 1504 of the Code or any group that has filed a combined, consolidated or
unitary state or local return (other than as a member of an affiliate group of which the parent is
the Company (such affiliated group, the “Group”)). None of the Taxpayers has any liability
for the Taxes of any other person under Treasury Regulations Section 1.1502-6 or Section 1.1502-78
(or any similar

33

 

provision of state, local, or foreign law), as a transferee or successor, by
contract or otherwise (other than for Taxes of other members of the Group).

          (o) None of the Taxpayer is or has been a “United States real property holding corporation”
within the meaning of Section 897(c)(2) of the Code during the applicable period specified in
Section 897(c)(1)(A)(ii) of the Code.

          (p) None of the Taxpayers, or any other member of any tax reporting group of which any
Taxpayer is a member shall be required to include in a taxable period beginning after the Closing
Date (a “Post-Closing Tax Period”) taxable income
attributable to income of any Taxpayer that accrued in a Pre-Closing Tax Period but was not
recognized in any Pre-Closing Tax Period including without limitation, by reason of (i) the
installment method of accounting, (ii) the long-term contract method of accounting, (iii) a
“closing agreement” described in Section 7121 of the Code (or any provision of any foreign, state
or local Tax law having similar effect), or (iv) Section 481 of the Code (or any provision of any
foreign, state or local Tax law having similar effect), or (v) earnings and profits of any Taxpayer
being recharacterized as “Subpart F income” (as defined under the provisions of Section 952 of the
Code) under the provisions of Section 952(c)(2) of the Code. The Company will not be required to
include in taxable income under Section 951 of the Code for any taxable period (or portion thereof)
ending after the Closing Date any amount of income arising from transactions or events occurring in
a taxable period (or portion thereof) ending on or prior to the Closing Date.

          (q) None of the Taxpayers that are organized under the laws of any country other than the
United States (i) has an investment in US property within the meaning of Section 956 of the Code;
(ii) is engaged in a US trade or business for US federal income Tax purposes or (iii) is a passive
foreign investment company within the meaning of the Code.

          (r) None of the Taxpayers has had a permanent establishment in any country other than in its
country of incorporation as defined in any applicable tax treaty or convention between the country
of incorporation and such foreign country.

          (s) There are no Advance Pricing Agreements between any of the Taxpayers and the Internal
Revenue Service or any other Taxing Authority in effect at the Closing Date.

          (t) None of the Taxpayers is required to make any disclosure to the IRS with respect to (i) a
“reportable transaction” within the meaning of Treasury Regulation Section 1.6011-4(b) or (ii) any
“confidential corporate tax shelter” within the meaning of Section 6111 of the Code and the
Treasury Regulations promulgated thereunder. Each Taxpayer has disclosed on their US federal
income Tax Returns all positions taken therein that could give rise to a substantial understatement
of US federal income Tax within the meaning of Section 6662 of the Code.

34

 

     5.10 Real Property.

          (a) Schedule 5.10(a) sets forth a complete list of (i) all real property and interests
in real property, including improvements thereon and easements appurtenant thereto owned in fee by
the Company and the Subsidiaries (individually, an “Owned Property” and collectively, the
“Owned Properties”), (ii) all real property and interests in real property leased by the
Company or the Subsidiaries (individually, a “Real Property Lease” and collectively, the
“Real Property Leases” and, together with the Owned Properties, being referred to herein
individually as a “Company Property” and collectively as the “Company Properties”)
as lessee or lessor, including a description of
each such Real Property Lease (including the name of the third party lessor or lessee and the
date of the lease or sublease and all amendments thereto). The Company and the Subsidiaries have
(i) good fee title to all Owned Property and (ii) a valid leasehold interest in, and enjoys
peaceful and undisturbed possession (consistent with historical use and pursuant to the terms of
the applicable lease) of, all Company Properties subject to Real Property Leases, in each case free
and clear of all Liens of any nature whatsoever, except (A) those Liens set forth on Schedule
5.10(a) and (B) Permitted Exceptions. The Company Properties constitute all interests in real
property currently used, occupied or currently held for use in connection with the business of the
Company and the Subsidiaries and which are necessary for the continued operation of the business of
the Company and the Subsidiaries as the business is currently conducted. All of the Company
Properties and buildings, fixtures and Improvements thereon are, to the Knowledge of the Company,
(i) in good operating condition, (ii) are free from material structural defects, and (iii) are
suitable, sufficient and appropriate in all respects for their current and contemplated uses. The
Company has delivered to Purchaser true, correct and complete copies of (i) all deeds, title
reports and surveys for the Owned Properties and (ii) the Real Property Leases, together with all
amendments, modifications or supplements, if any, thereto. The Company Properties are not subject
to any leases, rights, options, subleases, licenses, occupancy agreements, concessions or other
agreements or arrangements, written or oral, granting to any Person the right to purchase, or the
right to use or occupy any such Company Property, except the Real Property Leases.

          (b) Each of the Real Property Leases is in full force and effect. Neither the Company nor any
Subsidiary is (and, to the Knowledge of the Company, no other Person is) in default under any Real
Property Lease, and no breach by the Company (or, to the Knowledge of the Company, any other
Person) has occurred under any Real Property Lease which, if not remedied, would (whether with or
without notice or the passage of time or both) result in such a default.

          (c) The Company and the Subsidiaries have all certificates of occupancy and material Permits
of any Governmental Body necessary or useful for the current use and operation of each Company
Property, and any agreement, easement or other right from any other Person, necessary to permit the
lawful use and operation of the Improvements and the Company Property or any driveways, roads and
other means of egress and ingress to and from any Company Property and each such Permit, agreement,
easement or other right is in full force and effect, and there is no pending or, to the

35

 

Knowledge
of the Company, threatened proceeding which could result in the material and adverse modification
or cancellation thereof. No default or violation, or event that with the lapse of time or giving
of notice or both would become a default or violation, has occurred in the due observance of any
Permit. No Improvement, or the operation or maintenance thereof, violates any restrictive
covenant, or encroaches on any property owned or leased by any other Person, which has had or would
reasonably be expected to have a Material Adverse Effect.

          (d) Neither the Company nor any Subsidiary owns, holds, is obligated under or is a party to,
any option, right of first refusal or other contractual right to
purchase, acquire, sell, assign or dispose of any real estate or any portion thereof or
interest therein.

          (e) Subject to market limitations and the other events affecting the geographical area in
which any Company Property is located, the Company Property and the Improvements are sufficiently
supplied in all material respects with utilities and other services as reasonably necessary for the
operation of such Company Property and Improvements as currently operated including adequate water,
storm and sanitary sewer, gas, electric, cable and telephone facilities.

          (f) Neither the Company nor any of its Subsidiaries has received written notice of any
material special assessment relating to any Company Property or any portion thereof, and no such
special assessment is pending or, to the Knowledge of the Company, threatened. There are no
pending or, to the Knowledge of the Company, threatened condemnation or eminent domain proceedings
with respect to any material portion of any Company Property.

     5.11 Tangible Personal Property.

          (a) Schedule 5.11(a) sets forth all leases of personal property by the Company or a
Subsidiary (“Personal Property Leases”) involving annual payments in excess of $50,000.
Neither the Company nor any Subsidiary has received any written notice of, nor does the Company
have any Knowledge of, any default or any event that with notice or lapse of time, or both, would
constitute a default, by the Company or any Subsidiary under any of the Personal Property Leases.
Each of the Personal Property Leases is in full force and effect and enforceable in accordance with
its terms.

          (b) Except as set forth in Schedule 5.11(b), the Company or its Subsidiaries own and
have good title to all items of machinery, equipment, tools, spare parts, furniture, automobiles
and other fixed Assets reflected as owned by the Company or any of its Subsidiaries on the Balance
Sheet, in each case free and clear of any Encumbrances other than Permitted Encumbrances (the
“Machinery and Equipment”). The Machinery and Equipment, taken as a whole, are in good
operating condition and repair in all material respects (subject to normal wear and tear) and are
suitable in all material respects for the purposes for which they are currently used or have been
used in the Ordinary Course of Business. Except as otherwise contemplated by this Agreement, the
Company or its Subsidiaries own, or, in the case of leases and licenses, have valid,

36

 

enforceable
and subsisting leasehold interests or licenses in, all of the material Assets used in their
business, in each case free and clear of any Liens other than Permitted Exceptions.

     5.12 Intellectual Property.

          (a) List of Intellectual Property. Schedule 5.12(a) contains a complete and
accurate list of all material Patents, Marks and Copyrights held or used by the Company and the
Subsidiaries, including for each item listed, as applicable, the record owner, the jurisdiction in
which the item is issued or registered or in which any application for issuance or registration has
been filed, the application and/or registration/issuance number, the filing date, and the issuance
or registration date and together with all amendments, continuations, continuations-in-part,
reissuances and other material filings. All registration, renewal and maintenance fees and taxes
due and payable in respect of each of the applications and registrations listed on Schedule
5.12(a) have been paid in full.

          (b) Licenses. Schedule 5.12(b) sets forth a complete and accurate list of all
agreements (other than agreements with respect to “off-the-shelf” Software) between the Company or
any of its Subsidiaries, on the one hand, and any other Person, on the other hand, (i) granting any
other Person the right to use or practice any rights under any of the Intellectual Property owned
either by the Company or any of its Subsidiaries or (ii) granting the Company or a Subsidiary the
right to use or practice any rights under any Intellectual Property owned by another Person.

          (c) Protection of Proprietary Rights. The Company and the Subsidiaries own or have
valid enforceable royalty-free licenses to use all material Intellectual Property used by them,
free and clear of all Liens (except for Permitted Exceptions). Except as set forth on Schedule
5.12(c), (i) the material Intellectual Property used by the Company and the Subsidiaries are
not the subject of any pending or, to the Knowledge of the Company, threatened Legal Proceeding
challenging the validity, enforceability, registration, use or ownership by the Company or its
Subsidiaries of such Intellectual Property, (ii) neither the Company nor any Subsidiary has
received any written notice of any default or any event that with notice or lapse of time, or both,
would constitute a default under any material Intellectual Property license to which the Company or
any Subsidiary is a party or by which it is bound, (iii) to the Knowledge of the Company, no other
Person has the right to use any such Intellectual Property Rights, except pursuant to a Contract.

          (d) Intellectual Property Infringement. Except as set forth on Schedule
5.12(d), to the Knowledge of the Company, no other Person is infringing upon, misappropriating
or otherwise violating any Intellectual Property of the Company or any of its Subsidiaries. The
conduct of the Company’s or any of its Subsidiaries’ business as currently conducted (including the
use, distribution, marketing, sale, licensing of product and services by the Company or any of its
Subsidiaries) does not infringe upon, misappropriate or otherwise violate the Intellectual Property
of any other Person except as, individually or in the aggregate, has not had or would not
reasonably be expected to

37

 

have a Material Adverse Effect. No proceedings are pending or written
notices have been received by the Company or any of its Subsidiaries during the past three (3)
years alleging that the Company or any of its Subsidiaries has engaged in any activity or conduct
that materially infringes upon, misappropriates or otherwise violates any Intellectual Property of
another Person.

     5.13 Material Contracts.

          (a) Schedule 5.13(a) sets forth all of the following Contracts to which the Company or
any of the Subsidiaries is a party or by which any of them is bound as of the date of this
Agreement (collectively and together with any Contracts entered into prior to the Closing in
accordance with Section 8.2(b)(xiv) hereof, the “Material Contracts”):

     (i) Contracts with any Seller or any current officer, director or other Affiliate of
any Seller, the Company or any of the Subsidiaries or any family member of any such Person;

     (ii) Contracts with any labor union or association representing any employee of the
Company or any of the Subsidiaries and any written employment or severance agreement;

     (iii) Contracts for the sale of any material Assets of the Company or any of the
Subsidiaries (other than the sale of finished goods inventory in the Ordinary Course of
Business);

     (iv) Contracts relating to any acquisition to be made by the Company or any of the
Subsidiaries of any operating business or the capital stock of any other Person (or all or
any material portion of the Assets of any business, business unit, facility or Person);

     (v) Contracts relating to the incurrence of Indebtedness or the making of any loans to
any other Person by the Company or any of its Subsidiaries;

     (vi) Contracts which the Company reasonably anticipates will involve the expenditure
by or to the Company or its Subsidiaries of more than $250,000 in the aggregate or require
performance by any party more than one year from the date hereof;

     (vii) any sale and leaseback agreement covering a material Asset or any Contract
governing any business arrangement of this nature involving a material Asset;

     (viii) any Contract containing covenants limiting the freedom of the Company or any of
its Subsidiaries to engage in any line of business or compete with any Person;

38

 

     (ix) any material distribution, franchise, license, sales, commission, consulting
agency or advertising Contract which (A) involves annual payments, in excess of $50,000 or
(B) is not cancelable on thirty (30) calendar days’ notice without payment or penalty;

     (x) any licensing agreement or other Contract relating to Intellectual Property Rights
that is material to the operation of the business of the Company or any of its Subsidiaries
as conducted as of the date of this Agreement;

     (xi) any joint venture Contract, partnership agreement, limited liability company
agreement or other Contract (however named) involving a sharing of profits, losses, costs,
or liabilities by the Company or any of its Subsidiaries with any other Person;

     (xii) any Contract providing for capital expenditures after the date hereof in an
amount in excess of $100,000 individually or in the aggregate;

     (xiii) any material written warranty, guaranty or other similar undertaking with
respect to contractual performance extended by the Company or any of its Subsidiaries other
than in the Ordinary Course of Business;

     (xiv) any Contract with “take or pay” provisions, or “requirements” provisions
committing a Person to provide the quantity of goods or services required by another Person
which the Company reasonably anticipates will involve aggregate payments by or to the
Company or any of its Subsidiaries of more than $500,000;

     (xv) any Contract with any foreign sales agents;

     (xvi) any Contract with a customer of the Company or any of its Subsidiaries that
provides for pay-on-scan payment terms; and

     (xvii) any material agency agreement including without limitation material export
agency agreements.

In addition to the Contracts described in clauses (i) – (xvii) above, the defined term “Material
Contract” shall also include all unfulfilled purchase orders (or any series of related purchase
orders) involving the purchase or sale of products or services by the Company having an aggregate
value equal to or greater than $500,000, which purchase orders shall not be required to be
described or listed in Schedule 5.13(a).

          (b) Except as set forth on Schedule 5.13(b), neither the Company nor any Subsidiary is
in material breach or violation of, or default under, any Material Contract, nor has the Company or
any Subsidiary received any written notice of, nor does the Company have any Knowledge of, any
default or event that with notice or lapse of time, or both, would constitute a default by the
Company and the Subsidiaries under any Material Contract, nor, to the Knowledge of the Company or
the Sellers, is any other party to any Material Contract in breach of or default thereunder (other
than in the case of

39

 

purchase orders issued to the Company for the failure by any third party to pay
any amount due and owing thereunder). No party to any of the Material Contracts has exercised any
termination rights with respect thereto, and no party has given written notice of any material
dispute with respect to any Material Contract. The Company has made available to Purchaser true,
correct and complete copies of all of the Material
Contracts, together with all amendments, modifications or supplements thereto. Except as set
forth in Schedule 5.13(b), each Material Contract is in full force and effect (and will
remain in full force and effect upon consummation of the transactions contemplated by this
Agreement) and (i) is a valid agreement of the Company or Subsidiary which is a party thereto,
enforceable against such Company or Subsidiary in accordance with its terms and (ii) to the
Knowledge of the Company, is a valid agreement of each other party thereto, enforceable against
such party in accordance with its terms, except in each case where enforceability may be limited by
bankruptcy, insolvency or other similar laws affecting creditors’ rights generally and except where
enforceability is subject to the application of equitable principles or remedies. Except as
specifically noted in Schedule 5.13(b), no consent of any party to any Material Contract is
required in connection with the execution, delivery and performance of this Agreement by the
Company and the Sellers or the consummation of the transactions contemplated by this Agreement.

     5.14 Employee Benefits Plans.

          (a) Schedule 5.14(a) lists, by country, each “employee benefit plan” (as defined in
Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”)),
each bonus, stock option, stock purchase, incentive, deferred compensation, retirement, severance
and other employee benefit plans, programs and arrangements, and each employment and compensation
agreement (other than employment agreements that do not provide for severance, change in control or
similar payments), which is maintained, contributed to, or required to be contributed to by the
Company, any of its Subsidiaries or any ERISA Affiliates for the benefit of any current or former
employee, director or consultant of the Company or any of its Subsidiaries (each an
“Employee”), and with respect to which the Company or any of its Subsidiaries has or may
have any liability or obligation (each, a “Company Benefit Plan”). The Company has made
available to Purchaser correct and complete copies of (i) each Company Benefit Plan (or, in the
case of any such Company Benefit Plan that is unwritten, descriptions thereof), and all material
amendments thereto; (ii) each material consulting, relocation or repatriation agreement between the
Company or any of its Subsidiaries and any Employee; (iii) the two most recent Form 5500 or similar
tax returns (if any) for each Company Benefit Plan, if any; (iv) the most recent summary plan
description for each Company Benefit Plan for which such summary plan description is required; (iv)
each trust agreement and insurance or group annuity contract, if any, relating to any Company
Benefit Plan; (v) the most recent IRS determination or similar letter, if any, from any
Governmental Body relating to favorable tax treatment with respect to each Company Benefit Plan;
(vi) all material correspondence to or from any governmental agency pertaining to a Company Benefit
Plan, which was sent or received in the last two years; (vii) all discrimination tests, if any, for
each Company Benefit Plan for the most recent two plan years and (viii) the last two annual
actuarial valuations, if any, prepared for each Company Benefit Plan. Each Company Benefit Plan
has been

40

 

administered in all material respects in accordance with its terms. The Company and the
Subsidiaries, with respect to the Company Benefit Plans, are in compliance in all material respects
with the applicable provisions of ERISA, the Code and all other applicable
Laws. Neither the Company nor, to the Knowledge of the Company, any fiduciary of any Company
Benefit Plan has any material liability with respect to any transaction in violation of Sections
404 or 406 of ERISA or any “prohibited transaction,” as defined in Section 4975(c)(1) of the Code,
for which no exemption exists under Section 408 of ERISA or Section 4975(c)(2) or (d) of the Code.
The Company has not knowingly participated in a violation of Part 4 of Title I, Subtitle B of ERISA
by any plan fiduciary of any Plan and does not have any unpaid civil penalty under Section 502(l)
of ERISA which would result in a material liability.

          (b) Neither the Company nor any ERISA Affiliate sponsors, maintains or contributes to or,
within the past six (6) years, has sponsored, maintained or contributed to (i) any plan subject to
Title IV of ERISA or Section 412 of the Code, (ii) any “multiemployer plan,” as defined in Section
3(37) of ERISA, or (iii) any plan described in Section 413 of the Code. All liabilities with
respect to Company Benefit Plans that provide health benefits that are not fully insured through an
insurance contract are accrued in compliance with GAAP and all such Company Benefit Plans are
covered by stop-loss insurance policies that have been previously provided or made available to
Purchaser. Except as set forth in Schedule 5.14(b), no Company Benefit Plan provides
post-termination or retiree welfare benefits, and neither the Company nor any of its Subsidiaries
has any obligation to provide any post-termination or retiree welfare benefits other than health
care continuation as required by Section 4980B of the Code.

          (c) To the Knowledge of the Company, (i) each of the Company Benefit Plans that is an
“employee pension plan” (as defined in Section 3(2) of ERISA) that is intended to be tax qualified
under Section 401(a) of the Code (each, a “Company Pension Plan”) and that is maintained,
contributed to or sponsored by the Company or any of the Subsidiaries is so qualified and (ii) no
event has occurred since the date of the most recent determination letter or application therefor
relating to any such Company Pension Plan that would adversely affect the qualification of such
Company Pension Plan. Each Company Benefit Plan required to be registered or approved by a
Governmental Body has been registered with, or approved by, and has been maintained, in all
material respects, in good standing with the applicable Governmental Body and nothing has occurred
with respect to the operation of such Company Benefit Plans which is reasonably likely to cause the
loss of such good standing or the imposition of any material liabilities, penalty or tax under
applicable Law.

          (d) All contributions, premiums and benefit payments under or in connection with the Company
Benefit Plans that are required to have been made as of the date hereof in accordance with the
terms of the Company Benefit Plans have been timely made or have been reflected on the most recent
Balance Sheet. There are no pending actions, claims or lawsuits that have been asserted or
instituted against the Company Benefit Plans, the assets of any of the trusts under the Company
Benefit Plans or the sponsor or administrator of any of the Company Benefit Plans, or against any
fiduciary of

41

 

the Company Benefit Plans with respect to the operation of any of the Company Benefit
Plans (other than routine benefit claims).

          (e) With respect to each Company Benefit Plan that is not subject to United States Law (a
“Foreign Benefit Plan”), except as set forth in Schedule 5.14(e) or as would not
have or be reasonably expected to have a Material Adverse Effect: (i) all employer and employee
contributions to each Foreign Benefit Plan required by Law or by the terms of such Foreign Benefit
Plan have been made or, if applicable, accrued in accordance with normal accounting practices; (ii)
the fair market value of the assets of each funded Foreign Benefit Plan, the liability of each
insurer for any Foreign Benefit Plan funded through insurance or the book reserve established for
any Foreign Benefit Plan, together with any accrued contributions, is sufficient to procure or
provide for the accrued benefit obligations with respect to all current and former participants in
such plan, according to the actuarial assumptions and valuations most recently used and consistent
with applicable Law and normal accounting practices to determine employer contributions to such
Foreign Benefit Plan, and no transaction contemplated by this Agreement shall cause such assets,
reserve or insurance obligations to be less than such benefit obligations; and (iii) each Foreign
Benefit Plan required to be registered has been registered and has been maintained in good standing
with applicable regulatory authorities.

          (f) Except as contemplated by this Agreement, the execution of this Agreement and the
consummation of the transactions contemplated by this Agreement will not (whether alone or upon the
occurrence of any additional or subsequent events) constitute an event under any Company Benefit
Plan, trust or loan that will or may result in any payment (whether of severance pay or otherwise),
acceleration, forgiveness of indebtedness, vesting, distribution, increase in benefits or
obligation to fund benefits. No Company Benefit Plan provides for severance or change of control
benefits or a notice period upon termination of employment of more than three (3) months.

     5.15 Labor.

          (a) None of the Employees is represented in his or her capacity as an employee of the Company
or any of its Subsidiaries by any labor organization. Neither the Company nor any of its
Subsidiaries has recognized any labor organization, or has any labor organization been elected as
the collective bargaining agent of any Employees. Neither the Company nor any of its Subsidiaries
is a party to any collective bargaining agreement. Except as set forth in Schedule
5.15(a), neither the Company nor any of its Subsidiaries has entered into any severance or
similar arrangement in respect of any current or former employee of the Company or any of its
Subsidiaries that will result in any obligation (absolute or contingent) of Purchaser, the Company
or any of its Subsidiaries to make any payment to any current or former employee of the Company or
any of its Subsidiaries following termination of employment or upon a change of control of the
Company. There are no complaints, charges or claims against the Company or any of its Subsidiaries
pending or, to Knowledge of the Company, threatened, to be brought, by or filed with any
Governmental Body based on, arising out of, in connection with or

42

 

otherwise relating to the
employment or termination of employment or failure to employ by the Company or any of its
Subsidiaries, of any individual.

          (b) (i) There are no strikes, work stoppages, work slowdowns or lockouts pending or, to the
Knowledge of the Company, threatened with respect to the employees of the Company or any of its
Subsidiaries; and during the past three (3) years, neither the Company or any of its Subsidiaries
has experienced any strike, work stoppage, lock-up, slow-down or other material labor dispute or
any attempt by organized labor to cause the Company or any of its Subsidiaries to comply with or
conform to demands of organized labor relating to its employees or recognize any union or
collective bargaining units, or (ii) neither the Company nor any of its Subsidiaries has engaged in
any unfair labor practice and there are no grievances or complaints pending or, to the Knowledge of
the Company, threatened by or on behalf of any employee or group of employees of the Company or any
of the Subsidiaries.

          (c) Except as disclosed in Schedule 5.15(c), the Company and its Subsidiaries have
complied in all material respects with all Laws relating to employment, equal employment
opportunity, nondiscrimination, employment and reemployment rights of members of the uniformed
services, immigration, wages, hours, benefits, (including without limitation medical insurance,
unemployment insurance, pension and housing fund for employees of any Subsidiaries incorporated in
the PRC), collective bargaining, the payment of social security and similar taxes, occupational
safety and health and plant closings (hereinafter collectively referred to as the “Employment
Laws”). Neither the Company nor any of its Subsidiaries has any outstanding liability for the
payment of material taxes, fines, penalties or other amounts, however designated, for failure to
comply with any of the foregoing Employment Laws. There has been no “mass layoff” or “plant
closing” (as defined in WARN) with respect to the Company or any of its Subsidiaries within the
past six (6) months.

     5.16 Litigation. Except as set forth on Schedule 5.16, (a) there are no, and
during the three (3) years prior to the execution of this Agreement, there have been no Legal
Proceedings pending and, to the Knowledge of the Company, there are no Legal Proceedings threatened
against the Company or any of the Subsidiaries or any of the material Assets of the Company and its
Subsidiaries taken as a whole before any Governmental Body and (b) to the Knowledge of the Company,
neither the Company nor any of its Subsidiaries is, or during the three (3) years prior to the
execution of this Agreement has been, the subject of any pending investigation by any Governmental
Authority nor has any such investigation been threatened in writing. Neither the Company nor any
Subsidiary nor any of their Assets is subject to any Order of any Governmental Body that is
material to the Company and its Subsidiaries taken as a whole.

     5.17 Compliance with Laws; Permits.

          (a) Except as set forth in Schedule 5.17, the Company and the Subsidiaries are, and at
all times during the past three (3) years have been, in compliance
in all material respects with all Laws of any Governmental Body applicable to their

43

 

businesses. Neither the Company nor any Subsidiary has in the past three (3) years received any
written notice of or been charged with the material violation of any Laws. Neither the Company nor
any of its Subsidiaries has, during the past three (3) years, conducted any internal investigation
in connection with which the Company or its Subsidiaries retained outside legal counsel for the
purpose of conducting or assisting with such investigation with respect to any actual, potential or
alleged material violation of any Law by the Company, any of its Subsidiaries or any of their
employees.

          (b) The Company and the Subsidiaries currently have all material Permits which are required
for the operation of their respective businesses as presently conducted. Neither the Company nor
any of the Subsidiaries is in default or violation (and no event has occurred which, with notice or
the lapse of time or both, would constitute a default or violation) of any term, condition or
provision of any material Permit to which it is a party.

          (c) Notwithstanding the foregoing, no representation or warranty is made under this
Section 5.17 in respect of any matter relating to (i) Taxes that are addressed in
Section 5.9 (as to which no representation or warranty is made except as set forth in
Section 5.9) and (ii) environmental matters that are addressed in Section 5.18 (as
to which no representation or warranty is made except as set forth in Section 5.18).

     5.18 Environmental Matters.

          (a) Except as disclosed in Schedule 5.18 hereto, (i) the Company and each of its
Subsidiaries are and at all times during the past three (3) years have been in material compliance
with, and have no liability under, any and all applicable Environmental Laws, and (ii) the Company
and its Subsidiaries are in material compliance with all of their Permits issued under
Environmental Laws (“Environmental Permits”), and (iii) all instances of past noncompliance
have been cured, settled, and resolved in all material respects.

          (b) Except as disclosed in Schedule 5.18 hereto, all material Environmental Permits
required for the lawful ownership and operation of each Company Property have been obtained as of
the date hereof by or on behalf of the Company or any Subsidiaries, and remain in full force and
effect, and there are no pending Legal Proceedings by any Governmental Body that would reasonably
be expected to result in the termination, revocation, or adverse modification of any such
Environmental Permit.

          (c) Except as disclosed in Schedule 5.18 hereto, neither the Company nor any of its
Subsidiaries, with respect to any Company Property, has (i) received any written request for
information, or been notified in writing that it is a potentially responsible party, under the
Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended
(“CERCLA”), or any similar Environmental Law (whether in the United States, China, or
elsewhere), or (ii) been notified in writing that
any such Company Property has been or is proposed for listing on any list of sites requiring
investigation or cleanup.

44

 

          (d) Except as disclosed in Schedule 5.18 hereto, neither the Company nor any of its
Subsidiaries has received any written notice of any violation or alleged violation of any
Environmental Law.

          (e) Except as disclosed in Schedule 5.18 hereto, there are no outstanding Orders to
which the Company or its Subsidiaries are a party, and there are no Legal Proceedings or, to the
Knowledge of the Company, investigations to which the Company or its Subsidiaries are a party that
are pending or threatened, relating to the compliance of the Company with, or the liability of the
Company under, any Environmental Laws.

          (f) Except as disclosed in Schedule 5.18 hereto, (i) there is no Substance that poses
or would reasonably be expected to pose a material risk to the Environment on, at or under any
Company Property or any real property formerly owned, leased or operated by the Company or any of
its Subsidiaries, and (ii) there has heretofore been no Release of any such Substance on, at or
under any Company Property, in either case in an amount and of a nature which would reasonably be
expected to result in material liability to the Company or any of its Subsidiaries.

          (g) Neither the Company nor any Subsidiaries is party to any Contract pursuant to which it is
obligated to indemnify any other person with respect to, or be responsible for any liability
pursuant to or violation of, Environmental Law.

          (h) The Company and the Sellers have provided Purchaser with true and correct copies of all
environmental assessment reports (such as Phase I or Phase II reports) and any other environmental
studies in the possession of the Company, its Subsidiaries or any Seller relating to any Company
Property or any Handling of Substances.

     5.19 Product Liability, Warranty and Product Recalls. Except as set forth in
Schedule 5.19 or as would not, individually or in the aggregate, have or reasonably be
expected to have a Material Adverse Effect, to the Knowledge of the Company, neither the Company
nor any of its Subsidiaries has committed any act or omission which could reasonably be expected to
result in, or has any Knowledge of any facts or circumstances which could reasonably be expected to
give rise to (i) any product liability not covered by insurance (other than deductibles or
self-retention amounts under such insurance policies), (ii) any obligation to recall any products
produced by the Company or any of its Subsidiaries, or (iii) any costs to cure any breach of
warranty or failure to meet or exceed product specifications in excess of the reserve established
therefor on the Balance Sheet.

     5.20 Insurance.

          (a) Schedule 5.20 contains an accurate and complete description of all policies of
property, fire and casualty, product liability, workers’ compensation, and other forms of insurance
held by or for the benefit of the Company or any of its Subsidiaries (including any
occurrence-based policy that covers any insurable loss that occurred any

45

 

time after January 1,
2002). True, correct and complete copies of such insurance policies have been made available to
Purchaser.

          (b) All policies listed in Schedule 5.20 (i) are valid, outstanding, and enforceable
policies, (ii) provide adequate insurance coverage for the material Assets and the operations of
the business of the Company and its Subsidiaries for all material risks normally insured against by
a Person or entity carrying on the same business as the Company and (iii) will not terminate or
lapse by reason of the transactions contemplated by this Agreement. All premiums due with respect
to such policies have been timely paid.

          (c) Neither the Company nor any of its Subsidiaries has received (i) any notice of
cancellation of any policy listed in Schedule 5.20 or refusal of coverage thereunder, (ii)
any notice that any issuer of such policy has filed for protection under applicable bankruptcy laws
or is otherwise in the process of liquidating or has been liquidated, or (iii) any other notice
that such policies are no longer in full force or effect in any material respect or that the issuer
of any such policy is no longer willing or able to perform its obligations thereunder.

     5.21 Customers and Suppliers.

          (a) Schedule 5.21(a) sets forth the top 10 customer relationships of the Company
(based on aggregate total sales in U.S. dollars by the Company and its Subsidiaries for the fiscal
year ended December 31, 2005). Except as disclosed in Schedule 5.21(a), neither the
Company nor any of its Subsidiaries has received any written or oral notice that any such customer
has ceased, or will cease, to use its products, equipment, goods or services, or has substantially
reduced, or will substantially reduce, the use of such products, equipment, goods or services at
any time, or has requested or required, or will request or require, in a material and adverse
manner, any change in pricing or payment terms.

          (b) Schedule 5.21(b) sets forth the top 10 supplier relationships of the Company
(based on aggregate total purchases in U.S. dollars by the Company and its Subsidiaries for the
fiscal year ended December 31, 2005). Except as disclosed in Schedule 5.21(b), neither the
Company nor any of its Subsidiaries has received any written or oral notice that any such supplier
will not sell raw materials, supplies, merchandise and other goods to such Company or such
Subsidiary at any time after the Closing Date on terms and conditions substantially similar to
those currently in effect, subject only to general and customary price increases.

     5.22 Affiliate Transactions. Except as set forth in Schedule 5.22, no officer, shareholder or Affiliate of the
Company or any of its Subsidiaries or any individual related by blood, marriage or adoption to any
such Person or in which any such Person owns a greater than 10% beneficial interest, is, or in the
past three (3) years has been, a party to any Contract, commitment or transaction with the Company
or any of its Subsidiaries or has a material interest in any Assets used by the Company or any of
its Subsidiaries or has a material interest in any material property used or held for use by the

46

 

Company or any of its Subsidiaries (any such Contract, commitment, transaction or interest, a
“Related Party Transaction”). Neither the Company nor any of its Subsidiaries has
guaranteed or assumed any obligations of their respective officers, shareholders or Affiliates
(other than the Company and its Subsidiaries) or any of their family members.

     5.23 Financial Advisors. Except as set forth on Schedule 5.23, no Person has
acted, directly or indirectly, as a broker, finder or financial advisor for the Sellers or the
Company in connection with the transactions contemplated by this Agreement and no such Person is
entitled to any fee or commission or like payment from Purchaser in respect thereof.

     5.24 No Other Representations or Warranties; Schedules. Except for the
representations and warranties contained in this Article V (as modified by the Schedules
hereto), neither the Company nor any other Person makes any other express or implied representation
or warranty with respect the Company, the Subsidiaries or the transactions contemplated by this
Agreement, and the Company disclaims any other representations or warranties (and all liability and
responsibility with respect thereto), whether made by the Company, the Sellers or any of their
respective Affiliates, officers, directors, employees, agents or representatives, regardless of the
form in which it was made or communicated. Without limiting the generality of the foregoing, it is
understood that any information, projection, or advice that may have been or may be provided to
Purchaser by any director, officer, employee, agent, consultant, or representative of the Company
or the Sellers or any of their respective Affiliates as part of any management presentation or
otherwise are not and will not be deemed to be representations or warranties of the Company, except
as may be expressly set forth in this Agreement.

ARTICLE VI

REPRESENTATIONS AND WARRANTIES OF THE SELLERS

     Each Seller hereby represents, severally and not jointly, to Purchaser that:

     6.1 Organization and Good Standing. Such Seller is either (a) a corporation duly
organized, validly existing and in good standing under the laws of the jurisdiction of its
incorporation and has all requisite corporate power and authority to own, lease and operate its
properties and to carry on its business or (b) an individual.

     6.2 Authorization of Agreement. Such Seller has all requisite corporate or individual
power, authority and legal capacity to execute and deliver this Agreement and each other agreement,
document, or instrument or certificate contemplated by this Agreement or to be executed by such
Seller in connection with the consummation of the transactions contemplated by this Agreement
(together with this Agreement, the “Seller Documents”), and to consummate the transactions
contemplated hereby and thereby. The execution and delivery of this Agreement and each of the
Seller Documents and the consummation of the transactions contemplated hereby and thereby have been
duly authorized by all required corporate or individual action on the part of such Seller. This
Agreement has been, and each of the Seller Documents will be at or prior to the Closing,

47

 

duly and
validly executed and delivered by such Seller, and (assuming the due authorization, execution and
delivery by the other parties hereto and thereto) this Agreement constitutes, and each Seller
Document, when so executed and delivered will constitute, the legal, valid and binding obligation
of such Seller, enforceable against such Seller in accordance with its terms, subject to applicable
bankruptcy, insolvency, reorganization, moratorium and similar laws affecting creditors’ rights and
remedies generally, and subject, as to enforceability, to general principles of equity, including
principles of commercial reasonableness, good faith and fair dealing (regardless of whether
enforcement is sought in a proceeding at law or in equity).

     6.3 Conflicts; Consents of Third Parties.

          (a) Other than as provided in the Seller Stockholders Agreement, none of the execution and
delivery by such Seller of this Agreement or any of the Seller Documents, the consummation of the
transactions contemplated hereby or thereby, or compliance by such Seller with any of the
provisions hereof or thereof will conflict with, or result in any violation of or default (with or
without notice or lapse of time, or both) under, or give rise to a right of termination or
cancellation under, any provision of (i) the certificate of incorporation and by-laws (or other
organizational and governing documents) of such Seller; (ii) any Contract or Permit to which such
Seller is a party or by which any of the Assets of such Seller are bound; (iii) any Order of any
Governmental Body applicable to such Seller or by which any of the Assets of such Seller are bound;
or (iv) any applicable Law.

          (b) Other than as provided in the Seller Stockholders Agreement, no consent, waiver, approval,
Order, Permit or authorization of, or declaration or filing with, novation by, or notification to,
any Person or Governmental Body is required on the part of such Seller in connection with the
execution and delivery of this Agreement or the Seller Documents, or the compliance by such Seller
with any of the provisions hereof or thereof, the consummation of the transactions contemplated
hereby or thereby, except for (A) compliance with the applicable requirements of the HSR Act, and
(B) for such other consents, waivers, approvals, Orders, permits or authorizations the failure of
which to obtain would not prevent such Seller from consummating the transactions contemplated hereby or
under any of the Seller Documents.

     6.4 Ownership and Transfer of Securities. Such Seller is the record and beneficial
owner of the Securities indicated as being owned by such Seller on Exhibit A, free and
clear of any and all Liens. Other than as provided in the Seller Stockholders Agreement, such
Seller has the corporate or individual power and authority to sell, transfer, assign and deliver
the Securities as provided in this Agreement, and such delivery will convey to Purchaser good and
marketable title to such Securities, free and clear of any and all Liens.

     6.5 Litigation. There are no Legal Proceedings pending or, to the knowledge of such
Seller, threatened that are reasonably likely to prohibit or restrain the ability of such Seller to
enter into this Agreement or consummate the transactions contemplated hereby.

48

 

     6.6 Financial Advisors. Except as set forth on Schedule 6.6, no Person has
acted, directly or indirectly, as a broker, finder or financial advisor for such Seller in
connection with the transactions contemplated by this Agreement and no Person is entitled to any
fee or commission or like payment in respect thereof.

ARTICLE VII

REPRESENTATIONS AND WARRANTIES OF PURCHASER

          Purchaser hereby represents and warrants to the Sellers that:

     7.1 Organization and Good Standing. Purchaser is a corporation duly organized,
validly existing and in good standing under the laws of the State of Delaware and has all requisite
corporate power and authority to own, lease and operate properties and carry on its business.

     7.2 Authorization of Agreement. Purchaser has full corporate power and authority to
execute and deliver this Agreement and each other agreement, document, instrument or certificate
contemplated by this Agreement or to be executed by Purchaser in connection with the consummation
of the transactions contemplated hereby and thereby (the “Purchaser Documents”), and to
consummate the transactions contemplated hereby and thereby. The execution, delivery and
performance by Purchaser of this Agreement and each Purchaser Document have been duly authorized by
all necessary corporate action on behalf of Purchaser. This Agreement has been, and each Purchaser
Document will be at or prior to the Closing, duly executed and delivered by Purchaser and (assuming
the due authorization, execution and delivery by the other parties hereto and thereto) this Agreement
constitutes, and each Purchaser Document when so executed and delivered will constitute, the legal,
valid and binding obligation of Purchaser, enforceable against Purchaser in accordance with its
terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium and similar laws
affecting creditors’ rights and remedies generally, and subject, as to enforceability, to general
principles of equity, including principles of commercial reasonableness, good faith and fair
dealing (regardless of whether enforcement is sought in a proceeding at law or in equity).

     7.3 Conflicts; Consents of Third Parties.

          (a) None of the execution and delivery by Purchaser of this Agreement or any of the Purchaser
Documents, the consummation of the transactions contemplated hereby or thereby, or the compliance
by Purchaser with any of the provisions hereof or thereof will conflict with, or result in any
violation of or default (with or without notice or lapse of time, or both) under, or give rise to a
right of termination or cancellation under, any provision of (i) the certificate of incorporation
and by-laws of Purchaser (or other organizational or governing documents); (ii) any Contract or
Permit to which Purchaser is a party or by which Purchaser or its properties or Assets are bound;
(iii) any Order of any Governmental Body applicable to Purchaser or by which any of the properties
or Assets of Purchaser are bound; or (iv) any applicable Law.

49

 

          (b) No consent, waiver, approval, Order, Permit or authorization of, or declaration or filing
with, or notification to, any Person or Governmental Body is required on the part of Purchaser in
connection with the execution and delivery of this Agreement or the Purchaser Documents, the
compliance by Purchaser with any of the provisions hereof or thereof, the consummation of the
transactions contemplated hereby or thereby or the taking by Purchaser of any other action
contemplated hereby, except for (A) compliance with the applicable requirements of the HSR Act, and
(B) for such other consents, waives, approvals, Orders, permits or authorizations the failure of
which to obtain would not adversely affect Purchaser’s ability to consummate the transactions
contemplated hereby or under any of the Purchaser Documents.

     7.4 Litigation. There are no Legal Proceedings pending or, to the knowledge of
Purchaser, threatened that are reasonably likely to prohibit or restrain the ability of Purchaser
to enter into this Agreement or consummate the transactions contemplated hereby.

     7.5 Investment Intention. Purchaser is acquiring the Shares for its own account, for
investment purposes only and not with a view to the distribution (as such term is used in Section
2(11) of the Securities Act of 1933, as amended (the “Securities Act”) thereof. Purchaser
understands that the Shares have not been registered under the Securities Act and cannot
be sold unless subsequently registered under the Securities Act or an exemption from such
registration is available.

     7.6 Financial Advisors. No Person has acted, directly or indirectly, as a broker,
finder or financial advisor for Purchaser in connection with the transactions contemplated by this
Agreement and no Person (other than TC Group, L.L.C. and its Affiliates) is entitled to any fee or
commission or like payment in respect thereof.

     7.7 Financing. True, complete and correct copies of the debt commitment letter,
dated as of March 8, 2006, from Lehman Commercial Paper Inc., Lehman Brothers Inc., JPMorgan Chase
Bank, N.A. and J.P. Morgan Securities Inc. (the “Debt Commitment Letter”) is attached
hereto as Exhibit C. Assuming consummation of the financing contemplated by the Debt
Commitment Letter, Purchaser will have sufficient funds at the Closing to pay the Purchase Price.
The fee letter referenced in the Debt Commitment Letter does not contain any condition precedent
to, or any limitation on the amount of funds available at the time of, the initial borrowing under
the financing contemplated by the Debt Commitment Letter, other than those conditions precedent or
limitations contained in the Debt Commitment Letter.

     7.8 Condition of the Business. Notwithstanding anything contained in this Agreement
to the contrary, Purchaser represents, acknowledges and agrees that neither the Company nor any
Seller is making, and Purchaser is not relying on, any representations or warranties whatsoever,
express or implied, beyond those expressly given by the Company and the Sellers, as the case may
be, in Article V and Article VI, respectively (as modified by the Schedules
hereto), and Purchaser acknowledges and agrees that, except for the representations and warranties
contained herein, the Assets and the business of the Company and the Subsidiaries are being
transferred on a “where is”

50

 

and, as to condition, “as is” basis. Any claims Purchaser may have for
breach of representation or warranty shall be based solely on the representations and warranties of
the Company or the Sellers set forth in Article V or Article VI, respectively (as
modified by the Schedules hereto).

ARTICLE VIII

COVENANTS

     8.1 Access to Information. From the date hereof to the Closing, Purchaser shall be
entitled, through its officers, employees and representatives (including its legal advisors and
accountants), to make such investigation of the properties, businesses and operations of the
Company and the Subsidiaries and such examination of the books and records of the Company and the
Subsidiaries as it reasonably requests and to make extracts and copies of such books
and records. Any such investigation and examination shall be conducted during regular
business hours upon reasonable advance notice and under reasonable circumstances and shall be
subject to restrictions under applicable Law. The Company shall cause the officers, employees,
consultants, agents, accountants, attorneys and other representatives of the Company and the
Subsidiaries to cooperate with Purchaser and Purchaser’s representatives in connection with such
investigation and examination, and Purchaser and its representatives shall cooperate with the
Company and its representatives and shall use their reasonable efforts to minimize any disruption
to the business. Notwithstanding anything herein to the contrary, no such investigation or
examination shall be permitted to the extent that it would require the Company or any of the
Subsidiaries to disclose information subject to attorney-client privilege or conflict with any
confidentiality obligations to which the Company or any of the Subsidiaries is bound (it being
understood and agreed that the Company will use commercially reasonable efforts to obtain a waiver
of such confidentiality obligations). Notwithstanding anything to the contrary contained herein,
prior to the Closing, Purchaser shall not contact any suppliers to, or customers of, the Company
other than in the ordinary course of its business (which shall on no event include any discussion
of the transactions contemplated hereby without the participation of the Company, other than in
accordance with the agreed upon communications plan between Purchaser and the Company).

     8.2 Conduct of the Business Pending the Closing.

          (a) Prior to the Closing, except (I) as required by applicable Law, (II) as otherwise
contemplated by this Agreement or (III) with the prior written consent of Purchaser (which consent
shall not be unreasonably withheld, delayed or conditioned, unless the action to be taken by the
Company would be reasonably expected to have a Material Adverse Effect), the Company shall, and
shall cause the Subsidiaries to:

     (i) conduct the respective businesses of the Company and the Subsidiaries only in the
Ordinary Course of Business;

51

 

     (ii) use its commercially reasonable efforts to (A) preserve the present business
operations, organization and goodwill of the Company and the Subsidiaries, and (B) preserve
the present relationships with customers and suppliers of the Company and the Subsidiaries;
and

     (iii) willfully do any other act which, or fail to take any reasonable action which
failure, would cause any representation or warranty of the Company or any Seller in this
Agreement (without giving effect to any materiality limitations set forth therein) to
become untrue in any material respect.

          (b) Without limiting Section 8.2(a) above, except (I) as required by applicable Law, (II) as
otherwise contemplated by this Agreement or (III) with the prior written consent of Purchaser,
prior to the Closing, the Company shall not, and shall not permit the Subsidiaries to:

     (i) declare, set aside, make or pay any dividend or other distribution in respect of
the capital stock of the Company or repurchase, redeem or otherwise acquire any outstanding shares of the capital stock or other Equity Securities of, or other ownership interests in,
the Company or any of the Subsidiaries;

     (ii) transfer, issue, sell or dispose of any shares of capital stock or other Equity
Securities of the Company or any of the Subsidiaries or grant options, warrants, calls or
other rights to purchase or otherwise acquire shares of the capital stock or other Equity
Securities of the Company or any of the Subsidiaries;

     (iii) effect any recapitalization, reclassification or like change in the
capitalization of the Company or any of the Subsidiaries;

     (iv) except as provided in Section 8.15, amend the certificate of
incorporation or by-laws or comparable organizational documents of the Company or any of
the Subsidiaries;

     (v) (A) increase the annual level of compensation of any director or executive officer
of the Company or any of the Subsidiaries, (B) other than in the Ordinary Course of
Business, materially increase the annual level of compensation of any Employee who is not a
director or executive officer, (C) grant any unusual or extraordinary bonus, benefit or
other direct or indirect compensation to any Employee, (D) materially increase the coverage
or benefits available under any (or create any new) Company Benefit Plan or (E) enter into
any employment, deferred compensation, severance, consulting, non-competition or similar
agreement (or amend any such agreement) to which the Company or any of the Subsidiaries is
a party or involving a director or executive officer of the Company or any of the
Subsidiaries, except, in each case, as required by applicable Law from time to time in
effect or by the terms of any Company Benefit Plans;

52

 

     (vi) subject to any Lien, any of the Assets of the Company or any of the Subsidiaries,
except for Permitted Exceptions;

     (vii) sell, assign, license, transfer, convey, lease or otherwise dispose of any of
the material properties or Assets of the Company and the Subsidiaries (except for sales of
inventory in the Ordinary Course of Business);

     (viii) other than in the Ordinary Course of Business, cancel or compromise any
material debt or claim or waive or release any material right of the Company or any of the
Subsidiaries;

     (ix) enter into any commitment for capital expenditures of the Company and the
Subsidiaries in excess of $100,000 for any individual commitment and $250,000 for all
commitments in the aggregate other than (a) such commitments for capital expenditures that
are fully paid prior to Closing or
(b) such commitments in respect of capital expenditures included in the CapEx Budget;

     (x) enter into, modify or terminate any labor or collective bargaining agreement of
the Company or any of the Subsidiaries;

     (xi) permit the Company or any of the Subsidiaries to acquire by merger or
consolidation with, or merge or consolidate with, or purchase all or substantially all of
the Assets of, or otherwise acquire any material Assets or business of, any Person,
business, business unit, division or facility;

     (xii) change any of the Company’s or any of its Subsidiaries’ accounting methods,
principles or practices unless required by GAAP;

     (xiii) revalue any of the Assets, including writing off receivables or reserves, other
than in the Ordinary Course of Business;

     (xiv) enter into, extend, materially and adversely modify, or terminate any Material
Contract, other than customer or supplier contracts in the Ordinary Course of Business;

     (xv) (A) sell, assign, transfer, convey, lease, mortgage, pledge or otherwise dispose
of or encumber any material Assets or any interests therein other than to secure
Indebtedness, except for sales of finished goods inventory or obsolete Assets in the
ordinary course of business consistent with past practice or (B) sell, assign or transfer
any Assets to any of the Sellers or their Affiliates;

     (xvi) fail to expend funds for capital expenditures or commitments in accordance with
the CapEx Budget;

     (xvii) make any material loans or advances to any Person, or, except for expenses
incurred in the Ordinary Course of Business, to any employee of the Company or any of its
Subsidiaries;

53

 

     (xviii) collect accounts receivable and pay accounts payable other than in the
Ordinary Course of Business;

     (xix) fail to maintain the material Assets of the Company and each of its Subsidiaries
in substantially their current state of repair, excepting normal wear and tear;

     (xx) amend any Tax Return, make or rescind any material election relating to Taxes,
settle or compromise any claim, action, suit, litigation, proceeding, arbitration,
investigation, audit or controversy relating to Taxes, make any material change to any of
its methods of accounting or methods of reporting income or deductions for Tax or
accounting practice or policy from those employed in the preparation of its most recent Tax
Return or consent to any
extension or waiver of the limitation period applicable to any claim or assessment
relating to Taxes; or

     (xxi) agree to do anything prohibited by this Section 8.2.

     8.3 Consents. Purchaser and the Company shall use (and the Company shall cause the
Subsidiaries to use) their commercially reasonable efforts, and the Sellers shall cooperate with
Purchaser, the Company and the Subsidiaries, to obtain at the earliest practicable date all
consents and approvals required to consummate the transactions contemplated by this Agreement,
including, without limitation, the consents and approvals referred to in Sections 5.3(b),
6.3(b) and 7.3(b) hereof, if any; provided, however, that, except
for the filing fees in connection with filings contemplated in Section 8.4 hereof, no party
shall be obligated to pay any consideration to any third party from whom consent or approval is
requested.

     8.4 Regulatory Approvals.

          (a) Each of Purchaser, the Company and the Sellers (if necessary) shall (i) make or cause to
be made all filings required of each of them or any of their respective Subsidiaries or Affiliates
under the HSR Act, the Sherman Act, as amended, the Clayton Act, as amended, the Federal Trade
Commission Act, as amended, and any other United States federal or state or foreign statues, rules,
regulations, orders, decrees, administrative or judicial doctrines or other laws that are designed
to prohibit, restrict or regulate actions having the purpose or effect of monopolization, restraint
of trade, or the creation or enhancement of dominance (collectively, the “Antitrust Laws”) with
respect to the transactions contemplated hereby as promptly as practicable and, in any event,
within six (6) Business Days after the date of this Agreement in the case of all filings required
under the HSR Act and within one (1) week in the case of all other filings required by other
Antitrust Laws, (ii) comply at the earliest practicable date with any request under the HSR Act or
other Antitrust Laws for additional information, documents, or other materials received by each of
them or any of their respective subsidiaries or Affiliates from any other Governmental Body in
respect of such filings or such transactions and (iii) cooperate with each other in connection with
any such filing (including, to the extent permitted by applicable Law, providing copies of
additions,

54

 

deletions or changes suggested in connection therewith) and in connection with resolving
any investigation or other inquiry of any Governmental Body under any Antitrust Laws with respect
to any such filing or any such transaction. Each such party shall use commercially reasonable
efforts to furnish to each other all information required for any application or other filing to be
made pursuant to any applicable Law in connection with the transactions contemplated by this
Agreement. Each such party shall promptly inform the other parties hereto of any oral
communication with, and provide copies of written communications with, any Governmental Body
regarding any such filings or any such transaction. No party hereto shall independently
participate in any formal meeting with
any Governmental Body in respect of any such filings, investigation, or other inquiry without
giving the other parties hereto prior notice of the meeting and, to the extent permitted by such
Governmental Body, the opportunity to attend and/or participate. Subject to applicable Law, the
parties hereto will consult and cooperate with one another in connection with any analyses,
appearances, presentations, memoranda, briefs, arguments, opinions and proposals made or submitted
by or on behalf of any party hereto relating to proceedings under the HSR Act or other Antitrust
Laws.

          (b) Each of Purchaser and the Company shall use commercially reasonable efforts to take such
action as may be required to cause the expiration of the notice of periods under the HSR Act or
other Antitrust Laws with respect to such transactions as promptly as possible after the execution
of this Agreement. Each of Purchaser and the Company shall use commercially reasonable efforts to
resolve such objections, if any, as may be asserted by any Governmental Body with respect to the
transactions contemplated by this Agreement under the HSR Act, or other Antitrust Laws. In
connection therewith, if any Legal Proceeding is instituted (or threatened to be instituted)
challenging any transaction contemplated by this Agreement as in violation of any Antitrust Law,
each of Purchaser and the Company shall cooperate and use commercially reasonable efforts to
contest and resist any such Legal Proceeding, and to have vacated, lifted, reversed, or overturned
any decree, judgment, injunction or other order whether temporary, preliminary or permanent, that
is in effect and that prohibits, prevents, or restricts consummation of the transactions
contemplated by this Agreement, including by pursuing all available avenues of administrative and
judicial appeal, unless by mutual agreement, Purchaser and the Company decide that litigation is
not in their respective best interests. Notwithstanding anything to the contrary in this
Agreement, neither Purchaser nor any of its Affiliates (which for purposes of this sentence shall
include the Company) shall be required, in connection with the matters covered by this Section
8.4, (i) to hold separate (including by trust or otherwise) or divest any of their respective
businesses, product lines or Assets, or (ii) to agree to any limitation on the operation or conduct
of their or the Company’s or any of the Subsidiaries’ respective businesses.

     8.5 Further Assurances. Subject to, and not in limitation of, Section 8.4,
each of Purchaser and the Company shall use (and the Company shall cause each of the Subsidiaries
to use) its commercially reasonable efforts to (i) take all actions necessary or appropriate to
consummate the transactions contemplated by this Agreement and (ii) cause the fulfillment at the
earliest practicable date of all of the conditions to the other party’s obligations to consummate
the transactions contemplated by this Agreement.

55

 

Subject to the terms and conditions herein
provided, each of the parties hereto covenants and agrees to use commercially reasonable efforts to
deliver or cause to be delivered such documents and other papers and to take or cause to be taken
such further actions as may be necessary, proper or advisable under this Agreement or otherwise to
consummate and make effective the actions contemplated hereby. Without limiting the foregoing,
after the Closing Date, (i) to the extent any of the Books and Records, or other Assets, are in the
possession, custody or control of one or more of the Sellers, the Sellers shall promptly
deliver or cause to be delivered to the Company all such Books and Records and other Assets
and (ii) each Seller shall promptly deliver to the Company any mail (physical, electronic or
otherwise), facsimile or other correspondence or communication received by such Seller to the
extent related to the Assets, the Company or any of its Subsidiaries (and not received by such
Seller in its capacity as a shareholder, optionholder, warrantholder or lender), including any such
correspondence or communication from any customer, supplier or Governmental Body.

     8.6 Confidentiality.

          (a) Purchaser acknowledges that the information provided to it in connection with this
Agreement and the transactions contemplated hereby is subject to the terms of the confidentiality
agreement between Purchaser and the Company dated December 9, 2005, amended on February 1, 2006
(the “Company Confidentiality Agreement”), the terms of which are incorporated herein by
reference. Effective upon, and only upon, the Closing Date, the Company Confidentiality Agreement
shall terminate.

          (b) The Company acknowledges that the information provided to it in connection with this
Agreement and the transactions contemplated hereby is subject to the terms of the confidentiality
agreement between the Company and Purchaser dated December 14, 2005, as amended (the “Purchaser
Confidentiality Agreement”), the terms of which are incorporated herein by reference. The
terms of the Purchaser Confidentiality Agreement shall continue in full force and effect in
accordance with its terms, regardless of when, or whether, the Closing occurs.

          (c) For a period from the date of this Agreement to the date that is five (5) years after the
Closing Date, each of the Sellers shall treat all data and information relating to the Company and
its Subsidiaries and all data and information relating to the business, customers, financial
statements, conditions or operations of the Company and its Subsidiaries, as confidential, preserve
the confidentiality thereof, not duplicate or use or disclose to any Person such information and
cause his or her employees, Affiliates and representatives who have had access to such information
to keep confidential and not to use any such information (i) unless such information is now or is
hereafter disclosed, through no act or omission of any Seller or their Affiliates, employees or
representatives, in a manner making it available to the general public, or (ii) unless such
information is required by Law or legal process to be disclosed, (iii) to the extent necessary to
be disclosed in connection with resolution of any dispute with respect to this Agreement or (iv)
unless such Seller is an employee of Purchaser or its Affiliates and such information

56

 

is used  in
connection with Purchaser’s ongoing business. The Purchaser shall be entitled to injunctive relief
to enforce this Section 8.6(c) in accordance with Section 12.13 hereof.

     8.7 Indemnification, Exculpation and Insurance.

          (a) From and after the Closing Date, Purchaser shall cause the Company and its Subsidiaries to
continue to indemnify, defend and hold harmless, to the fullest extent permitted under applicable
Law, the individuals who on or prior to the Closing Date were directors, officers or employees of
the Company or any of the Subsidiaries (collectively, the “Indemnitees”) with respect to
all acts or omissions by them in their capacities as such or taken at the request of the Company or
any of the Subsidiaries at any time prior to the Closing Date to the fullest extent that the
Company or its Subsidiaries, as the case may be, would have been permitted under applicable Law.
Purchaser agrees that all rights of the Indemnitees to indemnification and exculpation from
liabilities for acts or omissions occurring at or prior to the Closing Date as provided in the
respective certificate of incorporation or by-laws or comparable organizational documents of the
Company or any of the Subsidiaries as now in effect shall survive the Closing Date and shall
continue in full force and effect in accordance with their terms. Such rights as they relate to
any period prior to Closing shall not be amended, or otherwise modified in any manner that would
adversely affect the rights of the Indemnitees, unless such modification is required by Law. In
addition, Purchaser shall pay any expenses of any Indemnitee under this Section 8.7, as
incurred to the fullest extent permitted under applicable Law, provided that the person to whom
expenses are advanced provides an undertaking to repay such advances (i) to the extent required by
applicable Law or (ii) if it is ultimately determined that such person is not entitled to
indemnification.

          (b) Purchaser, from and after the Closing Date, shall cause (i) the certificate of
incorporation and by-laws of Purchaser to contain provisions no less favorable to the Indemnitees
with respect to limitation of certain liabilities of directors, officers, employees and agents and
indemnification than are set forth as of the date of this Agreement in the certificate of
incorporation and by-laws of the Company and (ii) the certificate of incorporation and by-laws or
comparable organizational documents of each subsidiary of Purchaser to contain the current
provisions regarding indemnification of directors, officers, employees and agents which provisions
in each case shall not be amended, repealed or otherwise modified in a manner that would adversely
affect the rights thereunder of the Indemnitees.

          (c) Each Indemnitee shall have the right (but not the obligation) to control the defense of,
including the investigation of, any litigation, claim or proceeding (each, a “Claim”)
relating to any acts or omissions covered under this Section 8.7 with counsel selected by
the Indemnitee; provided, however, that (i) Purchaser shall be permitted to
participate in the defense of such Claim at its own expense and (ii) Purchaser shall not be liable
for any settlement effected without its written consent, which consent shall not be unreasonably
withheld or delayed.

57

 

          (d) In the event any Claim is asserted or made, any determination required to be made with
respect to whether an Indemnitee’s conduct complies with the standards set forth under applicable
Law, the applicable organizational documents of the Company or any of the Subsidiaries or any
indemnification agreements or arrangements of the Company or any of the Subsidiaries, as the case
may be, shall be made by independent legal counsel mutually selected by such Indemnitee and the
Purchaser.

          (e) Each of Purchaser and the Indemnitee shall cooperate, and cause their respective
Affiliates to cooperate, in the defense of any Claim and shall provide access to properties and
individuals as reasonably requested and furnish or cause to be furnished records, information and
testimony, and attend such conferences, discovery proceedings, hearings, trials or appeals, as may
be reasonably requested in connection therewith.

          (f) For the six-year period commencing immediately after the Closing Date, Purchaser shall
maintain in effect directors’ and officers’ liability insurance covering acts or omissions
occurring prior to the Closing Date with respect to those persons who are currently covered by the
Company’s and the Subsidiaries’ directors’ and officers’ liability insurance policies (true,
correct and complete copies of which have been heretofore made available to the Purchaser) on terms
with respect to such coverage and amount no less favorable to the Company’s and the Subsidiaries’
directors and officers currently covered by such insurance than those of such policy in effect on
the date hereof; provided, that in no event shall Purchaser be required to expend an amount
per year equal to one hundred fifty percent (150%) of the current annual premiums paid by the
Company and its Subsidiaries in the aggregate for such insurance coverage (the “Maximum
Amount”) to maintain or procure such insurance coverage as required hereunder. In the event
that the annual premiums required to procure or maintain such insurance coverage would exceed the
Maximum Amount, Purchaser shall procure and maintain for such six-year period as much coverage as
reasonably practicable for the Maximum Amount or provide Sellers the option of paying the
difference.

          (g) The provisions of this Section 8.7: (i) are intended to be for the benefit of,
and shall be enforceable by, each Indemnitee, his or her heirs and his or her representatives; and
(ii) are in addition to, and not in substitution for, any other rights to indemnification or
contribution that any such person may have by Contract or otherwise.

          (h) In the event that Purchaser or any of its successors or assigns (i) consolidates with or
merges into any other person and is not the continuing or surviving corporation or entity of such
consolidation or merger; or (ii) transfers or conveys all or substantially all of its properties
and Assets to any person, then, and in each such case, proper provision shall be made so that the
successors and assigns of Purchaser shall assume all of the obligations thereof set forth in this
Section 8.7.

          (i) The obligations of Purchaser under this Section 8.7 shall not be terminated or
modified in such a manner as to adversely affect any Indemnitee to whom this Section 8.7
applies without the written consent of the affected Indemnitee (it being

58

 

expressly agreed that the
Indemnitees to whom this Section 8.7 applies shall be third party beneficiaries of this
Section 8.7).

     8.8 Preservation of Records. The Sellers and Purchaser agree that each of them shall
preserve and keep the records held by them or their Affiliates relating to the respective
businesses of the Company and the Subsidiaries for a period of seven years from the Closing Date
and
shall make such records and personnel available to the other as may be reasonably required by
such party in connection with, among other things, any insurance claims by, Legal Proceedings or
tax audits against or governmental investigations of the Sellers or Purchaser or any of their
Affiliates or in order to enable the Sellers or Purchaser to comply with their respective
obligations under this Agreement and each other agreement, document or instrument contemplated
hereby or thereby. In the event the Sellers or Purchaser wish to destroy such records, such party
shall first give 90 days prior written notice to the other and such other party shall have the
right at its option and expense, upon prior written notice given to such party within that 90 day
period, to take possession of the records within 180 days after the date of such notice.

     8.9 Publicity.

          (a) Other than in accordance with the communication plan agreed to between the Company and
Purchaser prior to the date hereof, none of the Sellers, the Company or Purchaser shall issue any
press release or public announcement or communication of any nature concerning this Agreement or
the transactions contemplated hereby without obtaining the prior written approval of the other
parties hereto, which approval will not be unreasonably withheld or delayed, unless, in the
judgment of the Sellers, the Company or Purchaser, as applicable, disclosure is otherwise required
by applicable Law or by the applicable rules of any securities exchange on which the Sellers, the
Company or Purchaser lists securities, provided that, to the extent required by applicable Law, the
party intending to make such release shall use its commercially reasonable efforts consistent with
such applicable Law to consult with the other parties with respect to the timing and content
thereof.

          (b) Each of Purchaser, the Company and the Sellers agree that the terms of this Agreement
shall not be disclosed or otherwise made available to the public and that copies of this Agreement
shall not be publicly filed or otherwise made available to the public, except where such
disclosure, availability or filing is required by applicable Law and only to the extent required by
such Law or by the applicable rules of any securities exchange on which the Sellers, the Company or
Purchaser lists securities. In the event that such disclosure, availability or filing is required
by applicable Law, each of Purchaser, the Company and the Sellers agree to use its commercially
reasonable efforts to obtain “confidential treatment” of this Agreement with the U.S. Securities
and Exchange Commission (or the equivalent treatment by any other Governmental Body) and to redact
such terms of this Agreement as the other parties shall request.

          (c) Notwithstanding the foregoing, each of ACAS and The Carlyle Group (“Carlyle”) may
disclose the transactions contemplated hereby in a manner consistent with its respective past
disclosure practices of transactions substantially in the

59

 

form provided to Carlyle (in the case of
disclosure by ACAS) or ACAS (in the case of disclosure by Carlyle) prior to the date hereof.

     8.10 Financing.

          (a) In order to assist Purchaser with obtaining the debt financing contemplated by the Debt
Commitment Letter, the Company shall provide such assistance and cooperation as Purchaser and its
Affiliates may reasonably request, including (i) assisting in the preparation of any prospectus,
offering memorandum or similar document or marketing material, and cooperating with lenders, (ii)
making senior management of the Company and its Subsidiaries reasonably available for customary
road show or syndication presentations, lender or proposed financing source meetings and ratings
agencies presentations, (iii) cooperating with prospective lenders and their respective advisors in
performing their due diligence, (iv) entering into customary agreements with lenders and their
respective advisors, and (v) helping procure other definitive financing documents or other
reasonably requested certificates or documents, including pledge and security documents, comfort
letters, customary certificates (including a certificate of the chief financial officer of the
Company with respect to solvency matters), legal opinions and real estate title documentation
(provided that such cooperation shall not require any material expenditure by the Company or the
Sellers).

          (b) Purchaser shall execute and deliver to the requisite parties under the Debt Commitment
Letter, simultaneously with the execution and delivery of the Debt Commitment Letter, the fee
letter as contemplated by the Debt Commitment Letter. In addition, Purchaser shall not, and shall
cause its Affiliates not to, agree to any condition precedent to, or any limitation on the amount
of funds available at the time of, the initial borrowing under the financing contemplated by the
Debt Commitment Letter or the replacement financing contemplated under this Section 8.10,
not already contained in the Debt Commitment Letter which would reasonably be expected to delay or
prevent the Closing. Purchaser shall use commercially reasonable efforts to enter into definitive
financing agreements on or before the Closing Date on the terms and conditions set forth in the
Debt Commitment Letter or such other terms as are acceptable to Purchaser including (i) complying
with the terms and conditions of the fee letter referenced therein, (ii) to the extent required by
the Agent under the Debt Commitment Letter, preparing with the assistance of the Company and the
Company’s management and accounting advisors, the necessary prospectus, offering memorandum or
similar document or marketing material and negotiating definitive loan documentation, (iii) to the
extent required by the Agent under the Debt Commitment Letter, commencing and conducting, with the
assistance of the Company and the Company’s management, the road show and syndication activities
concerning the placement and syndication of the senior secured credit facility contemplated by the
Debt Commitment Letter, and (iv) accepting any changes in the terms of the proposed financing
contemplated in the “market flex.”

     8.11 Update of Schedules.

          (a) Not less than ten (10) Business Days prior to the proposed Closing Date, the Company may
elect to amend or supplement the disclosure schedules to this

60

 

Agreement with respect to any events,
facts or circumstances first arising or occurring after the date hereof by delivery of such amended
or supplemental disclosure schedules to the Company (the “Updated Schedules”) all of which
Updated Schedules shall be delivered on a single occasion. In the event that the Company delivers
the Updated Schedules to Purchaser, and the aggregate amount of Losses reasonably expected by
Purchaser to be incurred by the Purchaser Indemnified Parties based upon or resulting from the
matters set forth in the Updated Schedules exceeds $500,000, then Purchaser shall have the option,
in its sole and absolute discretion, to terminate this Agreement by delivery of written notice to
the Seller Representative within seven (7) Business Days of its receipt of the Updated Schedules.
If Purchaser timely delivers such a written notice of termination, the Seller Representative shall
have the option to either (i) cause the Company to cure all such breach(es) disclosed on the
Updated Schedules within thirty (30) days from delivery of such notice (during which thirty (30)
day period, Purchaser shall not be required to consummate nor shall it be permitted to terminate
the transactions contemplated by this Agreement and after which this Agreement shall terminate
unless such breach(es) have been cured in all material respects), or (ii) in the event that the
aggregate amount of Losses reasonably expected to be incurred by the Purchaser Indemnified Parties
based upon or resulting from the matters set forth in the Updated Schedules is less than
$3,000,000, to elect in writing (in a form reasonably satisfactory to Purchaser) to indemnify and
hold harmless the Purchaser Indemnified Parties from and against all Losses (in excess of the
Basket) based upon or resulting from the matters set forth in the Updated Schedules. If Purchaser
does not timely deliver such termination notice to the Seller Representative, or if such
termination notice is timely delivered and the Primary Indemnitors deliver the written agreement
described in the previous sentence, then Purchaser shall be deemed to have consented to the Updated
Schedules and from and after the Closing, the Updated Schedules shall have the effect of amending
and supplementing, as applicable, the disclosure schedules as if such amendment or supplement were
set forth on the disclosure schedules delivered on the date of this Agreement solely for purposes
of determining whether the applicable representation or warranty was breached as of the Closing
Date. To the extent any event, fact or circumstance is disclosed on the Updated Schedules the
Purchaser Indemnified Parties shall have no right to indemnification with respect to Losses
relating to such event, fact or circumstance based upon or resulting from the failure of any
representation or warranty to be true and correct on the Closing Date (after taking into account
the Updated Schedules), as if made on such date (unless the Primary Indemnitors agree to indemnify
the Purchaser Indemnified Parties for such Losses in accordance with this Section 8.11(a));
provided, however, that to the extent all such Losses based upon or resulting from
the failure of any representation or warranty to be true and correct on the Closing Date (without
regard to any limitation therein with respect to materiality, Material Adverse Effect or other
similar qualification) with respect to any such event, fact or circumstance, exceed the Sub-Basket,
then the full amount of such Losses (without regard to the Sub-Basket) shall be assessed against,
and correspondingly reduce, the Basket (but not the Cap) such that if such Losses (after taking
into account the Sub-Basket) exceed $500,000, then the Basket shall be reduced to zero.

          (b) The Company shall provide the Purchaser with (i) an unaudited consolidated balance sheet
and the related statements of income and cash flow for each

61

 

month from the date hereof through the
Closing Date within twenty (20) calendar days after the end of each such month and (ii) reasonably
requested information with respect to aggregate shipments and orders for each month from the date
hereof through the Closing Date within seven (7) calendar days after the end of each such month.

     8.12 Exclusivity. From the date hereof through the Closing Date, neither the Sellers
nor the Company shall, nor shall any of them knowingly permit its respective Affiliates, officers,
directors, employees, representatives and agents to, directly or indirectly, encourage, solicit,
participate in or initiate discussions or negotiations with, or provide any information to, any
Person or group of Persons (other than the Purchaser or any of its Affiliates) in furtherance of
any merger, sale of Assets, sale of shares of capital stock or similar transactions involving the
Company or any of its Subsidiaries or a substantial portion of the Assets. The Sellers and the
Company shall immediately notify the Purchaser (orally and in writing) if any discussions or
negotiations are sought to be initiated, any inquiry or proposal is made, any information is
requested with respect to the Contemplated Transactions or any offer is made with respect to the
Company or any of its Subsidiaries, the Common Stock, Preferred Stock or any of the material
Assets.

     8.13 Affiliate Transactions. The Sellers and the Company shall cause (i) all
accounts, whether payables or receivables, between the Company and its Subsidiaries, on the one
hand, and any Seller or any of its Affiliates, on the other hand, to be repaid or otherwise
satisfied in full at or prior to the Closing, except as set forth in Schedule 8.13, (ii)
except as set forth in Schedule 8.13, all other Related Party Transactions to be terminated
with no further liability or other force or effect after the Closing, except with respect to any
breach by any Seller or its Affiliate and (iii) the North Canton, OH facility sublease to be
amended in substantially the form attached as Exhibit E (the “Facility Sublease
Amendment”).

     8.14 Joint Venture Supply Agreement. At or prior to Closing, the Company shall, and
shall cause the Joint Venture to execute and deliver a Supply Agreement, the form of which shall be
reasonably acceptable to Purchaser (the “Joint Venture Supply Agreement”).

     8.15 Amendment to Company’s Certificate of Incorporation. At or prior to Closing, the
Company shall amend its certificate of incorporation such that its name shall not include “ACAS”,
“American Capital Strategies, Ltd.” or any similar or equivalent term that reflects the ownership
of the Company prior to the Closing.

     8.16 [Intentionally Omitted]

     8.17 Termination of Tax Sharing Agreements. The Company shall terminate or cause to
be terminated prior to Closing any Tax sharing or Tax allocation agreements among any of the
Company and its Subsidiaries, and after the Closing Date, none of the Company or any of its
Subsidiaries shall be bound thereby or have any liability thereunder.

62

 

     8.18 Section 280G. Prior to the Closing Date, the Company shall submit to its
stockholders for approval (in a manner satisfactory to Purchaser) by such number of stockholders as
is required by the terms of Section 280G(b)(5)(B) of the Code, any payments and/or benefits that
may separate or in the aggregate constitute “parachute payments” (within the meaning of Section
280G of the Code and the regulations promulgated thereunder), such that such payments and benefits
shall not be deemed “parachute payments” under Section 280G of the Code, and prior to the Closing
Date the Company shall deliver to Purchaser evidence satisfactory to Purchaser that (i) a
stockholder vote was held in conformity with Section 280G of the Code and the regulations
promulgated thereunder and the requisite stockholder approval was obtained with respect to any
payments and/or benefits that were subject to the stockholder vote (the “280G Approval”) or
(ii) that the 280G Approval was not obtained and as a consequence, that such “parachute payments”
shall not be made or provided, pursuant tot eh waivers of those payments and/or benefits which were
executed by the affected individuals prior to the date the payments and/or benefits were submitted
to the stockholders for approval.

     8.19 Environmental Matters.

          (a) Phase II Testing. The Company acknowledges and agrees that an environmental
consulting firm to be jointly selected by the Company and Purchaser (it being understood and agreed
by Purchaser that such environmental consulting firm shall not be ERM) shall conduct Phase II
subsurface soil and groundwater testing at the Xinyi, China site, the cost of which shall be borne
by the Purchaser. Any such work shall be conducted during regular business hours upon reasonable
notice and shall not unreasonably interfere with the routine operations at such facility.
Purchaser agrees to promptly share the results of all testing, monitoring or other similar
investigative work performed by such consulting firm with the Company.

          (b) Environmental Response Actions. In the event that Purchaser reasonably
determines, based upon the Phase II testing described in Section 8.19(a) above, that the
Existing Contamination (if any) at the Xinyi, China site poses a substantial risk to human health
or the Environment, then the Company shall undertake, or shall cause its Subsidiaries to undertake,
any Environmental Response Actions that are reasonably requested by Purchaser and are necessary, in
the reasonable opinion of the consulting firm retained to perform the Phase II testing, to mitigate
such substantial risk to human health or the Environment. Notwithstanding any other provision
contained herein, following the Closing, ACAS, severally in accordance with its Indemnification
Percentage, and Swaldo and Blackerby, on a joint and several basis with respect to the
balance, shall indemnify Purchaser for one-half of the costs of any such Environmental Response
Actions; provided that (i) the full amount of any such costs incurred by Purchaser or the
Company that are not indemnified by ACAS, Swaldo or Blackerby shall be assessed against, and
correspondingly reduce, the Basket (but not the Cap) such that if the amount of such costs exceed
$500,000, then the Basket shall be reduced to zero and (ii) the full amount of any such costs paid
by ACAS, Swaldo or Blackerby shall be assessed against, and correspondingly reduce, the Cap.

63

 

ARTICLE IX

CONDITIONS TO CLOSING

     9.1 Conditions Precedent to Obligations of Purchaser. The obligation of Purchaser to
consummate the transactions contemplated by this Agreement is subject to the fulfillment, on or
prior to the Closing Date, of each of the following conditions (any or all of which may be waived
by Purchaser in whole or in part to the extent permitted by applicable Law):

          (a) the representations and warranties of the Company set forth in this Agreement qualified as
to materiality shall be true and correct in all respects, and those not so qualified shall be true
and correct in all material respects, at and as of the Closing Date as though made on the Closing
Date, except to the extent such representations and warranties relate to an earlier date (in which
case such representations and warranties qualified as to materiality shall be true and correct in
all respects, and those not so qualified shall be true and correct in all material respects, on and
as of such earlier date), and Purchaser shall have received a certificate signed by an authorized
officer of the Company, dated the Closing Date, to the foregoing effect;

          (b) the representations and warranties of the Common Stock Sellers and ACAS set forth in this
Agreement qualified as to materiality shall be true and correct in all respects, and those not so
qualified shall be true and correct in all material respects, at and as of the Closing Date as
though made on the Closing Date, except to the extent such representations and warranties relate to
an earlier date (in which case such representations and warranties qualified as to materiality
shall be true and correct in all respects, and those not so qualified shall be true and correct in
all material respects, on and as of such earlier date), and Purchaser shall have received a
certificate signed by each of the Common Stock Sellers and an authorized officer of ACAS, dated the
Closing Date, to the foregoing effect, in each case solely as to its own representations and
warranties hereunder;

          (c) the Company and the Sellers shall have performed and complied in all material respects
with all obligations and agreements required by this Agreement to be performed or complied with by
them on or prior to the Closing Date, and Purchaser shall have received a certificate signed by an
authorized officer of the Company, dated the Closing Date, to the foregoing effect;

          (d) there shall not be in effect any Order by a Governmental Body of competent jurisdiction
restraining, enjoining or otherwise prohibiting the consummation of the transactions contemplated
hereby;

          (e) the waiting period applicable to the transactions contemplated by this Agreement under the
HSR Act shall have expired or early termination shall have been granted;

64

 

          (f) there shall not have been any event since the date of this Agreement that has had or would
be reasonably expected to have a Material Adverse Effect;

          (g) each of Theodore V. Swaldo (“Swaldo”) and William T. Blackerby, Jr.
(“Blackerby”) shall have executed and delivered to Purchaser an employment agreement
substantially in form and substance as set forth on Exhibit F in the case of Swaldo (the
“Swaldo Employment Agreement”) and Exhibit G in the case of Blackerby (the
“Blackerby Employment Agreement”),

          (h) Each of Linda Swaldo and Blackerby shall have executed and delivered to Parent the Parent
Stockholders Agreement substantially in the form set forth on Exhibit H and the Investor
Rights Agreement substantially in the form set forth on Exhibit I

          (i) Each of the Equity Sellers shall have executed and delivered to Purchaser the Earn-Out
Agreement substantially in the form set forth on Exhibit K;

          (j) Purchaser shall have received the funds contemplated by the Debt Commitment Letter on the
terms set forth in the Debt Commitment Letter;

          (k) the Escrow Agent, Linda Swaldo and William T. Blackerby, Jr. shall have executed and
delivered to Purchaser the Indemnity Escrow Agreement and the Adjustment Escrow Agreement;

          (l) except as otherwise agreed in writing by Purchaser prior to the Closing, each member of
the board of directors of the Company and each of its Subsidiaries shall have resigned as elected
or appointed directors of the Company and each of its Subsidiaries, as applicable, effective as of
the Closing;

          (m) the Company shall have executed and delivered (and shall have caused the Joint Venture to
execute and deliver) to Purchaser the Joint Venture Supply Agreement;

          (n) the Company shall have delivered to Purchaser a fully executed Facility Sublease
Amendment;

          (o) each of Linda Swaldo and William T. Blackerby, Jr. shall have executed and delivered to
Purchaser the Pledge Agreement, the form of which is set forth on Exhibit L;

          (p) with respect to any payments and/or benefits that may constitute “parachute payments”
under Section 280G of the Code, the Company’s stockholders shall have (i) approved, pursuant to the
method provided for in the regulations promulgated under Section 280G of the Code, any such
“parachute payments” or (ii) shall have voted upon and disapproved such parachute payments, and, as
a consequence, such “parachute payments” shall not be paid or provided for in any manner and
Purchaser shall not have any liabilities with respect to such “parachute payments”;

65

 

          (q) the Sellers shall have delivered, or caused to be delivered, and the Purchaser shall have
received:

     (i) stock certificates representing all of the Shares and all of the Preferred Stock,
in each case duly endorsed in blank or accompanied by stock transfer powers;

     (ii) an Option Cancellation Agreement executed by each Option Holder, the form of
which is set forth on Exhibit J;

     (iii) certificates of good standing of the Company and its Subsidiaries dated as close
as practicable (but in no event more than ten (10) days) prior to the Closing;

     (iv) a certificate of the secretary or other officer of the Company certifying: (A)
the true and correct charter documents of the Company and each Subsidiary, as of the
Closing; (B) the true and correct bylaws of the Company and each Subsidiary, as of the
Closing; (C) the names and true signatures of the officers or other authorized persons of
the Company authorized to sign this Agreement and the other documents to be delivered by
the Company hereunder; and (D) copies of the resolutions duly adopted by the Company,
authorizing the execution, delivery and performance by the Company of this Agreement and
each of the other agreements, instruments and documents contemplated hereby; and

     (v) the certificates described in Section 9.1(a) and 9.1(b);

     (vi) the legal opinion of Calfee, Halter & Griswold LLP substantially in the form of
Exhibit B hereto, on behalf of the Company;

     (vii) an executed affidavit, dated not more than thirty (30) days prior to the Closing
Date, in accordance with Code Section 1445(b)(2) and Treasury Regulation Section
1.1145-2(b), which statement certifies that such Seller is not a foreign person and sets
forth the Seller’s name, taxpayer identification number and address;

     (viii) such other documents relating to the transactions contemplated by this
Agreement as the Purchaser may reasonably request; and

          (r) the Sellers shall have delivered, or caused to be delivered, to the Company, the
instruments representing the Warrants and Options being cancelled hereunder.

     9.2 Conditions Precedent to Obligations of the Sellers. The obligations of the
Sellers to consummate the transactions contemplated by this Agreement are subject to the
fulfillment, prior to or on the Closing Date, of each of the following conditions (any or all of
which may be waived by the Seller Representative in whole or in part to the extent permitted by
applicable Law):

66

 

          (a) the representations and warranties of Purchaser set forth in this Agreement qualified as
to materiality shall be true and correct in all respects, and those not so qualified shall be true
and correct in all material respects, at and as of the Closing Date as though made on the Closing
Date, except to the extent such representations and warranties relate to an earlier date (in which
case such representations and warranties qualified as to materiality shall be true and correct in
all respects, and those not so qualified shall be true and correct in all material respects, on and
as of such earlier date), and the Sellers shall have received a certificate signed by an authorized
officer of Purchaser, dated the Closing Date, to the foregoing effect;

          (b) Purchaser shall have performed and complied in all material respects with all obligations
and agreements required by this Agreement to be performed or complied with by Purchaser on or prior
to the Closing Date, and the Sellers shall have received a certificate signed by an authorized
officer of Purchaser, dated the Closing Date, to the foregoing effect;

          (c) there shall not be in effect any Order by a Governmental Body of competent jurisdiction
restraining, enjoining or otherwise prohibiting the consummation of the transactions contemplated
hereby;

          (d) the waiting period applicable to the transactions contemplated by this Agreement under the
HSR Act;

          (e) Purchaser shall have executed and delivered (i) to Swaldo the Swaldo Employment Agreement,
(ii) to Blackerby the Blackerby Employment Agreement and (iii) to the Equity Sellers, the Earn-Out
Agreement;

          (f) Parent shall have executed and delivered to Linda Swaldo and Blackerby the Parent
Stockholders Agreement and the Investor Rights Agreement;

          (g) there shall not have occurred any event, development or circumstance since the date of the
Agreement that has caused a material adverse change in the business, assets, property or financial
condition of Purchaser and its Subsidiaries, taken as a whole; provided, that the following
shall be disregarded for purposes of this Section 9.2(g): (i) the effect of any change in
the United States or foreign economies or securities or financial markets in general (but solely to
the extent that any such change does not have a disproportionate effect on Purchaser or its
Subsidiaries); (ii) the effect of
any change that generally affects any industry in which Purchaser or any of the Subsidiaries
operates (but solely to the extent that any such change does not have a disproportionate effect on
Purchaser or its Subsidiaries); (iii) the effect of any action taken by the Company, any Seller or
any of their respective Affiliates with respect to the transactions contemplated hereby; (iv) the
effect of any changes in applicable Laws or accounting rules (but solely to the extent that any
such change does not have a disproportionate effect on Purchaser or its Subsidiaries) or (v) any
effect resulting from the public announcement of this Agreement, compliance with terms of this
Agreement or the consummation of the transactions contemplated by this Agreement; and

67

 

          (h) Purchaser shall have delivered, or caused to be delivered, to the Sellers:

     (i) a certificate of good standing of the Purchaser dated as close as practicable (but
in no event more not more than ten (10) days) prior to the Closing;

     (ii) a certificate of the secretary or other officer of the Purchaser certifying: (A)
the true and correct charter documents of the Purchaser, as of the Closing; (B) the true
and correct bylaws of the Purchaser, as of the Closing; (C) the names and true signatures
of the officers or other authorized persons of the Purchaser authorized to sign this
Agreement and the other documents to be delivered by the Purchaser hereunder; and (D)
copies of the resolutions duly adopted by the Purchaser, authorizing the execution,
delivery and performance by the Purchaser of this Agreement and each of the other
agreements, instruments and documents contemplated hereby;

     (iii) the certificates described in Section 9.2(a) and 9.2(b); and

     (iv) such other documents relating to the transactions contemplated by this Agreement
as the Seller or the Seller Representative may reasonably request.

ARTICLE X

INDEMNIFICATION

     10.1 Survival of Representations and Warranties. Subject to the limitations and other
provisions herein, (i) the representations and warranties of the parties contained in this
Agreement shall survive the Closing and shall remain in full force and effect for a period of
eighteen (18) months following the Closing Date; provided, however, that the
representations and warranties (a) of each Seller set forth in Sections 6.1 (Organization),
6.2 (Authorization), 6.4 (Ownership), and 6.6 (Financial Advisors) shall
survive the Closing indefinitely, (b) of the Company set forth (i) in Sections 5.1
(Organization), 5.2 (Authorization), 5.4 (Capitalization), 5.5
(Subsidiaries) and 5.23 (Financial Advisors) shall survive the Closing indefinitely, (ii)
5.9 (Taxes) shall survive the Closing for a period of ninety (90) days following the
expiration of the applicable statutes of limitation and (iii) 5.18
(Environmental Matters) shall survive the Closing for a period of five years following the
Closing Date, and (c) of Purchaser set forth in Sections 7.1 (Organization), 7.2
(Authorization), 7.6 (Financial Advisors) and 7.8 (Conditions of the Business)
shall survive the Closing indefinitely (in each case, the “Survival Period”);
provided, however, that any obligations under Sections 10.2(a) and
10.3(a) shall not terminate with respect to any Losses as to which the Person to be
indemnified shall have given notice (stating in reasonable detail the basis of the claim for
indemnification and an estimate of the amount of Losses related thereto, if determinable) to the
indemnifying party in accordance with Section 10.4 before the expiration of the applicable
Survival Period, and (ii) the covenants and agreements of the parties hereto shall survive the
Closing for a period of eighteen (18) months following the Closing Date (unless this Agreement
expressly

68

 

provides that such covenant or agreement shall survive for a longer period in which event
it shall survive for such longer period).

     10.2 Indemnification by Primary Indemnitors.

          (a) Subject to Sections 10.5 and 10.6 hereof, and except for claims arising
out of or in connection with the matters covered by the indemnification for tax obligations in
Section 11.1, which shall be governed by such Section (but which shall remain subject to
Section 10.5), from and after the Closing, the Primary Indemnitors hereby agree, on behalf
of the Sellers, to the extent provided herein, to indemnify and hold Purchaser, the Company and its
Subsidiaries and their respective directors, officers, employees, Affiliates, stockholders, agents,
attorneys, representatives, successors and permitted assigns (collectively, the “Purchaser
Indemnified Parties”) harmless from and against any and all losses, liabilities, claims,
demands, judgments, damages, fines, suits, actions, costs and expenses (including the costs of
reasonable investigation, remediation and accountants’ and attorneys’ fees) (individually, a
“Loss” and, collectively, “Losses”) as follows:

     (i) ACAS hereby agrees to indemnify and hold harmless the Purchaser Indemnified
Parties from and against Losses, based upon or resulting from the failure of any of the
representations or warranties made by ACAS in Article VI to be true and correct on
the date hereof and on the Closing Date, as if made on such date, and, Swaldo and
Blackerby, on a joint and several basis, hereby agree to indemnify and hold harmless the
Purchaser Indemnified Parties from and against all Losses based upon or resulting from the
failure of any of the representations or warranties made by any Seller other than ACAS in
Article VI to be true and correct on the date hereof and on the Closing Date, as if
made on such date, in each case without any regard to any limitation therein with respect
to materiality, Material Adverse Effect or other similar qualification;

     (ii) ACAS severally in accordance with its Indemnification Percentage, and Swaldo and
Blackerby, on a joint and several basis with respect to the balance, agree to indemnify and
hold harmless the Purchaser Indemnified Parties from and against Losses based upon the
failure of any of the
representations and warranties of the Company in Article V of this Agreement
to be true and correct in all respects at and as of the date hereof and at and as of the
Closing Date, as if made on such date, in each case without any regard to any limitation
therein with respect to materiality, Material Adverse Effect or other similar
qualification;

     (iii) ACAS hereby agrees to indemnify and hold harmless the Purchaser Indemnified
Parties from and against all Losses based upon or resulting from the breach of any covenant
or agreement of ACAS contained in this Agreement, and Swaldo and Blackerby, on a joint and
several basis, hereby agree to indemnify and hold harmless the Purchaser Indemnified
Parties from and against all Losses based upon or resulting from the breach of any covenant
or agreement by any Seller other than ACAS contained in this Agreement; and

69

 

     (iv) Swaldo and Blackerby, on a joint and several basis, agree to indemnify and hold
harmless the Purchaser Indemnified Parties from and against all Losses based upon or
resulting from the breach of any covenant or agreement of the Company contained in this
Agreement.

     10.3 Indemnification by Purchaser.

          (a) Subject to Section 10.5 and 10.6 hereof, Purchaser hereby agrees to
indemnify and hold the Sellers and their respective directors, officers, employees, Affiliates,
stockholders, agents, attorneys, representatives, successors and permitted assigns (collectively,
the “Seller Indemnified Parties”) harmless from and against, and pay to the applicable
Seller Indemnified Parties the amount of, any and all Losses:

     (i) based upon or resulting from the failure of any of the representations or
warranties made by Purchaser in this Agreement to be true and correct in all respects at
the date hereof and as of the Closing Date; and

     (ii) based upon or resulting from the breach of any covenant or agreement on the part
of Purchaser under this Agreement.

     10.4 Indemnification Procedures.

          (a) A claim for indemnification for any matter not involving a third-party claim may be
asserted by notice to the party from whom indemnification is sought prior to expiration of the
applicable Survival Period.

          (b) In the event that any Legal Proceedings shall be instituted, or any claim shall be
asserted, by any third party in respect of which payment may be sought under Section 10.2
or 10.3 hereof (regardless of the limitations set forth in Section 10.5) (an
“Indemnification Claim”), the indemnified party shall promptly cause written notice
of the assertion of any Indemnification Claim of which it has knowledge which is covered by
this indemnity to be forwarded to (i) the Seller Representative, in the case of indemnification
pursuant to Section 10.2 and (ii) Purchaser, in the case of indemnification pursuant to
Section 10.3(a) (the recipient of such notice referred to below as the “indemnifying party”
it being understood and agreed that the Seller Representative shall represent all Sellers in the
event of any breach of the representations, warranties or covenants of the Company hereunder and
shall be entitled to bind all such Sellers in connection therewith (subject to the limitations
contained herein)). The failure of the indemnified party to give reasonably prompt notice of any
Indemnification Claim shall not release, waive or otherwise affect the indemnifying party’s
obligations with respect thereto except to the extent that the indemnifying party is prejudiced as
a result of such failure. If the indemnifying party acknowledges in writing its obligation to
indemnify the indemnified party with respect to any such Legal Proceedings that give rise to an
Indemnification Claim, a indemnifying party shall have the right, at its sole option and expense,
to be represented by counsel of its choice in connection with such Legal Proceedings, which must be
reasonably satisfactory to the indemnified party, and to defend against, negotiate, settle or
otherwise deal with such Indemnification Claim which

70

 

relates to any Losses indemnified against by
it hereunder but any reasonable documented out of pockets costs of any such undertaking (including
the costs of a single counsel for all indemnifying parties) shall reduce the Cap applicable to such
parties. If the indemnifying party elects to defend against, negotiate, settle or otherwise deal
with any Indemnification Claim which relates to any Losses indemnified against by it hereunder, it
shall within 10 days after receipt of an Indemnification Claim (or sooner, if the nature of the
Indemnification Claim so requires) notify the indemnified party of its intent to do so. If the
indemnifying party fails to assume the defense of such Indemnification Claim within such 10-day
period, the indemnified party may defend against, negotiate, settle or otherwise deal with such
Indemnification Claim. If the indemnifying party elects to assume the defense of any
Indemnification Claim, the indemnified party may participate, at his or its own expense, in the
investigation and defense of such Indemnification Claim; provided, however, that
such indemnified party shall be entitled to participate in any such defense with separate counsel
in each jurisdiction at the expense of the indemnifying party (which expenses, fees and costs shall
be paid at least quarterly) if, (i) so requested by the indemnifying party to participate or (ii)
(A) in the reasonable opinion of counsel to the indemnified party, a conflict or potential conflict
exists between the indemnified party and the indemnifying party that would make such separate
representation advisable or (B) the claim seeks nonmonetary relief which, if granted, could
materially and adversely affect the indemnified party or its Affiliates (in which case,
notwithstanding anything to the contrary in this Agreement, the indemnifying party shall not have
the right to control the defense or investigation of such Legal Proceeding). In no event shall the
indemnifying party be required to pay for more than one set of counsel (plus any appropriate local
counsel) for all indemnified parties in connection with any Indemnification Claim. The parties
hereto agree to cooperate fully with each other in connection with the defense, negotiation or
settlement of any such Indemnification Claim. Notwithstanding anything in this Section
10.4 to the contrary, neither the indemnifying party nor the indemnified party shall, without
the written consent of the other party, settle or compromise any Indemnification Claim or permit a
default or
consent to entry of any judgment unless the claimant and such party provide to such other
party an unqualified release from all liability in respect of the Indemnification Claim.
Notwithstanding the foregoing, if a settlement offer solely for money damages is made by the
applicable third party claimant, and the indemnifying party notifies the indemnified party in
writing of the indemnifying party’s willingness to accept the settlement offer and, subject to the
applicable limitations of Sections 10.5 and 10.6, pay the amount called for by such
offer, and the indemnified party declines to accept such offer, the indemnified party may continue
to contest such Indemnification Claim, free of any participation by the indemnifying party, and the
amount of any ultimate liability with respect to such Indemnification Claim that the indemnifying
party has an obligation to pay hereunder shall be limited to the lesser of (A) the amount of the
settlement offer that the indemnified party declined to accept plus the Losses of the indemnified
party relating to such Indemnification Claim through the date of its rejection of the settlement
offer or (B) the aggregate Losses of the indemnified party with respect to such Indemnification
Claim.

          (c) After any final decision, judgment or award shall have been rendered by a Governmental
Body of competent jurisdiction and the expiration of the

71

 

time in which to appeal therefrom, or a
settlement shall have been consummated, or the indemnified party and the indemnifying party shall
have arrived at a mutually binding agreement with respect to an Indemnification Claim hereunder,
the indemnified party shall forward to the indemnifying party notice of any sums due and owing by
the indemnifying party pursuant to this Agreement with respect to such matter.

     10.5 Certain Limitations on Indemnification.

          (a) Notwithstanding the provisions of Articles X and XI and except as
otherwise provided herein, (i) neither the Primary Indemnitors nor Purchaser shall have any
indemnification obligations for Losses under Section 10.2(a)(i) or (ii),
Section 10.3(a)(i) or Article XI, (1) for any individual item, or group of related
items which shall include claims by unrelated parties arising out of the same or substantially
similar factual allegations (e.g., class action claims) to the extent all Losses with respect to
such item or series of related items are less than $50,000 (the “Sub-Basket”) and (2) in
respect of each item or series of related items for which all Losses are equal to or greater than
the Sub-Basket, unless the aggregate amount of all such Losses exceeds $500,000 (the
“Basket”), and then only to the extent of such excess, and (ii) in no event shall the
aggregate amounts to be paid by the Primary Indemnitors under this Article X, Section
8.19(b) and Article XI exceed $20,000,000 (the “Cap”); provided,
however, that (x) none of the foregoing limitations shall apply to any Losses arising out
of, resulting from or related to any breach, inaccuracy or failure to be true of any representation
or warranty set forth in Sections 5.1 (Organization), 5.2 (Authorization),
5.4 (Capitalization), 5.5 (Subsidiaries), 6.1 (Organization), 6.2
(Authorization), 6.4 (Ownership), 7.1 (Organization) and 7.2
(Authorization) (the “Cap Exceptions”) and (y) any Losses for which tax indemnification is
provided in Article XI shall not be subject to the Sub-Basket.

          (b) Notwithstanding anything herein to the contrary, except as provided in the last sentence
of Section 10.5(c), (i) the aggregate amount for which any Primary Indemnitor shall be
liable hereunder shall be (x) such Primary Indemnitor’s Indemnification Percentage multiplied by
(y) an amount equal to the sum of the Aggregate Equity Value plus the ACAS Warrant Amount;
and (ii) the aggregate amount for which any Primary Indemnitor shall be liable with respect to
Losses suffered by Purchaser Indemnified Parties pursuant to Section 10.2(a)(i) or
(ii) for any breaches or inaccuracies of any representations and warranties in Article
V or Article VI (other than representations and warranties included in the definition
of Cap Exceptions), Section 8.19(b) or Article XI shall in no event exceed (x) such
Primary Indemnitor’s Indemnification Percentage multiplied by (y) the Cap Amount. For the
avoidance of doubt, amounts which count toward the limit set forth in clause (ii) above count
against the limit in clause (i), but not vice versa.

          (c) Notwithstanding anything else herein to the contrary, ACAS shall not be liable for any
amount with respect to Losses incurred by Purchaser Indemnified Parties pursuant to Section
10.2(a)(i) (other than Sections 6.1 (Organization), 6.2 (Authorization) and
6.3 (Ownership and Transfer of Securities) (each, the “ACAS Cap Exceptions”)),
Section 10.2(a)(ii), or Section 8.19(b) in excess of $2,000,000, less amounts paid
by ACAS under the ACAS Contribution Agreement (the “ACAS Cap”). In

72

 

the event Purchaser
Indemnified Parties have Losses pursuant to Section 10.2(a)(i) (other than with respect to
the ACAS Cap Exceptions) or Section 10.2(a)(ii) in excess of the ACAS Cap, the remaining
Primary Indemnitors shall be jointly and severally liable for the full amount ACAS’s
Indemnification Percentage of such Losses in excess of the ACAS Cap in accordance with the
remaining limitations of this Section 10.5.

          (d) No Purchaser Indemnified Party shall make any claim for indemnification under this
Article X in respect of any matter to the extent that is taken into account in the
calculation of any adjustment to the Purchase Price pursuant to Section 3.2.

          (e) Except as provided in Section 8.19, the Purchaser Indemnified Parties shall not be
entitled to indemnification with respect to a breach of the representations and warranties in
Section 5.18 to the extent resulting from any investigation of environmental conditions at any
Company Property conducted by, or at the direction of, Purchaser other than (i) any such
investigation required under applicable Law (including any Law requiring that such testing be
completed in connection with any construction, material maintenance activity, expansion or closure
of all or any part of any Facility), (ii) any such investigation required by any Governmental Body,
(iii) any such investigation in response to any Environmental Claim to the extent reasonably
related thereto, (iv) any air or wastewater testing required by Environmental Law in
connection with any maintenance or modification of all or any part of any Facility (including any
testing required to obtain any Environmental Permit that may be required in connection therewith)
or (v) any Phase I assessment or other similar noninvasive environmental audit conducted in
preparation for or in connection with any M&A or financing transaction, or securities offering
involving Purchaser, the Company or their Affiliates; provided, however, that with
respect to this clause (v), the Primary Indemnitors shall have no
liability or obligation to the Purchaser Indemnified Parties under this Agreement with respect
to any Phase II or other invasive testing (including the results thereof) undertaken by the
Purchaser Indemnified Parties as a result of such non-invasive Phase I assessment or other similar
noninvasive environmental audit.

     10.6 Indemnity Escrow.

          (a) Establishment of Indemnity Escrow Account; Payments. On the Closing Date,
Purchaser shall, on behalf of Swaldo and Blackerby, pay to La Salle Bank, as escrow agent to
Purchaser and Swaldo and Blackerby (the “Escrow Agent”), in immediately available funds, to
a separate escrow account (the “Indemnity Escrow Account”) established by the Indemnity
Escrow Agent, an amount equal to $7,000,000 (the “Indemnity Escrow Amount”), in accordance
with the terms of this Agreement and the Indemnity Escrow Agreement. Any payment the Primary
Indemnitors (other than any payments required to be made by ACAS pursuant to Section
10.2(a)(i) or (iii)) are obligated to make to any Purchaser Indemnified Parties
pursuant to this Article X, Article XI or Section 8.19(b) (and
notwithstanding the fact that such liability is several as among ACAS and Swaldo and Blackerby)
shall be paid first, to the extent there are sufficient funds in the Indemnity Escrow Account, by
release of funds to the Purchaser Indemnified Parties from the Indemnity Escrow Account by the
issuance of joint written instructions

73

 

by the Seller Representative and Purchaser to the Escrow
Agent within five (5) Business Days after the date notice of any sums due and owing is given to
Theodore V. Swaldo (with a copy to the Seller Representative and the Escrow Agent pursuant to the
Escrow Agreement) by the applicable Purchaser Indemnified Party and shall accordingly reduce the
Indemnity Escrow Amount and, second, to the extent the Indemnity Escrow Amount is insufficient to
pay any remaining sums due, then the Primary Indemnitors shall be required to pay their
Indemnification Percentage of all of such additional sums due and owing to the Purchaser
Indemnified Parties by wire transfer of immediately available funds within five (5) Business Days
after the date of such notice (subject to the limitations in Section 10.5).

          (b) Release of Indemnity Escrow.

     (i) On the date (the “Step-Down Date”) that is eighteen (18) months following
the Closing Date, the Escrow Agent shall release to Swaldo and Blackerby (pro rata in
accordance with the amounts contributed to the Indemnification Escrow Account), the portion
of the Indemnification Escrow Amount in excess of an amount equal to the sum of (A)
$3,500,000 plus (B) an amount equal to the aggregate of all claims for
indemnification of the Purchaser Indemnified Parties under this Article X asserted but not
yet resolved (“Unresolved Claims”) prior to the Step-Down Date. The Indemnity
Escrow Amount in excess of $3,500,000 that was retained for Unresolved Claims shall be
released by the Escrow Agent (to the extent not utilized to pay Purchaser for any such
claims resolved in favor of Purchaser) as soon as reasonably practicable
upon their resolution in accordance with this Article X and the terms of the Escrow
Agreement.

     (ii) On the date that is three (3) years after the Closing Date, the Escrow Agent
shall release to Swaldo and Blackerby (pro rata in accordance with the amounts contributed
to the Indemnification Escrow Account), all or any remaining portion of the Indemnification
Escrow Amount less an amount equal to the aggregate of all Unresolved Claims on
such date. Thereafter, as soon as reasonably practicable after the resolution of any such
Claims, in the event and to the extent that the remaining portion of the Indemnification
Escrow Amount exceeds the aggregate amount of all Unresolved Claims, the Escrow Agent shall
release to Swaldo and Blackerby (pro rata in accordance with the amounts contributed to the
Indemnification Escrow Account), any such excess amount.

     (iii) The Seller Representative and the Purchaser shall promptly deliver joint written
instructions to the Escrow Agent required pursuant to the terms of the Escrow Agreement in
order to make the distributions required by this Section 10.6(b).

     10.7 Calculation of Losses.

          (a) The amount of any Losses for which indemnification is provided under this Article
X shall be net of any (i) Tax benefits actually realized by way of a

74

 

current reduced cash
outlay for Taxes by the indemnified party, and amounts actually recovered by the indemnified party
under insurance policies or otherwise with respect to such Losses (net of any Tax or expenses
incurred in connection with such recovery), (ii) amounts recovered by the indemnified party
pursuant to any indemnification by or indemnification or other agreement with any third party,
(iii) any insurance proceeds or other cash receipts or sources of reimbursement received as a
direct offset against such Loss (net of any costs incurred to recover such amounts) (each source
named in clauses (ii) and (iii) a “Collateral Source”). The indemnifying party may require
an indemnified party to assign the rights to seek recovery from a Collateral Source;
provided that the indemnifying party will then be responsible for pursuing such recovery at
its own expense. Purchaser shall use its commercially reasonable efforts to recover under
insurance policies for any Losses prior to seeking indemnification under this Agreement. For
purposes of determining when the indemnified party has realized a Tax benefit under this Section,
if the indemnified party or any consolidated group of which it is a member for Tax purposes has
other items of deduction, loss or credit for any taxable period ending no later than the last day
of the taxable year in which the indemnity payment is made, the items of Tax benefit arising out of
the Losses for which indemnity is sought shall be deemed used first prior to use of any such other
items. The party seeking indemnification under this Article X shall use commercially
reasonable efforts to seek recovery from Collateral Sources. The parties acknowledge and agree
that no right of subrogation shall accrue or inure to the benefit of any Collateral Source
hereunder.

          (b) Notwithstanding anything to the contrary elsewhere in this Agreement, no party shall in
any event be liable to any other Person for any consequential, special or punitive damages or any
Losses based upon any multiple of lost earnings or other similar methodology used to value the
Company or the Securities based on the financial performance or results of operations of the
Company or its Subsidiaries, except, in each case, to the extent that any third party asserts a
claim against the Company or any of its Subsidiaries for any such damages that is indemnifiable
hereunder.

     10.8 Tax Treatment of Indemnity Payments. The Sellers and Purchaser agree to treat
any indemnity payment made pursuant to this Article X as an adjustment to the Purchase
Price for federal, state, local and foreign income tax purposes.

     10.9 Exclusive Remedy. From and after the Closing, except (i) in the event of fraud
(in which case the parties shall be entitled to exercise all of their rights, and seek all damages
available to them, under law or equity), (ii) as provided in Section 8.19 (Environmental
Matters); Article XI (Tax Matters) and Section 12.3 (Seller Representative and
Equity Sellers Representative), and (iii) for specific performance of obligations to be performed
at and after the Closing, the sole and exclusive remedy of the parties hereto for breach of this
Agreement shall be indemnification in accordance with this Article X. In furtherance of
the foregoing, effective as of the Closing, each Seller, on behalf of itself and each of its past,
present and future Affiliates, beneficiaries and assigns (“Related Persons”), hereby
releases and forever discharges the Company and each of its past, present and future Affiliates,
Subsidiaries, shareholders, members, successors and assigns, and their respective officers,
directors and employees (each individually, a “Releasee” and collectively,
“Releasees”), from any and all claims, demands,

75

 

proceedings, causes of action (including
rights of contribution, if any, court orders, obligations, contracts, agreements (express or
implied), debts and liabilities under or relating to the Company Common Stock, the Company
Preferred Stock, the Warrants, the Company, its Subsidiaries or their respective predecessors in
interest, including any liability or obligation arising under or pursuant to any shareholder
agreement, employment agreement or other compensation arrangement (other than agreements and
arrangements entered into between the Company and a Seller on or after the Closing Date, accrued
and unpaid compensation to the extent included on the Closing Balance Sheet, or any claim for
indemnification pursuant to the Company’s or its Subsidiaries certificate of incorporation or other
charter document to the extent not arising as a result of any claim by Purchaser against such
Releasee or its Related Persons hereunder) in each case, whether known or unknown, suspected or
unsuspected, both at law and in equity, which such Seller or any of its Related Persons now has,
has ever had or hereafter has against the respective Releasees.

ARTICLE XI

TAX MATTERS

     11.1 Indemnification for Tax Obligations. From and after the Closing Date, the
Primary Indemnitors shall jointly and severally defend, indemnify and hold harmless the Purchaser
Indemnified Parties from and against all Losses arising out of or in connection with: (i) any Taxes
payable by any of the Taxpayers with respect to any Pre-Closing Tax Period or for the Straddle
Period, to the extent allocable or attributable (as provided in Section 11.2) to the
portion of such period beginning before and ending on the Closing Date; (ii) any liability of any
of the Taxpayers for Taxes of others (for example, by reason of transferee liability or application
of Treasury Regulation Section 1.1502-6); (iii) any inaccuracy of any representation or any breach
of warranty contained in Section 5.8(iii) or Section 5.9; (iv) any breach by any
Taxpayer of any covenant contained in Section 8.2(b)(xx) or this Article XI; (v)
any Transfer Taxes for which the Sellers are liable pursuant to Section 12.1 hereof; (vi)
any failure of any of the Stockholders, Equity Seller Representative or any Taxpayer to comply with
the provisions of this Article XI; (vii) any VAT receivable set forth on the Closing
Statement that is taken into account in the determination of Closing Working Capital that is not
collected in full by one or more of the Taxpayers within 180 days following Closing, and (viii)
Taxes arising out of or in connection with any breach by the Equity Seller Representative or the
Stockholders of any covenant contained in this Agreement. The Sellers shall not be liable for
Taxes to the extent of the amount of the reserve for Taxes that is set forth as a current liability
(other than any reserve for deferred Taxes established to reflect timing differences between book
and Tax income) on the Closing Statement and that is taken into account in the determination of the
Closing Date Net Working Capital, with such reserve reduced by any amounts credited against Taxes
otherwise payable by the Equity Sellers pursuant to Section 11.6 and the Closing Deductions
as actually reflected on the Short Period federal income Tax Return (the Closing Deductions thus
adjusted, the “Actual Closing Deductions,” and such reserve thus adjusted, the
“Adjusted Tax Reserve”). Notwithstanding the provisions of this Section 11.1,
claims for indemnification under this Section 11.1, together with claims for
indemnification under Article X, shall be subject to

76

 

the Basket and the Cap as provided in
Section 10.5. Except as otherwise provided in Section 10.7 concerning Losses being
determined net of any Tax benefit, for purposes of this Article XI, references to any
“Loss” shall be deemed to include amounts that would have constituted a “Loss” but for the set-off
or other utilization of any loss, deduction or credit realized in, or attributable to a
Post-Closing Tax Period.

     11.2 Allocation of Taxes. In the case of Taxes that are payable with respect to the
Straddle Period, the portion of such Taxes for the Pre-Closing Tax Period shall be (i) in the case
of ad valorem or property Taxes, the amount of such Taxes for the entire period multiplied by a
fraction, the numerator of which is the number of calendar days during the period ending on the
Closing Date and the denominator of which is the total number of calendar days in
the entire period, and (ii) in the case of all other Taxes be determined based on an interim
closing of the books as of the close of business on the Closing Date. The Closing Deductions
shall, in all events, be treated as occurring in the Short Period (as defined in Section 11.6(a))
and/or in the pre-Closing portion of the Straddle Period.

     11.3 Indemnity Payments. All amounts paid with respect to indemnity claims under this
Agreement shall be treated by the parties hereto for all income Tax purposes as adjustments to the
Purchase Price.

     11.4 Tax Benefits.

          (a) On the Closing Date, (i) the cancellation of the Options hereunder will give rise to
compensation deductions to the extent permitted by applicable Law (the “Option Deduction”),
(ii) the unamortized fees, unamortized interest and other expenses incurred by the Company or its
Subsidiaries in connection with the incurrence of any indebtedness to be paid off at Closing may be
deductible for income Tax purposes (the “Financing Fees Deduction”), and (iii) certain
Transaction Expenses incurred by the Company or its Subsidiaries may be deductible for income Tax
purposes (the “Transaction Fees Deduction” and collectively with the Option Deduction and
the Financing Fees Deduction, the “Closing Deductions”).

          (b) Purchaser shall pay the following amounts (collectively, the “Tax Benefit
Amount”), at the following times, to the Common Stock Sellers

     (i) Within five (5) Business Days after receipt by any member of the Buying Group (as
defined in clause (iii) below), the total amount of the Tax refund (inclusive of interest)
paid to any member of the Buying Group or any amount of Tax credited against Tax which any
member of the Buying Group otherwise would be or would have been required to pay, in either
case, with respect to any Pre-Closing Tax period but for the utilization of any of the
Closing Deductions utilizing the Ordering Rule as defined in subsection (iii) below
(including with respect to Prior Returns filed pursuant to Section 11.6(b)), except
to the extent (A) attributable to the carryback of any tax attribute from a post-Closing
Tax period (or portion thereof), (B) expressly taken into account in the computation of
Closing Working Capital, or (C) otherwise payable in accordance

77

 

with the provisions of
subsection (ii) below (any such amount, a “Closing Deduction Refund or Credit”).

     (ii) Within five (5) Business Days after the filing of any Tax Return or the payment
of any estimated Taxes, for any taxable period covered by Section 11.4(b)(iii),
Purchaser shall (A) provide to the Equity Sellers Representative a written certificate as
to the amount, if any, and the calculation thereof, of the Utilized Tax Attributes (as
defined in clause (iii) below) for the Buying Group for
such Tax Return; and (B) pay to the Common Stock Sellers an amount equal to such
Utilized Tax Attributes.

     (iii) For purposes hereof, “Utilized Tax Attributes” shall mean any reduction
in the cash outlay for Taxes of any member of the Company or Buying Group that otherwise
would be payable (including with respect to any Short Period and the portion of any
Straddle Period ending on and including the Closing Date) but for the utilization of the
Closing Deductions, determined by giving effect to the Ordering Rule, to the extent such
reduction in cash outlay is reflected or taken into account (A) on any estimated tax
payment or Tax Return filed on or before March 15, 2015, or, (B) as a result of any benefit
from any Federal or state net operating loss or credit carryforward to a post-Closing tax
period, in each case generated by the Closing Deductions. If the Company or the Buying
Group has other items of deduction, loss or credit, such other items shall be deemed used
subsequent to use of the Closing Deductions in connection with the determination of the
amount of any Utilized Tax Attributes payable to the Common Stock Sellers under this
subsection (c) (such convention with respect to the ordering of the use of the Closing
Deductions and other Tax benefits, the “Ordering Rule”). For purposes hereof,
“Buying Group” shall mean Purchaser and each of its Subsidiaries and any other
member included in any consolidated income tax filing by the group in which Purchaser
and/or Parent are a member.

     (iv) Any Closing Deductions Refund or Credit and any Utilized Tax Attributes required
to be paid hereunder shall be reduced by (i) any amount required by applicable Law to be
withheld from such payments, including the incremental (net of Federal tax benefit) payroll
taxes (e.g., FICA, Medicare, FUTA, SUTA), (ii) if applicable, 401(k) matches paid by the
Company or its Subsidiaries with respect to the gross wages generated by the Closing
Deductions, to the extent applicable thereto and (iii) any reasonable out-of-pocket expense
incurred in connection with realizing any cash benefit of Closing Deduction Refund or
Credit or Utilized tax Attributes.

     (v) For the avoidance of doubt, the parties agree that the provisions of Section
11.1, Section 11.4 and Section 11.6 are intended to be interpreted to
provide the Equity Sellers with value which is no less, and no more, than the value of the
Tax Benefit Amount.

          (c) Purchaser shall provide access and make available upon request (at reasonable times, on
adequate notice and subject to the payment by the Equity Sellers

78

 

Representative of any
out-of-pocket charges imposed on any member of the Buying Group), to the Equity Sellers
Representative and its representatives, all applicable post-Closing Tax Returns, workpapers,
personnel, representatives and such other information requested that is reasonably necessary to
verify the propriety of the calculation of any Tax Benefit Amount or any Utilized Tax Attributes;
provided, that the foregoing shall be subject to professional standards and the Company’s
independent accountant’s generally applicable firm policy; and provided further
that such materials shall be treated by the Equity Sellers Representative, and the Equity Sellers
Representative shall cause its
representatives to treat such materials, as confidential, and not disclose such materials to
any other party except as required by applicable law or to establish its entitlement to payment
under this Section 11.4.

     11.5 Tax Contests. The Purchaser shall promptly notify the Equity Sellers
Representative in writing upon receipt by the Purchaser, a Taxpayer or any of their Affiliates of a
written notice (the “Tax Claim Notice”) of any pending or threatened Tax audits or
assessments for which the Sellers may have liability pursuant to this Agreement (“Tax Contest
Claims”); provided, however, no failure or delay by the Purchaser to provide
notice of a Tax Contest Claim shall reduce or otherwise affect the obligation of the Sellers
hereunder except to the extent the Sellers are prejudiced thereby. The Purchaser and the Equity
Sellers Representative shall cooperate with each other in the conduct of any Tax Contest Claim.
The Equity Sellers Representative shall have the right to control the conduct of any Tax Contest
Claim if it exercises such right by delivering a written notice to such effect to the Purchaser
within ten (10) business days after receipt of the Tax Claim Notice with respect to the Tax Contest
Claim in question, provided that: (i) the Equity Sellers Representative shall keep the Purchaser
informed regarding the progress and substantive aspects of any Tax Contest Claim, including
providing the Purchaser with all written materials relating to such Tax proceeding received from
and submitted to the relevant Taxing Authority within ten (10) business days of receipt or
submission of such materials, (ii) the Purchaser shall have an opportunity to comment on any
written materials prepared in connection with any Sellers’ Tax Contest Claim at least five (5)
business days prior to submission and (iii) shall have the right to attend any conferences relating
to any Tax Contest Claim and to consent (which consent shall not be unreasonably withheld,
conditioned or delayed) to any compromise or settlement, in each case, if such Tax Contest Claim
could reasonably be expected to have any material adverse effect on any of the Purchaser or any of
the Taxpayers or any of their affiliates in any Post-Closing tax period. Except as otherwise
provided above in this Section 11.5, Purchaser shall be entitled to control all other
examinations, audits, or administrative, judicial or other proceedings with respect to Taxes.

     11.6 Preparation of Tax Returns.

          (a) In order to apportion appropriately any Taxes relating to a taxable period that otherwise
would include (but not end on) the Closing Date, the parties hereto will, to the extent permitted
by applicable Law, cause the taxable year of the Company to close on (and include) the Closing Date
(a “Short Period”).

79

 

          (b) Equity Sellers Representative shall cause to be prepared by the Company’s regular
pre-Closing accountants, at the Company’s expense (to be reimbursed by the Equity Sellers within 30
days after presentation of a written invoice from the Company), as promptly as practicable after
the Closing Date, but in no event later than thirty (30) days prior to the due date for filing any
such Tax Return (taking into account
any applicable extensions of time to file) for review and comment by the Equity Sellers
Representative and the Purchaser: all Tax Returns required to be filed for any Pre-Closing Tax
Periods (the “Pre-Closing Tax Returns”), including (i) the federal, state and local income Tax
Returns for the fiscal year ending December 31, 2005; (ii) net operating loss carryback claims
arising out of the Closing Deductions for any filed Tax Return of the Company to the extent
permitted by applicable Law; and (iii) Tax Returns for the period beginning on January 1, 2006 and
ending on the Closing Date (the “Stub Period Returns”) (such Tax Returns and claims
described in clauses (i-iii) above are collectively referred to as the “Prior Returns”).
Except to the extent of the Adjusted Tax Reserve, as defined in Section 11.1 (other than any
reserve for deferred Taxes established to reflect timing differences between book and Tax income)
and any Estimated Taxes previously paid, the Common Stock Sellers shall pay all Taxes shown as due
and owing with respect to such Pre-Closing Tax Returns to the Company no later than two (2)
Business Days prior to the due date for filing such returns, giving effect to applicable
extensions, and the Company shall file such returns and pay the Taxes due and owing with respect
thereto. No election under Treasury Regulation Section 1.1502-76(b)(2)(ii)(D) to ratably allocate
income to the Short Period shall be made. The Equity Sellers Representative shall cause to be
prepared, and Purchaser shall cause the Company to file, the Prior Returns on a basis consistent
with those prepared for prior taxable periods to the extent permitted by applicable Law, and to
include the Closing Deductions in the Stub Period Returns to the extent permitted by applicable
Law; provided that the amount of the Closing Deductions included shall be subject to the prior
written approval of the Purchaser as to their deductibility for income Tax purposes, not to be
unreasonably withheld, conditioned or delayed. The Purchaser shall not subsequently claim for its
benefit, and will cause the Taxpayers and their Affiliates not claim for their benefit, any Closing
Deductions that it does not approve pursuant to the preceding sentence. No election under Section
172(b)(3) of the Code will be made to forego the net operating loss carryback.

          (c) The Purchaser shall cause to be prepared in a manner consistent with past practices
(except where otherwise required by applicable Law) and in accordance with Section 11.6 of
this Agreement all Tax Returns of the Taxpayers for any Straddle Periods (“Straddle Period
Returns”), and shall cause such Tax Returns to be delivered to the Equity Sellers
Representative for consent (which consent shall not be unreasonably withheld, conditioned, or
delayed), no later than thirty (30) days prior to the due date for filing any such Straddle Period
Return (taking into account any applicable extensions of time to file). Except to the extent
reflected in the Adjusted Tax Reserve (other than any reserve for deferred Taxes established to
reflect timing differences between book and Tax income), no later than two (2) Business Days prior
to the due date for the payment of any Taxes with respect to any such Straddle Period Return, the
Equity Sellers Representative, on behalf of the Common Stock Sellers, shall pay to the Purchaser an
amount equal to the portion of Taxes attributable to the pre-Closing portion of the Straddle Period
as determined pursuant to the principles set forth in Section 11.2. The

80

 

Purchaser shall
cause such Straddle Period Returns to be timely filed and shall cause to be paid any Taxes payable
with respect to such Straddle Period Returns. The Equity Sellers Representative and the Purchaser
shall provide each other with any information reasonably necessary to prepare and file complete and
accurate Tax Returns.

     11.7 Cooperation. The Equity Sellers Representative and Purchaser shall cooperate as
and to the extent reasonably requested by the other party and at the requesting party’s
out-of-pocket expenses, in connection with the filing of any Tax Returns for the Taxpayers, the
filing of any Tax Returns for the Taxpayers, the filing and prosecution of any Tax claims and any
audit, litigation, or other proceeding with respect to Taxes of the Taxpayers. Such cooperation
shall include the retention of all books and records relating to the Taxpayers’ Taxes for a period
of six (6) years after the Closing and (upon the other party’s request and expense) the provision
of records and information which are reasonably relevant to any such audit, litigation or other
proceeding and making employees available on a mutually convenient basis to provide additional
information and explanation of any material provided hereunder.

     11.8 Conflict. To the extent there is any conflict between the provisions of this
Article XI and Article X, the provisions of this Article XI shall control.

     11.9 Survival. The covenants and agreements of the parties contained in this
Article XI shall survive the Closing and shall remain in full force and effect until such
covenant or agreement is fully performed.

     11.10 Successors. For purposes of this Article XI, references to any of the
Company, the Sellers, the Equity Sellers Representative, the Purchaser or any Taxpayer shall
include successor entities.

ARTICLE XII

MISCELLANEOUS

     12.1 Payment of Sales, Use or Similar Taxes. All sales, use, transfer, intangible,
recordation, documentary stamp or similar Taxes or charges, of any nature whatsoever, applicable
to, or resulting from, the transactions contemplated by this Agreement shall be borne one-half by
Purchaser and one-half by the Sellers as a Transaction Expense when due, and the Sellers will, at
their expense, file all necessary Tax Returns and other documentation with respect to all such
Taxes. If required by applicable law, the Purchaser will, and will cause its Affiliates to, join
in the execution of any such Tax Returns and other documentation.

     12.2 Expenses. Except as otherwise provided in this Agreement, (a) the Purchaser shall bear its own
expenses incurred in connection with the negotiation and execution of this Agreement and each other
agreement, document and instrument contemplated by this Agreement and the consummation of the
transactions contemplated hereby and thereby and (b) the Company shall bear all expenses
incurred by the Company, the Sellers and their Affiliates in connection with the negotiation and

81

 

execution of this Agreement and each other agreement, document and instrument contemplated by this
Agreement and the consummation of the transactions contemplated hereby and thereby (it being
understood and agreed that the Sellers will reimburse the Company for any such expenses not paid as
Transaction Expenses and not otherwise accrued as liabilities in Closing Working Capital);
provided, however, that the fees and expenses of the Independent Accountant, if
any, shall be paid in the manner set forth in Section 3.2(d).

     12.3 Seller Representative and Equity Sellers Representative.

          (a) With respect to all matters other than those reserved for the Equity Sellers
Representative under Section 3.2 and Article XI, each Seller hereby irrevocably
appoints ACAS (the “Seller Representative”) as such Seller’s representative,
attorney-in-fact and agent, with full power of substitution to act in the name, place and stead of
such Seller with respect to the transfer of such Seller’s Securities to Purchasers in accordance
with the terms and provisions of this Agreement and to act on behalf of such Seller in any
amendment of or litigation or arbitration involving this Agreement (other than those arising under
Section 3.2 and Article XI), including, without limitation, defending, negotiating,
settling or otherwise dealing with claims under Article X hereof, and to do or refrain from
doing all such further acts and things, and to execute all such documents, as such Seller
Representative shall deem necessary or appropriate in conjunction with any of the transactions
contemplated by this Agreement (subject to the foregoing limitation), including, without
limitation, the power:

     (i) to take all action necessary or desirable in connection with the waiver of any
condition to the obligations of the Sellers to consummate the transactions contemplated by
this Agreement;

     (ii) to negotiate, execute and deliver all ancillary agreements, statements,
certificates, notices, approvals, extensions, waivers, undertakings, amendments and other
documents required or permitted to be given in connection with the consummation of the
transactions contemplated by this Agreement (it being understood that such Seller shall
execute and deliver any such documents which the Seller Representative agrees to execute);

     (iii) to give and receive all notices and communications to be given or received under
this Agreement and the transactions contemplated hereby and to receive service of process
in connection with the any claims (other than those arising under Section 3.2 and
Article XI) under this Agreement and the transactions contemplated hereby; and

     (iv) to take all actions which under this Agreement and the transactions contemplated
hereby may be taken by the Sellers and to do or refrain from doing any further act or deed
on behalf of the Sellers which the Seller Representative deems necessary or appropriate in
its sole discretion relating to the subject matter of this Agreement and the transactions
contemplated hereby as fully and completely as such Seller could do if personally present.

82

 

          (b) With respect to all matters reserved for the Equity Sellers Representative under
Section 3.2 and Article XI, each Equity Seller hereby irrevocably appoints William
T. Blackerby, Jr. (the “Equity Sellers Representative”) as such Equity Seller’s
representative, attorney-in-fact and agent, with full power of substitution to act on behalf of
such Equity Seller in litigation or arbitration involving this Agreement (limited to those matters
arising under Section 3.2 and Article XI), including, without limitation,
defending, negotiating, settling or otherwise dealing with claims under Article XI hereof,
and to do or refrain from doing all such further acts and things, and to execute all such
documents, as such Equity Sellers Representative shall deem necessary or appropriate in conjunction
with any of the transactions contemplated by this Agreement (subject to the foregoing limitation),
including, without limitation, the power:

     (i) to give and receive all notices and communications to be given or received under
this Agreement and the transactions contemplated hereby and to receive service of process
in connection with the any claims (limited to those arising under Section 3.2 and
Article XI) under this Agreement and the transactions contemplated hereby; and

     (ii) to take all actions which under this Agreement and the transactions contemplated
hereby may be taken by the Equity Sellers and to do or refrain from doing any further act
or deed on behalf of the Equity Sellers which the Equity Sellers Representative deems
necessary or appropriate in its sole discretion relating to the subject matter of this
Agreement and the transactions contemplated hereby as fully and completely as such Equity
Seller could do if personally present.

          (c) Neither the Seller Representative nor the Equity Sellers Representative shall be liable to
the Sellers for any act taken or omitted by it as permitted under this Agreement and the
transactions contemplated hereby, except if such act is taken or omitted in bad faith or by willful
misconduct. Both the Seller Representative and the Equity Sellers Representative shall also be
fully protected against the Sellers in relying upon any written notice, demand, certificate or
document that it in good faith believes to be genuine (including facsimiles thereof).

          (d) Until the amount of Losses in accordance with Section X exceeds the ACAS Cap, the
Primary Indemnitors agree, severally but not jointly, in accordance with their respective
Indemnification Percentage, to indemnify the Seller Representative, and Theodore V. Swaldo and
William T. Blackerby Jr. agree, jointly and severally, to indemnify (i) the Equity Sellers
Representative and (ii) after the amount of Losses under Section X exceeds the ACAS Cap,
the Seller Representative for, and to hold each of the
Seller Representative and the Equity Sellers Representative harmless against, any loss,
liability or expense incurred without willful misconduct or bad faith on the part of the Seller
Representative or the Equity Sellers Representative, arising out of or in connection with the
Seller Representative’s or the Equity Sellers Representative’s carrying out its duties under this
Agreement and the transactions contemplated hereby, including costs and expenses of successfully
defending Seller Representative and Equity Sellers Representative against any claim of liability
with respect thereto. The Seller

83

 

Representative and the Equity Sellers Representative may consult
with counsel of its own choice and will have full and complete authorization and protection for any
action taken and suffered by it in good faith and in accordance with the opinion of such counsel.

          (e) If ACAS becomes unable to serve as Seller Representative, or William T. Blackerby, Jr.
becomes unable to serve as Equity Sellers Representative, such other Person or Persons as may be
designated by a majority of the Sellers, based on each Seller’s Pro Rata Share, shall succeed as
the Seller Representative or Equity Sellers Representative, as the case may be. If ACAS’s liability
for Losses shall have reached the ACAS Cap, then ACAS shall resign as Seller Representative and
the Equity Sellers Representative shall also become the Seller Representative.

     12.4 Submission to Jurisdiction; Consent to Service of Process.

          (a) The parties hereto hereby irrevocably submit to the jurisdiction of any federal or state
court located within the borough of Manhattan of the City, County and State of New York over any
dispute arising out of or relating to this Agreement or any of the transactions contemplated hereby
and each party hereby irrevocably agrees that all claims in respect of such dispute or any suit,
action proceeding related thereto may be heard and determined in such courts. The parties hereby
irrevocably waive, to the fullest extent permitted by applicable Law, any objection which they may
now or hereafter have to the laying of venue of any such dispute brought in such court or any
defense of inconvenient forum for the maintenance of such dispute. Each of the parties hereto
agrees that a judgment in any such dispute may be enforced in other jurisdictions by suit on the
judgment or in any other manner provided by Law.

          (b) Each of the parties hereto hereby consents to process being served by any party to this
Agreement in any suit, action or proceeding by the delivery of a copy thereof in accordance with
the provisions of Section 12.7.

     12.5 Entire Agreement; Amendments and Waivers. This Agreement (including the
schedules and exhibits hereto), the Company Confidentiality Agreement and the Purchaser
Confidentiality Agreement and each other agreement being entered into among the parties in writing
substantially concurrently herewith represent the entire understanding and agreement between the
parties hereto with respect to the subject matter hereof and thereof. This Agreement can be
amended, supplemented or changed, and any provision hereof can be waived, only by
written instrument making specific reference to this Agreement signed by the party against
whom enforcement of any such amendment, supplement, modification or waiver is sought. No action
taken pursuant to this Agreement, including any investigation by or on behalf of any party, shall
be deemed to constitute a waiver by the party taking such action of compliance with any
representation, warranty, covenant or agreement contained herein. The waiver by any party hereto
of a breach of any provision of this Agreement shall not operate or be construed as a further or
continuing waiver of such breach or as a waiver of any other or subsequent breach. No failure on
the part of any party to exercise, and no delay in exercising, any right, power or remedy hereunder
shall operate as a waiver thereof, nor shall any single or partial

84

 

exercise of such right, power or
remedy by such party preclude any other or further exercise thereof or the exercise of any other
right, power or remedy.

     12.6 Governing Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of New York applicable to contracts made and performed in such State
without giving effect to the choice of law principles of such state that would require or permit
the application of the laws of another jurisdiction.

     12.7 Notices. All notices and other communications under this Agreement shall be in
writing and shall be deemed given (i) when delivered personally by hand (with written confirmation
of receipt), (ii) when sent by facsimile (with written confirmation of transmission) or (iii) one
business day following the day sent by overnight courier (with written confirmation of receipt), in
each case at the following addresses and facsimile numbers (or to such other address or facsimile
number as a party may have specified by notice given to the other party pursuant to this
provision):

If to any Seller, to:

American Capital Strategies, Ltd., as Seller Representative

461 Fifth Avenue

25th Floor

New York, NY 10017

Attn:   Todd Wilson

Facsimile:   (212) 213-2060

William T. Blackerby, Jr., as Equity Sellers Representative

6902 Victoria Court Street

Canton, OH 44718

With a copy (which shall not constitute notice) to:

American Capital Strategies, Ltd.

2 Bethesda Metro Center

14th Floor

Bethesda, MD 20814

Attn:   Compliance Officer

Telecopier:   (301) 654-6714

With a copy (which shall not constitute notice) to:

Weil, Gotshal & Manges LLP

767 Fifth Avenue

New York, NY 10153

Attn:   Christopher Aidun, Esq.

Facsimile:   (212) 310-8007

85

 

With a copy (which shall not constitute notice) to:

Calfee, Halter & Griswold LLP

1400 McDonald Investment Center

800 Superior Avenue

Cleveland, OH 44114-2688

Attn: Robert Ross, Esq.

Facsimile: (216) 622-8454

If to Purchaser, to:

United Components, Inc.

Highway 41 North

Evansville, IN 47725

Attn:   Keith Zar, General Counsel

Facsimile:   (812) 867-4157

With copies to:

The Carlyle Group

1001 Pennsylvania Avenue, N.W.

Suite 220 South

Washington, DC 20004

Attn:   Ian Fujiyama

Facsimile:   (202) 347-1818

and:

Latham & Watkins LLP

555 11th Street, N.W.

Suite 1000

Washington, DC 20004

Attn:   David S. Dantzic, Esq.

Facsimile:   (202) 637-2201

     12.8 Severability. If any term or other provision of this Agreement is invalid,
illegal, or incapable of being enforced by any law or public policy, all other terms or provisions
of this Agreement shall nevertheless remain in full force and effect so long as the economic or
legal substance of the transactions contemplated hereby is not affected in any manner materially
adverse to any party. Upon such determination that any term or other provision is invalid,
illegal, or incapable of being enforced, the parties hereto shall negotiate in good faith to modify
this Agreement so as to effect the original intent of the parties as closely as possible in an
acceptable manner in order that the transactions contemplated hereby are consummated as originally
contemplated to the greatest extent possible.

     12.9 No Conflict. Purchasers and the Company (on behalf of itself and its
Subsidiaries) agree that, notwithstanding any current or prior representation of the

86

 

Company and
the Subsidiaries by Weil, Gotshal & Manges LLP (“WGM”) or Calfee, Halter & Griswold, LLP
(“CHG”), WGM and/or CHG shall be allowed to represent any Seller, the Seller
Representative, the Equity Sellers Representative or any of their Affiliates in any matters and
disputes (or any other matter), including in any matter or dispute adverse to Purchasers, the
Company or any Subsidiary that either is existing on the date hereof or that arises in the future
and relates to this Agreement and the transactions contemplated hereby and Purchasers and the
Company (on behalf of itself and the Subsidiaries) hereby waive any claim they have or may have
that WGM or CHG has a conflict of interest or is otherwise prohibited from engaging in such
representation.

     12.10 Binding Effect; Assignment. This Agreement shall be binding upon and inure to
the benefit of the parties and their respective successors and permitted assigns. Nothing in this
Agreement shall create or be deemed to create any third party beneficiary rights in any person or
entity not a party to this Agreement except as provided below. No assignment of this Agreement or
of any rights or obligations hereunder may be made by either the Sellers or Purchaser, directly or
indirectly (by operation of law or otherwise), without the prior written consent of the other
parties hereto and any attempted assignment without the required consents shall be void;
provided, however, that nothing herein shall prevent Purchaser from granting a Lien
(for customary collateral purposes) on this Agreement to
its lenders providing the financing contemplated pursuant to the Debt Commitment Letter. No
assignment of any obligations hereunder shall relieve the parties hereto of any such obligations.
Upon any such permitted assignment, the references in this Agreement to Purchaser shall also apply
to any such assignee unless the context otherwise requires.

     12.11 Counterparts. This Agreement may be executed in one or more counterparts, each
of which will be deemed to be an original copy of this Agreement and all of which, when taken
together, will be deemed to constitute one and the same agreement.

     12.12 Termination of Agreements.

          (a) Effective upon the Closing, each of the Company and the Sellers agree that the Seller
Stockholders Agreement shall be terminated in its entirety and no party thereto shall have any
further rights, duties, liabilities or obligations of any nature whatsoever with respect to, in
connection with or otherwise arising under the Seller Stockholders Agreement. With respect to the
transactions contemplated by this Agreement, each of the Company and the Sellers hereby waives
compliance with the Seller Stockholders Agreement (including with respect to notice), to the extent
that any section would require any action or notice on the part of the Company or the Sellers on or
prior to the Closing Date.

          (b) Effective upon the Closing, each of the Company and ACAS agree that the Letter Agreement
and the ACAS Management Agreement shall be terminated in its entirety and no party thereto shall
have any further rights, duties, liabilities or obligations of any nature whatsoever with respect
to, in connection with or otherwise arising under the Letter Agreement.

87

 

     12.13 Specific Performance. The Sellers agree that the Company Common Stock
represents unique property that cannot be readily obtained on the open market and that the
Purchaser would be irreparably injured if this Agreement is not specifically enforced after
default. Therefore, the Purchaser shall have the right to specifically enforce the Sellers’ and
the Company’s performance of their obligations under this Agreement, and the Sellers and the
Company agree to waive the defense in any such suit that the Purchaser has an adequate remedy at
law and to interpose no opposition, legal or otherwise, as to the propriety of specific performance
as a remedy, and that the Purchaser shall have the right to obtain specific performance of the
terms of this Agreement without being required to prove actual damages, post bond or furnish other
security. In addition, the Purchaser shall be entitled to obtain from any Seller or the Company
against whom specific performance is granted, court costs and reasonable attorneys’ fees incurred
by the Purchaser in enforcing its rights hereunder. As a condition to seeking specific
performance, the Purchaser shall not be required to have tendered the Purchase Price but shall be
ready, willing and able to do so.

** REMAINDER OF PAGE INTENTIONALLY LEFT BLANK **

88

 

     IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their
respective authorized officers, as of the date first written above.

	 	 	 	 	 	 	 
	 	 	UNITED COMPONENTS, INC.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Name:	 	 
	 

	 	 	 	Title:	 	 
	 
	 	 	 	 	 	 
	 	 	ACAS ACQUISITIONS (ASC), INC.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Name:	 	 
	 

	 	 	 	Title:	 	 
	 
	 	 	 	 	 	 
	 	 	SELLERS:	 	 
	 
	 	 	 	 	 	 
	 	 	AMERICAN CAPITAL STRATEGIES, LTD.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Name:	 	 
	 

	 	 	 	Title:	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 	 	Linda Swaldo	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 	 	William T. Blackerby, Jr.	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 	 	Christina Blackerby	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 	 	Scott Swaldo	 	 

 

 

EXHIBIT A

Seller Information and Indemnification Percentage

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Seller	 	Total	 	Rollover	 	Cancelled	 	Pro Rata	 	Indemnification
	 	 	Shares	 	Amount	 	Options	 	Share	 	Percentage
	 	 	 	 	 	 	 	 	 	 	Vested	 	 	 	 	 	 	 	 
	Common Stock Sellers
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Linda Swaldo
	 	 	131,000	 	 	$	8,000,000	 	 	 	 	 	 	 	81.237	%	 	 	N/A	 
	William T. Blackerby, Jr.
	 	 	15,000	 	 	$	300,000	 	 	 	 	 	 	 	9.300	%	 	see below
	Christina Blackerby
	 	 	2,000	 	 	 	 	 	 	 	 	 	 	 	1.240	%	 	 	N/A	 
	Scott Swaldo
	 	 	2,000	 	 	 	 	 	 	 	1,186	 	 	 	1.975	%	 	 	N/A	 
	Option Holders
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Ying Hua Li
	 	 	 	 	 	 	 	 	 	 	1,186	 	 	 	0.735	%	 	 	N/A	 
	Tao Ain
	 	 	 	 	 	 	 	 	 	 	1,186	 	 	 	0.735	%	 	 	N/A	 
	Jeff Sandt
	 	 	 	 	 	 	 	 	 	 	1,186	 	 	 	0.735	%	 	 	N/A	 
	Geoff Doke
	 	 	 	 	 	 	 	 	 	 	1,186	 	 	 	0.735	%	 	 	N/A	 
	Dave Tate
	 	 	 	 	 	 	 	 	 	 	1,186	 	 	 	0.735	%	 	 	N/A	 
	Chris Johnson
	 	 	 	 	 	 	 	 	 	 	1,186	 	 	 	0.735	%	 	 	N/A	 
	Song De Shi
	 	 	 	 	 	 	 	 	 	 	1,186	 	 	 	0.735	%	 	 	N/A	 
	William Thomas
	 	 	 	 	 	 	 	 	 	 	1,186	 	 	 	0.735	%	 	 	N/A	 
	Al Barry
	 	 	 	 	 	 	 	 	 	 	593	 	 	 	0.368	%	 	 	N/A	 
	Primary Indemnitors
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Linda Swaldo
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	60.03	%
	William T. Blackerby, Jr.
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	6.67	%
	ACAS
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	33.30	%

 

			
	*	 	Both a Common Stock Seller and an Option Holder.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00131-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00131-of-00352.parquet"}]]